{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "3d48399a",
   "metadata": {},
   "outputs": [],
   "source": [
    "#importing all the dependencies packages\n",
    "import json\n",
    "import csv\n",
    "import nltk\n",
    "from nltk.corpus   import stopwords\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.tokenize import RegexpTokenizer\n",
    "from nltk.stem     import PorterStemmer\n",
    "from nltk.stem     import WordNetLemmatizer\n",
    "from nltk.stem.lancaster import LancasterStemmer\n",
    "import string\n",
    "import re\n",
    "import csv\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "st = LancasterStemmer()\n",
    "REPLACE_BY_SPACE_RE = re.compile('[/(){}\\[\\]\\|@,;]')\n",
    "BAD_SYMBOLS_RE = re.compile('[^0-9a-z #+_]')\n",
    "STOPWORDS = set(stopwords.words('english'))    \n",
    "def extract_documents(sentence1,productName):\n",
    "    #removing punctuations and stopwords to extract main relavant data\n",
    "    document_list = []\n",
    "    sentence1 = sentence1.lower() # lowercase text\n",
    "    sentence1 = REPLACE_BY_SPACE_RE.sub(' ', sentence1) # replace REPLACE_BY_SPACE_RE symbols by space in text. substitute the matched string in REPLACE_BY_SPACE_RE with space.\n",
    "    sentence1 = BAD_SYMBOLS_RE.sub('', sentence1) # remove symbols which are in BAD_SYMBOLS_RE from text. substitute the matched string in BAD_SYMBOLS_RE with nothing. \n",
    "    sentence1 = sentence1.replace('x', '')\n",
    "    sentence1 = ' '.join(word for word in sentence1.split() if word not in STOPWORDS) # remove stopwords from text\n",
    "    extracted_words_from_sentence = set()\n",
    "    \n",
    "    for key in end_json:\n",
    "        for word in end_json[key]:\n",
    "            pattern = r\"\\b\" + re.escape(word) + r\"\\b\"\n",
    "            match = re.search(pattern, sentence1)\n",
    "            if match:\n",
    "                extracted_words_from_sentence.add(key)\n",
    "#     print(\"words from sentence\")\n",
    "#     print(extracted_words_from_sentence)\n",
    "    #comparisions based on products\n",
    "    df = pd.read_excel (r'./test_sample_1.xlsx')\n",
    "    data = df[['Keywords (m)','Product','Document Name','DOC ID']]\n",
    "    data = data.sort_values(by=['Product'])\n",
    "    data = data.dropna()\n",
    "    data = data.replace(r'^\\s*$', np.nan, regex=True)\n",
    "    data['Product'] = data['Product'].apply(str.lower)\n",
    "    data['extracted_words'] = str(extracted_words_from_sentence)\n",
    "    data['Keywords (m)'] = data['Keywords (m)'].str.lower()\n",
    "    data = data[data.Product.str.contains('none|n/a|no data|nan')==False]\n",
    "    data = data[data.Product.str.contains(str(productName).lower())]\n",
    "    data['new_keywords'] = ''\n",
    "    data['score']=0.0\n",
    "    #importing the keywords excel for comparision\n",
    "    for sent in data['Keywords (m)']:\n",
    "        t = re.sub(r'\\s*,\\s*',',',str(sent))\n",
    "        data['Keywords (m)'] = data['Keywords (m)'].replace([sent],t)\n",
    "    for idx1,sentence2 in data['Keywords (m)'].iteritems():\n",
    "        string_words_new = ''\n",
    "        extracted_words_from_key_words = set()\n",
    "        if str(sentence2).lower() not in ('nan','n/a','none','no data'):\n",
    "            for key in end_json:\n",
    "                for word in end_json[key]:\n",
    "                    new_sentence_split = np.array(sentence2.split(','))\n",
    "                    if word in new_sentence_split:\n",
    "                        extracted_words_from_key_words.add(key)\n",
    "            for val in extracted_words_from_key_words:\n",
    "                string_words_new = string_words_new+ ',' + val\n",
    "            data.at[idx1, 'new_keywords'] = string_words_new\n",
    "    for idx,sentence in data['new_keywords'].iteritems():\n",
    "        if str(sentence).lower() not in ('nan','n/a','none','no data','','[none]'):\n",
    "            array_toCompare = np.array(sentence.split(','))\n",
    "            flt_sent2 = [w for w in array_toCompare if not w.lower() in STOPWORDS and w not in string.punctuation and w not in ('nan','n/a','none','no data','','[none]')]\n",
    "            ac = [x.lower() for x in flt_sent2]\n",
    "            common_elements = list(extracted_words_from_sentence.intersection(ac))\n",
    "            union_elements = list(set(extracted_words_from_sentence).union(set(ac)))\n",
    "            #Calculating the score\n",
    "            score = len(common_elements)/len(union_elements)*100\n",
    "            data.at[idx, 'score'] = score\n",
    "    data.to_csv('pavan.csv')\n",
    "    df_final = data.nlargest(3, 'score')\n",
    "    result_final_output = df_final.to_json(orient=\"records\")\n",
    "    #result_final_json_output = json.loads(result_final_output)\n",
    "    return result_final_output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "8210d040",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "words from sentence\n",
      "{'needles', 'gastric', 'post', 'information', 'regain', 'allergy', 'gastroparesis', 'bypass', 'weight', 'glp-1', 'gastric bypass'}\n",
      "[]\n",
      "[]\n"
     ]
    }
   ],
   "source": [
    "output_sentence = extract_documents(\"Provider wants to know if novo needles contain nickel for patient that has nickel allergy Also, wants information on GLP-1 and gastroparesis in the setting of post gastric bypass in the setting of weight regain\",\"General-Obesity\")\n",
    "print(output_sentence)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "4b15d3b5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'overview,approval,summary', 'Product': 'wegovy', 'Document Name': 'Approval and Product Overview (SEOB 010) (v3.0)', 'DOC ID': 'SEOB 010', 'extracted_words': \"{'dr', 'available', 'overview'}\", 'new_keywords': ',summary,approval,overview', 'score': 20.0}, {'Keywords (m)': 'medicaid,formulary,summary,overview', 'Product': 'wegovy', 'Document Name': 'Wegovy Medicaid Summary (SEOB 400) (v2.0)', 'DOC ID': 'SEOB 400', 'extracted_words': \"{'dr', 'available', 'overview'}\", 'new_keywords': ',medicaid,summary,formulary,overview', 'score': 16.6666666667}, {'Keywords (m)': 'step,overview,slide,clinical,pi', 'Product': 'wegovy', 'Document Name': 'Clinical Overview of Wegovy (SEOB 601) (v1.0)', 'DOC ID': 'SEOB 601', 'extracted_words': \"{'dr', 'available', 'overview'}\", 'new_keywords': ',step,slide,clinical,pi,overview', 'score': 14.2857142857}]\n",
      "[{'Keywords (m)': 'hypoglycemia,hypo,safety', 'Product': 'ozempic', 'Document Name': 'Hypoglycemia (SEM 120) (v9.0)', 'DOC ID': 'SEM 120', 'extracted_words': \"{'study', 'tumor', '2', 'type 2', 'ozempic', 'safety', 'diabetes', 'start', 'pancreas', 'type 2 diabetes', 'benign'}\", 'new_keywords': ',hypo,hypoglycemia,safety', 'score': 7.6923076923}, {'Keywords (m)': 'type 1,diabetes,t1dm,t1d', 'Product': 'ozempic', 'Document Name': 'Type 1 Diabetes (SEM 090) (v12.0)', 'DOC ID': 'SEM 090', 'extracted_words': \"{'study', 'tumor', '2', 'type 2', 'ozempic', 'safety', 'diabetes', 'start', 'pancreas', 'type 2 diabetes', 'benign'}\", 'new_keywords': ',diabetes,t1dm,t1d,type 1', 'score': 7.1428571429}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'tumor', '2', 'type 2', 'ozempic', 'safety', 'diabetes', 'start', 'pancreas', 'type 2 diabetes', 'benign'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 7.1428571429}]\n",
      "[{'Keywords (m)': 'long-term,longest,duration,longer,time', 'Product': 'ozempic', 'Document Name': 'Long-Term Data (SEM 174) (v5.0)', 'DOC ID': 'SEM 174', 'extracted_words': \"{'2', 'type 2', 'long', 'cancer', 'ozempic', 'longterm', 'long term', 'risk', 'diabetes', 'use', 'type 2 diabetes', 'longest', 'term'}\", 'new_keywords': ',time,duration,longterm,long-term,longest', 'score': 12.5}, {'Keywords (m)': 'neoplasms,cancer,neoplasm', 'Product': 'ozempic', 'Document Name': 'Neoplasms  (SEM 134) (v7.0)', 'DOC ID': 'SEM 134', 'extracted_words': \"{'2', 'type 2', 'long', 'cancer', 'ozempic', 'longterm', 'long term', 'risk', 'diabetes', 'use', 'type 2 diabetes', 'longest', 'term'}\", 'new_keywords': ',neoplasm,cancer', 'score': 7.1428571429}, {'Keywords (m)': 'prevention,cardiovascular,mace,cv,risk,', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-Primary vs. Secondary Prevention (SEM 167) (v5.0)', 'DOC ID': 'SEM 167', 'extracted_words': \"{'2', 'type 2', 'long', 'cancer', 'ozempic', 'longterm', 'long term', 'risk', 'diabetes', 'use', 'type 2 diabetes', 'longest', 'term'}\", 'new_keywords': ',cardiovascular,mace,prevention,risk', 'score': 6.25}]\n",
      "[{'Keywords (m)': 'clinical,overview,slide,slides,deck', 'Product': 'ozempic', 'Document Name': 'Clinical Overview of Ozempic (SEM 601) (v4.0)', 'DOC ID': 'SEM 601', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',clinical,deck,slide,overview', 'score': 40.0}, {'Keywords (m)': 'sustain,overview,slide,slides,clinical', 'Product': 'ozempic', 'Document Name': 'Cover to Ozempic Clinical Overview Deck (SEM 600) (v5.0)', 'DOC ID': 'SEM 600', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',sustain,clinical,slide,overview', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'clinical,overview,slide,slides,deck', 'Product': 'ozempic', 'Document Name': 'Clinical Overview of Ozempic (SEM 601) (v4.0)', 'DOC ID': 'SEM 601', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',clinical,deck,slide,overview', 'score': 40.0}, {'Keywords (m)': 'sustain,overview,slide,slides,clinical', 'Product': 'ozempic', 'Document Name': 'Cover to Ozempic Clinical Overview Deck (SEM 600) (v5.0)', 'DOC ID': 'SEM 600', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',sustain,clinical,slide,overview', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'slide', 'deck', 'ozempic'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'mechanism,weight,weight loss', 'Product': 'ozempic', 'Document Name': 'Mechanism of Weight Loss (SEM 141) (v6.0)', 'DOC ID': 'SEM 141', 'extracted_words': \"{'effect', 'data', 'ozempic', 'weight loss', 'weight'}\", 'new_keywords': ',weight loss,mechanism,weight', 'score': 33.3333333333}, {'Keywords (m)': 'weight,victoza', 'Product': 'ozempic', 'Document Name': 'Weight vs. Victoza (SEM 142) (v6.0)', 'DOC ID': 'SEM 142', 'extracted_words': \"{'effect', 'data', 'ozempic', 'weight loss', 'weight'}\", 'new_keywords': ',weight,victoza', 'score': 16.6666666667}, {'Keywords (m)': 'obesity,weight', 'Product': 'ozempic', 'Document Name': 'Obesity Indication (SEM 155) (v13.0)', 'DOC ID': 'SEM 155', 'extracted_words': \"{'effect', 'data', 'ozempic', 'weight loss', 'weight'}\", 'new_keywords': ',weight,obesity', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'gastrointestinal,gi,management,ae', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Management of GI Adverse Events (GLP1 014) (v1.0)', 'DOC ID': 'GLP1 014', 'extracted_words': \"{'tumor', 'data', 'ozempic', 'tumors', 'use', 'gi'}\", 'new_keywords': ',management,gi,ae', 'score': 12.5}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'tumor', 'data', 'ozempic', 'tumors', 'use', 'gi'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 11.1111111111}, {'Keywords (m)': 'gi,gastrointestinal,safety,ae,adverse events', 'Product': 'ozempic', 'Document Name': 'GI Adverse Events (SEM 005) (v11.0)', 'DOC ID': 'SEM 005', 'extracted_words': \"{'tumor', 'data', 'ozempic', 'tumors', 'use', 'gi'}\", 'new_keywords': ',ae,gi,safety,adverse event', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'dr', 'pen', 'ozempic', 'pens'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 14.2857142857}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'dr', 'pen', 'ozempic', 'pens'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 11.1111111111}, {'Keywords (m)': 'pen,device,pen overview,device overview,dosing,volume,dose,flextouch,flexpen', 'Product': 'ozempic', 'Document Name': 'Pen Overview (SEM 028) (v10.0)', 'DOC ID': 'SEM 028', 'extracted_words': \"{'dr', 'pen', 'ozempic', 'pens'}\", 'new_keywords': ',pen overview,volume,dose,device,flexpen,pen,device overview,flextouch', 'score': 9.0909090909}]\n",
      "[{'Keywords (m)': 'renal,kidney,outcomes,creatinine,uar,scr,glomerular,gfr', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Renal Outcomes (GLP1 012) (v2.0)', 'DOC ID': 'GLP1 012', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,scr,outcomes,renal,gfr,kidney,uar,glomerular', 'score': 12.5}, {'Keywords (m)': 'renal,kidney,dialysis,esrd,gfr,egfr,creatinine,clearance,crcl,nephrotic,transplant', 'Product': 'ozempic', 'Document Name': 'Renal Impairment (SEM 125) (v13.0)', 'DOC ID': 'SEM 125', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,clearance,nephrotic,dialysis,renal,gfr,kidney,egfr,transplant,crcl,esrd', 'score': 10.5263157895}, {'Keywords (m)': 'hypoglycemia,hypo,safety', 'Product': 'ozempic', 'Document Name': 'Hypoglycemia (SEM 120) (v9.0)', 'DOC ID': 'SEM 120', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',hypo,hypoglycemia,safety', 'score': 8.3333333333}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'renal,kidney,outcomes,creatinine,uar,scr,glomerular,gfr', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Renal Outcomes (GLP1 012) (v2.0)', 'DOC ID': 'GLP1 012', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,scr,outcomes,renal,gfr,kidney,uar,glomerular', 'score': 12.5}, {'Keywords (m)': 'renal,kidney,dialysis,esrd,gfr,egfr,creatinine,clearance,crcl,nephrotic,transplant', 'Product': 'ozempic', 'Document Name': 'Renal Impairment (SEM 125) (v13.0)', 'DOC ID': 'SEM 125', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,clearance,nephrotic,dialysis,renal,gfr,kidney,egfr,transplant,crcl,esrd', 'score': 10.5263157895}, {'Keywords (m)': 'hypoglycemia,hypo,safety', 'Product': 'ozempic', 'Document Name': 'Hypoglycemia (SEM 120) (v9.0)', 'DOC ID': 'SEM 120', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',hypo,hypoglycemia,safety', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'renal,kidney,outcomes,creatinine,uar,scr,glomerular,gfr', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Renal Outcomes (GLP1 012) (v2.0)', 'DOC ID': 'GLP1 012', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,scr,outcomes,renal,gfr,kidney,uar,glomerular', 'score': 12.5}, {'Keywords (m)': 'renal,kidney,dialysis,esrd,gfr,egfr,creatinine,clearance,crcl,nephrotic,transplant', 'Product': 'ozempic', 'Document Name': 'Renal Impairment (SEM 125) (v13.0)', 'DOC ID': 'SEM 125', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',creatinine,clearance,nephrotic,dialysis,renal,gfr,kidney,egfr,transplant,crcl,esrd', 'score': 10.5263157895}, {'Keywords (m)': 'hypoglycemia,hypo,safety', 'Product': 'ozempic', 'Document Name': 'Hypoglycemia (SEM 120) (v9.0)', 'DOC ID': 'SEM 120', 'extracted_words': \"{'level', 'overall', 'send', 'function', 'impact', 'creatinine', 'vs', 'hypoglycemia', 'kidney', 'information'}\", 'new_keywords': ',hypo,hypoglycemia,safety', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'weight', 'weight loss', 'wegovy', 'information'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 14.2857142857}, {'Keywords (m)': 'surmount,weight,gip,glp-1,glp1,tirzepatide,mounjaro,gip', 'Product': 'wegovy', 'Document Name': 'vs tirzepatide (SEOB 063) (v3.0)', 'DOC ID': 'SEOB 063', 'extracted_words': \"{'weight', 'weight loss', 'wegovy', 'information'}\", 'new_keywords': ',tirzepatide,mounjaro,gip,weight,glp-1,surmount', 'score': 11.1111111111}, {'Keywords (m)': 'mtc,men 2,anti-obesity,glp-1 ras,wegovy,saxenda,aom', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'MTC (Medullary Thyroid Carcinoma) (GOBS 003) (v1.0)', 'DOC ID': 'GOBS 003', 'extracted_words': \"{'weight', 'weight loss', 'wegovy', 'information'}\", 'new_keywords': ',anti-obesity,men 2,wegovy,saxenda,aom,mtc,glp-1 ras', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'use', 'rybelsus', 'allergy'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 16.6666666667}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'use', 'rybelsus', 'allergy'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 14.2857142857}, {'Keywords (m)': 'allergic,allergy,hypersensitivity,sensitivity,anaphylaxis,anaphylactic,urticaria,rash,immunogenic,immunogenicity', 'Product': 'rybelsus', 'Document Name': 'Allergic Reactions (OSEM 044) (v8.0)', 'DOC ID': 'OSEM 044', 'extracted_words': \"{'use', 'rybelsus', 'allergy'}\", 'new_keywords': ',immunogenic,hypersensitivity,anaphylaxis,anaphylactic,allergy,urticaria,sensitivity,rash', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 12.5}, {'Keywords (m)': 'heart,failure,hospitalization,chf,hf,nyha,', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-Heart Failure (SEM 163) (v7.0)', 'DOC ID': 'SEM 163', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',hf,nyha,heart,hospitalization,chf,failure', 'score': 10.0}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 12.5}, {'Keywords (m)': 'heart,failure,hospitalization,chf,hf,nyha,', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-Heart Failure (SEM 163) (v7.0)', 'DOC ID': 'SEM 163', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',hf,nyha,heart,hospitalization,chf,failure', 'score': 10.0}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'data', 'ozempic', 'send', 'gfr', 'chf'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'rationale,dosing,dose,qw,week', 'Product': 'wegovy', 'Document Name': 'Rationale for QW Dosing (SEOB 002) (v8.0)', 'DOC ID': 'SEOB 002', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',qw,rationale,week,dose', 'score': 12.5}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'rationale,dosing,dose,qw,week', 'Product': 'wegovy', 'Document Name': 'Rationale for QW Dosing (SEOB 002) (v8.0)', 'DOC ID': 'SEOB 002', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',qw,rationale,week,dose', 'score': 12.5}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'rationale,dosing,dose,qw,week', 'Product': 'wegovy', 'Document Name': 'Rationale for QW Dosing (SEOB 002) (v8.0)', 'DOC ID': 'SEOB 002', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',qw,rationale,week,dose', 'score': 12.5}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'rationale,dosing,dose,qw,week', 'Product': 'wegovy', 'Document Name': 'Rationale for QW Dosing (SEOB 002) (v8.0)', 'DOC ID': 'SEOB 002', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',qw,rationale,week,dose', 'score': 12.5}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'move', 'week', 'send', 'mi', 'request'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'antibody,antibodies,immunogenicity', 'Product': 'ozempic', 'Document Name': 'Antibodies (SEM 007) (v8.0)', 'DOC ID': 'SEM 007', 'extracted_words': \"{'level', 'high', 'ozempic', 'antibody'}\", 'new_keywords': ',immunogenic,antibody', 'score': 20.0}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'level', 'high', 'ozempic', 'antibody'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 14.2857142857}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'level', 'high', 'ozempic', 'antibody'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'sustain,overview,slide,slides,clinical', 'Product': 'ozempic', 'Document Name': 'Cover to Ozempic Clinical Overview Deck (SEM 600) (v5.0)', 'DOC ID': 'SEM 600', 'extracted_words': \"{'slide', 'data', 'ozempic', 'program', 'a1c', 'hemoglobin', 'hemoglobin a1c', 'last', 'speaker'}\", 'new_keywords': ',sustain,clinical,slide,overview', 'score': 8.3333333333}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'slide', 'data', 'ozempic', 'program', 'a1c', 'hemoglobin', 'hemoglobin a1c', 'last', 'speaker'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 8.3333333333}, {'Keywords (m)': 'clinical,overview,slide,slides,deck', 'Product': 'ozempic', 'Document Name': 'Clinical Overview of Ozempic (SEM 601) (v4.0)', 'DOC ID': 'SEM 601', 'extracted_words': \"{'slide', 'data', 'ozempic', 'program', 'a1c', 'hemoglobin', 'hemoglobin a1c', 'last', 'speaker'}\", 'new_keywords': ',clinical,deck,slide,overview', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'neoplasm,safety,neoplasms', 'Product': 'saxenda', 'Document Name': 'Neoplasms (SAX 104) (v3.0)', 'DOC ID': 'SAX 104', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',neoplasm,safety', 'score': 16.6666666667}, {'Keywords (m)': 'adverse,events,safety', 'Product': 'saxenda', 'Document Name': 'Adverse Events-Clinical Trials (SAX 027) (v6.0)', 'DOC ID': 'SAX 027', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',events,adverse,safety', 'score': 14.2857142857}, {'Keywords (m)': 'cancer,tumor,oncology,neoplasm,carcinoma,breast', 'Product': 'saxenda', 'Document Name': 'Breast Neoplasms (SAX 010) (v7.0)', 'DOC ID': 'SAX 010', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',tumor,breast,cancer,neoplasm,oncology,carcinoma', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'neoplasm,safety,neoplasms', 'Product': 'saxenda', 'Document Name': 'Neoplasms (SAX 104) (v3.0)', 'DOC ID': 'SAX 104', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',neoplasm,safety', 'score': 16.6666666667}, {'Keywords (m)': 'adverse,events,safety', 'Product': 'saxenda', 'Document Name': 'Adverse Events-Clinical Trials (SAX 027) (v6.0)', 'DOC ID': 'SAX 027', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',events,adverse,safety', 'score': 14.2857142857}, {'Keywords (m)': 'cancer,tumor,oncology,neoplasm,carcinoma,breast', 'Product': 'saxenda', 'Document Name': 'Breast Neoplasms (SAX 010) (v7.0)', 'DOC ID': 'SAX 010', 'extracted_words': \"{'cancer', 'safety', 'dr', 'papillary', 'follicular'}\", 'new_keywords': ',tumor,breast,cancer,neoplasm,oncology,carcinoma', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'swelling', 'injection', 'female', 'ozempic'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 14.2857142857}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'swelling', 'injection', 'female', 'ozempic'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 11.1111111111}, {'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'swelling', 'injection', 'female', 'ozempic'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 7.6923076923}]\n",
      "[{'Keywords (m)': 'click,clicks,unmarked dosing,pen,marked,unmarked,increment,dosing,dial,dose,doses', 'Product': 'ozempic', 'Document Name': 'Pen-Dosing by Clicks (SEM 173) (v4.0)', 'DOC ID': 'SEM 173', 'extracted_words': \"{'click'}\", 'new_keywords': ',unmarked dosing,increment,click,unmarked,dose,dial,marked,pen', 'score': 12.5}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'click'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, ozempic, rybelsus', 'Document Name': 'NIOSH Classification (Sema) (SEM 300) (v6.0)', 'DOC ID': 'SEM 300', 'extracted_words': \"{'click'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'exercise,dosing,physical activity', 'Product': 'rybelsus', 'Document Name': 'Dosing-Impact of Exercise (OSEM 091) (v6.0)', 'DOC ID': 'OSEM 091', 'extracted_words': \"{'data', 'rybelsus', 'question', 'dose', 'low', 'start', 'metformin'}\", 'new_keywords': ',physical activity,exercise,dose', 'score': 11.1111111111}, {'Keywords (m)': '3 mg,initiation,starting,starter', 'Product': 'rybelsus', 'Document Name': '3 mg Safety and Efficacy (OSEM 053) (v12.0)', 'DOC ID': 'OSEM 053', 'extracted_words': \"{'data', 'rybelsus', 'question', 'dose', 'low', 'start', 'metformin'}\", 'new_keywords': ',start,initiation,3 mg', 'score': 11.1111111111}, {'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'data', 'rybelsus', 'question', 'dose', 'low', 'start', 'metformin'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 10.0}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 12.5}, {'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 12.5}, {'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'study', 'ozempic', 'information'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'switching,switch,wegovy,semaglutide', 'Product': 'saxenda', 'Document Name': 'Switching from GLP-1 RAs (SAX 102) (v5.0)', 'DOC ID': 'SAX 102', 'extracted_words': \"{'recommendation', 'compatible', 'switching', 'wegovy', 'dose'}\", 'new_keywords': ',switching,semaglutide,wegovy,switch', 'score': 28.5714285714}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'recommendation', 'compatible', 'switching', 'wegovy', 'dose'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 12.5}, {'Keywords (m)': 'mtc,men 2,anti-obesity,glp-1 ras,wegovy,saxenda,aom', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'MTC (Medullary Thyroid Carcinoma) (GOBS 003) (v1.0)', 'DOC ID': 'GOBS 003', 'extracted_words': \"{'recommendation', 'compatible', 'switching', 'wegovy', 'dose'}\", 'new_keywords': ',anti-obesity,men 2,wegovy,saxenda,aom,mtc,glp-1 ras', 'score': 9.0909090909}]\n",
      "[{'Keywords (m)': 'weight,victoza', 'Product': 'ozempic', 'Document Name': 'Weight vs. Victoza (SEM 142) (v6.0)', 'DOC ID': 'SEM 142', 'extracted_words': \"{'transition', 'ozempic', 'victoza'}\", 'new_keywords': ',weight,victoza', 'score': 25.0}, {'Keywords (m)': 'structure,victoza', 'Product': 'ozempic', 'Document Name': 'Structure vs Victoza  (SEM 129) (v6.0)', 'DOC ID': 'SEM 129', 'extracted_words': \"{'transition', 'ozempic', 'victoza'}\", 'new_keywords': ',structure,victoza', 'score': 25.0}, {'Keywords (m)': 'victoza,liraglutide,sustain 10', 'Product': 'ozempic', 'Document Name': 'vs Victoza (SEM 116) (v11.0)', 'DOC ID': 'SEM 116', 'extracted_words': \"{'transition', 'ozempic', 'victoza'}\", 'new_keywords': ',liraglutide,sustain 10,victoza', 'score': 20.0}]\n",
      "[{'Keywords (m)': 'step', 'Product': 'wegovy', 'Document Name': 'Media-STEP 1 Video (SEOB 3001) (v1.0)', 'DOC ID': 'SEOB 3001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step', 'score': 25.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 14.2857142857}, {'Keywords (m)': 'step,sustain,forte,diabetes,t2d', 'Product': 'ozempic, wegovy', 'Document Name': 'STEP 2 vs SUSTAIN FORTE (SEOB 057) (v1.0)', 'DOC ID': 'SEOB 057', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step,forte,t2d,sustain,diabetes', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'step', 'Product': 'wegovy', 'Document Name': 'Media-STEP 1 Video (SEOB 3001) (v1.0)', 'DOC ID': 'SEOB 3001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step', 'score': 25.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 14.2857142857}, {'Keywords (m)': 'step,sustain,forte,diabetes,t2d', 'Product': 'ozempic, wegovy', 'Document Name': 'STEP 2 vs SUSTAIN FORTE (SEOB 057) (v1.0)', 'DOC ID': 'SEOB 057', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step,forte,t2d,sustain,diabetes', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'step', 'Product': 'wegovy', 'Document Name': 'Media-STEP 1 Video (SEOB 3001) (v1.0)', 'DOC ID': 'SEOB 3001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step', 'score': 25.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 14.2857142857}, {'Keywords (m)': 'step,sustain,forte,diabetes,t2d', 'Product': 'ozempic, wegovy', 'Document Name': 'STEP 2 vs SUSTAIN FORTE (SEOB 057) (v1.0)', 'DOC ID': 'SEOB 057', 'extracted_words': \"{'trials', 'trial', 'step', 'wegovy'}\", 'new_keywords': ',step,forte,t2d,sustain,diabetes', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'bariatric,gastric,bypass,sleeve,surgery', 'Product': 'ozempic', 'Document Name': 'Bariatric Surgery (SEM 154) (v6.0)', 'DOC ID': 'SEM 154', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',gastric,bariatric,surgery,bypass,sleeve', 'score': 27.2727272727}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 8.3333333333}, {'Keywords (m)': 'surgery,operation,pre-op,npo,procedure,anesthesia', 'Product': 'ozempic', 'Document Name': 'Surgery (SEM 160) (v4.0)', 'DOC ID': 'SEM 160', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',npo,operation,surgery,procedure,anesthesia,pre-op', 'score': 7.1428571429}]\n",
      "[{'Keywords (m)': 'bariatric,gastric,bypass,sleeve,surgery', 'Product': 'ozempic', 'Document Name': 'Bariatric Surgery (SEM 154) (v6.0)', 'DOC ID': 'SEM 154', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',gastric,bariatric,surgery,bypass,sleeve', 'score': 27.2727272727}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 8.3333333333}, {'Keywords (m)': 'surgery,operation,pre-op,npo,procedure,anesthesia', 'Product': 'ozempic', 'Document Name': 'Surgery (SEM 160) (v4.0)', 'DOC ID': 'SEM 160', 'extracted_words': \"{'study', 'gastric', 'ozempic', 'information', 'rybelsus', 'dr', 'surgery', 'bypass', 'gastric bypass'}\", 'new_keywords': ',npo,operation,surgery,procedure,anesthesia,pre-op', 'score': 7.1428571429}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'renal,kidney,dialysis,esrd,gfr,egfr,creatinine,clearance,crcl,nephrotic,transplant', 'Product': 'ozempic', 'Document Name': 'Renal Impairment (SEM 125) (v13.0)', 'DOC ID': 'SEM 125', 'extracted_words': \"{'2', 'type 2', 'ozempic', 'dialysis', 'egfr'}\", 'new_keywords': ',creatinine,clearance,nephrotic,dialysis,renal,gfr,kidney,egfr,transplant,crcl,esrd', 'score': 14.2857142857}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'2', 'type 2', 'ozempic', 'dialysis', 'egfr'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 12.5}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'2', 'type 2', 'ozempic', 'dialysis', 'egfr'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'thyroid,neoplasms,carcinoma,cancer,thyroid cancer,ptc,papillary thyroid carcinoma,mtc,medullary thyroid carcinoma,men2,men 2,multiple endocrine neoplasia syndrome type 2,neoplasia,follicular thyroid cancer,ftc', 'Product': 'ozempic', 'Document Name': 'Thyroid Neoplasms (SEM 016) (v10.0)', 'DOC ID': 'SEM 016', 'extracted_words': \"{'cancer', 'ozempic', 'dr', 'thyroid cancer', 'thyroid', 'information'}\", 'new_keywords': ',cancer,ptc,men 2,multiple endocrine neoplasia syndrome type 2,men2,neoplasm,mtc,ftc,neoplasia,thyroid cancer,medullary thyroid carcinoma,thyroid,follicular thyroid cancer,papillary thyroid carcinoma,carcinoma', 'score': 16.6666666667}, {'Keywords (m)': 'neoplasms,cancer,neoplasm', 'Product': 'ozempic', 'Document Name': 'Neoplasms  (SEM 134) (v7.0)', 'DOC ID': 'SEM 134', 'extracted_words': \"{'cancer', 'ozempic', 'dr', 'thyroid cancer', 'thyroid', 'information'}\", 'new_keywords': ',neoplasm,cancer', 'score': 14.2857142857}, {'Keywords (m)': 'thyroid cancer,hypothyroidism,hyperthyroidism,goiter,thyroid,nodules,thyroidectomy,ptc,papillary thyroid carcinoma,mtc,medullary thyroid carcinoma,men2,men2,multiple endocrine neoplasia syndrome type 2', 'Product': 'ozempic', 'Document Name': 'Thyroid Conditions (SEM 012) (v5.0)', 'DOC ID': 'SEM 012', 'extracted_words': \"{'cancer', 'ozempic', 'dr', 'thyroid cancer', 'thyroid', 'information'}\", 'new_keywords': ',hypothyroidism,goiter,ptc,multiple endocrine neoplasia syndrome type 2,thyroidectomy,men2,nodules,hyperthyroidism,mtc,thyroid cancer,medullary thyroid carcinoma,thyroid,papillary thyroid carcinoma', 'score': 11.7647058824}]\n",
      "[{'Keywords (m)': 'thyroid,thyroid neoplasms,mtc,men 2,calcitonin', 'Product': 'saxenda', 'Document Name': 'Thyroid Neoplasms (SAX 018) (v1.0)', 'DOC ID': 'SAX 018', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',men 2,calcitonin,mtc,thyroid,thyroid neoplasms', 'score': 12.5}, {'Keywords (m)': 'cancer,tumor,oncology,neoplasm,carcinoma,breast', 'Product': 'saxenda', 'Document Name': 'Breast Neoplasms (SAX 010) (v7.0)', 'DOC ID': 'SAX 010', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',tumor,breast,cancer,neoplasm,oncology,carcinoma', 'score': 11.1111111111}, {'Keywords (m)': 'pancreas,cancer,pancreatic,tumor,oncology,neoplasm,carcinoma', 'Product': 'saxenda', 'Document Name': 'Pancreatic Cancer (SAX 015) (v7.0)', 'DOC ID': 'SAX 015', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',tumor,cancer,neoplasm,pancreas,pancreatic,oncology,carcinoma', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'switch,convert,glp-1,glucagon-like peptide-1,glp,conversion,switching,dosing,saxenda,victoza,liraglutide,exenatide,byetta,bydureon,dulaglutide,trulicity,lixisenatide,adlyxin,ozempic,rybelsus', 'Product': 'wegovy', 'Document Name': 'Switching to-from Other GLP-1 RAs (SEOB 121) (v2.0)', 'DOC ID': 'SEOB 121', 'extracted_words': \"{'switching', 'hcp'}\", 'new_keywords': ',victoza,glp,switching,saxenda,liraglutide,trulicity,dose,convert,dulaglutide,switch,rybelsus,byetta,exenatide,bydureon,glp-1,glucagon-like peptide-1,lixisenatide,ozempic,adlyxin,conversion', 'score': 4.7619047619}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'switching', 'hcp'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'switching', 'hcp'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'study', 'data', 'rybelsus', 'cardiovascular', 'information'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 25.0}, {'Keywords (m)': 'soul,cardiovascular outcomes,cv,ongoing', 'Product': 'rybelsus', 'Document Name': 'Rybelsus and the SOUL Trial (OSEM 139) (v2.0)', 'DOC ID': 'OSEM 139', 'extracted_words': \"{'study', 'data', 'rybelsus', 'cardiovascular', 'information'}\", 'new_keywords': ',cardiovascular outcomes,cardiovascular,ongoing,soul', 'score': 12.5}, {'Keywords (m)': 'cardiovascular,cvot,pioneer 6,p6,pioneer', 'Product': 'rybelsus', 'Document Name': 'Media-PIONEER 6 Video (OSEM 3006) (v2.0)', 'DOC ID': 'OSEM 3006', 'extracted_words': \"{'study', 'data', 'rybelsus', 'cardiovascular', 'information'}\", 'new_keywords': ',cardiovascular,pioneer,pioneer 6,cvot', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'rybelsus', 'information'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 20.0}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'rybelsus', 'information'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 16.6666666667}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, ozempic, rybelsus', 'Document Name': 'NIOSH Classification (Sema) (SEM 300) (v6.0)', 'DOC ID': 'SEM 300', 'extracted_words': \"{'rybelsus', 'information'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'ozempic,versus,vs', 'Product': 'wegovy', 'Document Name': 'vs Ozempic (SEOB 026) (v5.0)', 'DOC ID': 'SEOB 026', 'extracted_words': \"{'ozempic', 'wegovy', 'insurance', 'pen', 'cover', 'available'}\", 'new_keywords': ',vs,ozempic,versus', 'score': 12.5}, {'Keywords (m)': 'ozempic,switch,transition', 'Product': 'wegovy', 'Document Name': 'Switching from Ozempic (SEOB 065) (v7.0)', 'DOC ID': 'SEOB 065', 'extracted_words': \"{'ozempic', 'wegovy', 'insurance', 'pen', 'cover', 'available'}\", 'new_keywords': ',transition,ozempic,switch', 'score': 12.5}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'ozempic', 'wegovy', 'insurance', 'pen', 'cover', 'available'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'amcp,dossier,4 pg,norditropin', 'Product': 'norditropin', 'Document Name': 'Norditropin Medicaid Summary-4 page (GHC 401) (v4.0)', 'DOC ID': 'GHC 401', 'extracted_words': \"{'3', 'temperature', 'room', 'room temperature', 'past', 'use', 'norditropin'}\", 'new_keywords': ',norditropin,4 pg,dossier,amcp', 'score': 10.0}, {'Keywords (m)': 'amcp,summary,dossier,norditropin', 'Product': 'norditropin', 'Document Name': 'Norditropin Medicaid Summary - 1 page (GHC 400) (v4.0)', 'DOC ID': 'GHC 400', 'extracted_words': \"{'3', 'temperature', 'room', 'room temperature', 'past', 'use', 'norditropin'}\", 'new_keywords': ',norditropin,summary,dossier,amcp', 'score': 10.0}, {'Keywords (m)': 'in-use,storage,stability,expiration,fridge,frozen,freeze,heat,hot,refrigerate,refrigeration,refrigerator,stable,store,temp,temperature,unopen,unopened,warm,room,cool,stored', 'Product': 'norditropin', 'Document Name': 'Storage and Stability (GHC 002) (v5.0)', 'DOC ID': 'GHC 002', 'extracted_words': \"{'3', 'temperature', 'room', 'room temperature', 'past', 'use', 'norditropin'}\", 'new_keywords': ',refrigerator,temp,hot,temperature,freeze,warm,room,frozen,unopen,stored,expiration,fridge,heat,store,stable,cool,storage,in-use', 'score': 8.6956521739}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'soul,cardiovascular outcomes,cv,ongoing', 'Product': 'rybelsus', 'Document Name': 'Rybelsus and the SOUL Trial (OSEM 139) (v2.0)', 'DOC ID': 'OSEM 139', 'extracted_words': \"{'rybelsus', 'trial', 'soul', 'information'}\", 'new_keywords': ',cardiovascular outcomes,cardiovascular,ongoing,soul', 'score': 14.2857142857}, {'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'rybelsus', 'trial', 'soul', 'information'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 14.2857142857}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'rybelsus', 'trial', 'soul', 'information'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'data', 'rybelsus', 'trial', 'indication', 'diabetes', 'management', 'weight', 'obesity', 'trials'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 16.6666666667}, {'Keywords (m)': 'gastrointestinal,gi,management,ae', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Management of GI Adverse Events (GLP1 014) (v1.0)', 'DOC ID': 'GLP1 014', 'extracted_words': \"{'data', 'rybelsus', 'trial', 'indication', 'diabetes', 'management', 'weight', 'obesity', 'trials'}\", 'new_keywords': ',management,gi,ae', 'score': 9.0909090909}, {'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'data', 'rybelsus', 'trial', 'indication', 'diabetes', 'management', 'weight', 'obesity', 'trials'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'sustain,insulin,basal,glargine,degludec,lantus,tresiba,nph', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 5 (add on to basal insulin) (SEM 105) (v6.0)', 'DOC ID': 'SEM 105', 'extracted_words': \"{'basal insulin', 'insulin', 'ozempic', 'send', 'sustain', 'basal'}\", 'new_keywords': ',insulin,sustain,nph,glargine,tresiba,basal,lantus,degludec', 'score': 27.2727272727}, {'Keywords (m)': 'basal,insulin,glargine,lantus', 'Product': 'ozempic', 'Document Name': 'vs Basal insulin (SEM 113) (v7.0)', 'DOC ID': 'SEM 113', 'extracted_words': \"{'basal insulin', 'insulin', 'ozempic', 'send', 'sustain', 'basal'}\", 'new_keywords': ',glargine,insulin,lantus,basal', 'score': 25.0}, {'Keywords (m)': 'insulin,combination,glargine,degludec,tresiba,nph,lantus,basal,aspart,mdi,transition-t2d', 'Product': 'ozempic', 'Document Name': 'Combination with Insulin (SEM 121) (v7.0)', 'DOC ID': 'SEM 121', 'extracted_words': \"{'basal insulin', 'insulin', 'ozempic', 'send', 'sustain', 'basal'}\", 'new_keywords': ',insulin,aspart,nph,combination,glargine,tresiba,transition-t2d,basal,lantus,degludec,mdi', 'score': 13.3333333333}]\n",
      "[{'Keywords (m)': 'retinopathy,eye,drc,diabetic retinopathy complications,diabetic retinopathy,blindness,blind,vitreous hemorrhage,retina,visual,microvascular', 'Product': 'ozempic', 'Document Name': 'Retinopathy (SEM 004) (v16.0)', 'DOC ID': 'SEM 004', 'extracted_words': \"{'study', 'monitor', 'retinopathy', 'ongoing'}\", 'new_keywords': ',visual,microvascular,diabetic retinopathy,drc,blindness,blind,vitreous hemorrhage,retinopathy,eye,diabetic retinopathy complications,retina', 'score': 7.1428571429}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'study', 'monitor', 'retinopathy', 'ongoing'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, ozempic, rybelsus', 'Document Name': 'NIOSH Classification (Sema) (SEM 300) (v6.0)', 'DOC ID': 'SEM 300', 'extracted_words': \"{'study', 'monitor', 'retinopathy', 'ongoing'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'hepatic,liver,impairment,ast,alt,alanine aminotransferase,aspartate aminotransferase,hepatic enzymes', 'Product': 'ozempic', 'Document Name': 'Hepatic Function and Impairment (SEM 139) (v8.0)', 'DOC ID': 'SEM 139', 'extracted_words': \"{'impairment', 'liver', 'ozempic', 'cirrhosis'}\", 'new_keywords': ',hepatic enzymes,alt,ast,impairment,alanine aminotransferase,liver,aspartate aminotransferase,hepatic', 'score': 20.0}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'impairment', 'liver', 'ozempic', 'cirrhosis'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 14.2857142857}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'impairment', 'liver', 'ozempic', 'cirrhosis'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 't1d,type 1,insulin', 'Product': 'wegovy', 'Document Name': 'Type 1 Diabetes (SEOB 054) (v1.0)', 'DOC ID': 'SEOB 054', 'extracted_words': \"{'insulin', 'high', 'send', 'hcp', 'dialysis', 'use', 'pd', 'semaglutide', 'available', 'information'}\", 'new_keywords': ',insulin,t1d,type 1', 'score': 8.3333333333}, {'Keywords (m)': 'pharmacokinetics,pharmacodynamics,pk,pd', 'Product': 'wegovy', 'Document Name': 'PK-PD (SEOB 076) (v1.0)', 'DOC ID': 'SEOB 076', 'extracted_words': \"{'insulin', 'high', 'send', 'hcp', 'dialysis', 'use', 'pd', 'semaglutide', 'available', 'information'}\", 'new_keywords': ',pharmacodynamics,pd,pharmacokinetics', 'score': 8.3333333333}, {'Keywords (m)': 'hypoglycemia,glucose,sugar,sulfonylurea,insulin,secretagogue', 'Product': 'wegovy', 'Document Name': 'Hypoglycemia (SEOB 022) (v5.0)', 'DOC ID': 'SEOB 022', 'extracted_words': \"{'insulin', 'high', 'send', 'hcp', 'dialysis', 'use', 'pd', 'semaglutide', 'available', 'information'}\", 'new_keywords': ',insulin,sugar,glucose,hypoglycemia,sulfonylurea,secretagogue', 'score': 6.6666666667}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'medication', 'thyroid', 'administer', 'rybelsus'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 14.2857142857}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'medication', 'thyroid', 'administer', 'rybelsus'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 12.5}, {'Keywords (m)': 'synthroid,thyroid,levothyroxine,t3,t4,tsh', 'Product': 'rybelsus', 'Document Name': 'DDI Levothyroxine (OSEM 112) (v15.0)', 'DOC ID': 'OSEM 112', 'extracted_words': \"{'medication', 'thyroid', 'administer', 'rybelsus'}\", 'new_keywords': ',t4,levothyroxine,tsh,t3,thyroid,synthroid', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'ozempic', 'mi', 'rybelsus', 'response', 'nausea', 'compare'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 25.0}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'ozempic', 'mi', 'rybelsus', 'response', 'nausea', 'compare'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 22.2222222222}, {'Keywords (m)': 'ozempic,comparison,semaglutide injection,semaglutide sq,semaglutide sc,semaglutide subcutaneous,semaglutide comparison', 'Product': 'rybelsus', 'Document Name': 'vs Ozempic (OSEM 040) (v16.0)', 'DOC ID': 'OSEM 040', 'extracted_words': \"{'ozempic', 'mi', 'rybelsus', 'response', 'nausea', 'compare'}\", 'new_keywords': ',semaglutide subcutaneous,ozempic,semaglutide injection,semaglutide comparison,compare,semaglutide sc,semaglutide sq', 'score': 18.1818181818}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 10.0}, {'Keywords (m)': 'summary,overview,information,monograph', 'Product': 'saxenda', 'Document Name': 'Product Overview (SAX 025) (v7.0)', 'DOC ID': 'SAX 025', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',information,summary,overview,monograph', 'score': 10.0}, {'Keywords (m)': 'switching,switch,wegovy,semaglutide', 'Product': 'saxenda', 'Document Name': 'Switching from GLP-1 RAs (SAX 102) (v5.0)', 'DOC ID': 'SAX 102', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',switching,semaglutide,wegovy,switch', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 10.0}, {'Keywords (m)': 'summary,overview,information,monograph', 'Product': 'saxenda', 'Document Name': 'Product Overview (SAX 025) (v7.0)', 'DOC ID': 'SAX 025', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',information,summary,overview,monograph', 'score': 10.0}, {'Keywords (m)': 'switching,switch,wegovy,semaglutide', 'Product': 'saxenda', 'Document Name': 'Switching from GLP-1 RAs (SAX 102) (v5.0)', 'DOC ID': 'SAX 102', 'extracted_words': \"{'share', 'dr', 'wegovy', 'use', 'glp-1', 'nash', 'information'}\", 'new_keywords': ',switching,semaglutide,wegovy,switch', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'long-term,longest,duration,longer,long,step 5', 'Product': 'wegovy', 'Document Name': 'Long-Term Data (SEOB 088) (v3.0)', 'DOC ID': 'SEOB 088', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',long,step 5,duration,longterm,long-term,longest', 'score': 25.0}, {'Keywords (m)': 'step 5,long term,2 year,104 weeks,sustained', 'Product': 'wegovy', 'Document Name': 'Cover to STEP 5 (SEOB 105) (v2.0)', 'DOC ID': 'SEOB 105', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',sustained,step 5,longterm,long term,2 year,104 weeks', 'score': 15.3846153846}, {'Keywords (m)': 'cancer,neoplasm,pancreas,pancreatic', 'Product': 'wegovy', 'Document Name': 'Pancreatic Cancer (SEOB 021) (v4.0)', 'DOC ID': 'SEOB 021', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',neoplasm,cancer,pancreas,pancreatic', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'long-term,longest,duration,longer,long,step 5', 'Product': 'wegovy', 'Document Name': 'Long-Term Data (SEOB 088) (v3.0)', 'DOC ID': 'SEOB 088', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',long,step 5,duration,longterm,long-term,longest', 'score': 25.0}, {'Keywords (m)': 'step 5,long term,2 year,104 weeks,sustained', 'Product': 'wegovy', 'Document Name': 'Cover to STEP 5 (SEOB 105) (v2.0)', 'DOC ID': 'SEOB 105', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',sustained,step 5,longterm,long term,2 year,104 weeks', 'score': 15.3846153846}, {'Keywords (m)': 'cancer,neoplasm,pancreas,pancreatic', 'Product': 'wegovy', 'Document Name': 'Pancreatic Cancer (SEOB 021) (v4.0)', 'DOC ID': 'SEOB 021', 'extracted_words': \"{'long', 'longterm', 'long term', 'glp1-ra', 'pancreas', 'chronic', 'use', 'longest', 'term'}\", 'new_keywords': ',neoplasm,cancer,pancreas,pancreatic', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'type 1 diabetes mellitus,type 1 diabetes,type 1,t1d,t1dm', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Type 1 Diabetes (GLP1 008) (v3.0)', 'DOC ID': 'GLP1 008', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',t1dm,t1d,type 1', 'score': 20.0}, {'Keywords (m)': 'type 1,diabetes,t1dm,t1d', 'Product': 'ozempic', 'Document Name': 'Type 1 Diabetes (SEM 090) (v12.0)', 'DOC ID': 'SEM 090', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',diabetes,t1dm,t1d,type 1', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'type 1 diabetes mellitus,type 1 diabetes,type 1,t1d,t1dm', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Type 1 Diabetes (GLP1 008) (v3.0)', 'DOC ID': 'GLP1 008', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',t1dm,t1d,type 1', 'score': 20.0}, {'Keywords (m)': 'type 1,diabetes,t1dm,t1d', 'Product': 'ozempic', 'Document Name': 'Type 1 Diabetes (SEM 090) (v12.0)', 'DOC ID': 'SEM 090', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',diabetes,t1dm,t1d,type 1', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'study', 'ozempic', 'type 1'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'long-term,longest,duration,longer,long,step 5', 'Product': 'wegovy', 'Document Name': 'Long-Term Data (SEOB 088) (v3.0)', 'DOC ID': 'SEOB 088', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',long,step 5,duration,longterm,long-term,longest', 'score': 21.4285714286}, {'Keywords (m)': 'step 5,long term,2 year,104 weeks,sustained', 'Product': 'wegovy', 'Document Name': 'Cover to STEP 5 (SEOB 105) (v2.0)', 'DOC ID': 'SEOB 105', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',sustained,step 5,longterm,long term,2 year,104 weeks', 'score': 13.3333333333}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 7.1428571429}]\n",
      "[{'Keywords (m)': 'long-term,longest,duration,longer,long,step 5', 'Product': 'wegovy', 'Document Name': 'Long-Term Data (SEOB 088) (v3.0)', 'DOC ID': 'SEOB 088', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',long,step 5,duration,longterm,long-term,longest', 'score': 21.4285714286}, {'Keywords (m)': 'step 5,long term,2 year,104 weeks,sustained', 'Product': 'wegovy', 'Document Name': 'Cover to STEP 5 (SEOB 105) (v2.0)', 'DOC ID': 'SEOB 105', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',sustained,step 5,longterm,long term,2 year,104 weeks', 'score': 13.3333333333}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 7.1428571429}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'long-term,longest,duration,longer,long,step 5', 'Product': 'wegovy', 'Document Name': 'Long-Term Data (SEOB 088) (v3.0)', 'DOC ID': 'SEOB 088', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',long,step 5,duration,longterm,long-term,longest', 'score': 21.4285714286}, {'Keywords (m)': 'step 5,long term,2 year,104 weeks,sustained', 'Product': 'wegovy', 'Document Name': 'Cover to STEP 5 (SEOB 105) (v2.0)', 'DOC ID': 'SEOB 105', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',sustained,step 5,longterm,long term,2 year,104 weeks', 'score': 13.3333333333}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 7.1428571429}]\n",
      "[{'Keywords (m)': 'pediatrics,teens,adolescents,children,pediatric', 'Product': 'saxenda', 'Document Name': 'Pediatrics (SAX 047) (v9.0)', 'DOC ID': 'SAX 047', 'extracted_words': \"{'study', 'pediatric', 'data'}\", 'new_keywords': ',pediatric,adolescent,pediatrics,children,teens', 'score': 14.2857142857}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'study', 'pediatric', 'data'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, saxenda, victoza, xultophy 100/3.6', 'Document Name': 'NIOSH Classification (Lira) (GLP1 300) (v6.0)', 'DOC ID': 'GLP1 300', 'extracted_words': \"{'study', 'pediatric', 'data'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'cardiovascular,outcomes,cvd,cv,ascvd', 'Product': 'ozempic', 'Document Name': 'CV Outcomes (SEM 114) (v7.0)', 'DOC ID': 'SEM 114', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',ascvd,cardiovascular,cvd,outcomes', 'score': 14.2857142857}, {'Keywords (m)': 'kapitza,beta,insulin,response', 'Product': 'ozempic', 'Document Name': 'Cover to Kapitza et al. (Insulin Response) (SEM 151) (v5.0)', 'DOC ID': 'SEM 151', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',beta,insulin,kapitza,response', 'score': 14.2857142857}, {'Keywords (m)': 'verma,cv,cardiovascular,cvd,established cvd,cv risk factors,cvot,rewind', 'Product': 'ozempic, rybelsus', 'Document Name': 'Cover to Verma et al (REWIND CVD Post-hoc Analysis) (OSEM 084) (v4.0)', 'DOC ID': 'OSEM 084', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',cvot,cardiovascular,cvd,established cvd,cv risk factors,rewind,verma', 'score': 11.7647058824}]\n",
      "[{'Keywords (m)': 'cardiovascular,outcomes,cvd,cv,ascvd', 'Product': 'ozempic', 'Document Name': 'CV Outcomes (SEM 114) (v7.0)', 'DOC ID': 'SEM 114', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',ascvd,cardiovascular,cvd,outcomes', 'score': 14.2857142857}, {'Keywords (m)': 'kapitza,beta,insulin,response', 'Product': 'ozempic', 'Document Name': 'Cover to Kapitza et al. (Insulin Response) (SEM 151) (v5.0)', 'DOC ID': 'SEM 151', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',beta,insulin,kapitza,response', 'score': 14.2857142857}, {'Keywords (m)': 'verma,cv,cardiovascular,cvd,established cvd,cv risk factors,cvot,rewind', 'Product': 'ozempic, rybelsus', 'Document Name': 'Cover to Verma et al (REWIND CVD Post-hoc Analysis) (OSEM 084) (v4.0)', 'DOC ID': 'OSEM 084', 'extracted_words': \"{'insulin', '2', 'type 2', 'data', 'ozempic', 'a1c', 'cardiovascular', 'cvd', 'response', 'diabetes', 'type 2 diabetes', 'metformin'}\", 'new_keywords': ',cvot,cardiovascular,cvd,established cvd,cv risk factors,rewind,verma', 'score': 11.7647058824}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'ozempic', 'rybelsus', 'switching', 'maintenance', '7', 'dr', 'dose', 'information'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 12.5}, {'Keywords (m)': 'missed,change,missed,dose,dosing', 'Product': 'ozempic', 'Document Name': 'Dosing-Missed Dose (SEM 011) (v7.0)', 'DOC ID': 'SEM 011', 'extracted_words': \"{'ozempic', 'rybelsus', 'switching', 'maintenance', '7', 'dr', 'dose', 'information'}\", 'new_keywords': ',missed,change,dose', 'score': 10.0}, {'Keywords (m)': 'dosing,guidelines,guideline,missed dose', 'Product': 'ozempic', 'Document Name': 'Dosing-Guidelines (SEM 017) (v6.0)', 'DOC ID': 'SEM 017', 'extracted_words': \"{'ozempic', 'rybelsus', 'switching', 'maintenance', '7', 'dr', 'dose', 'information'}\", 'new_keywords': ',missed dose,guideline,guidelines,dose', 'score': 9.0909090909}]\n",
      "[{'Keywords (m)': 'pediatrics,teens,adolescents,children,pediatric', 'Product': 'saxenda', 'Document Name': 'Pediatrics (SAX 047) (v9.0)', 'DOC ID': 'SAX 047', 'extracted_words': \"{'pediatric', 'adolescent', 'medications', 'medication', 'weight', 'obesity'}\", 'new_keywords': ',pediatric,adolescent,pediatrics,children,teens', 'score': 22.2222222222}, {'Keywords (m)': 'adolescent,adolescents,teens', 'Product': 'saxenda', 'Document Name': 'Adolescents with Obesity (SCALE TEENS) (SAX 103) (v2.0)', 'DOC ID': 'SAX 103', 'extracted_words': \"{'pediatric', 'adolescent', 'medications', 'medication', 'weight', 'obesity'}\", 'new_keywords': ',teens,adolescent', 'score': 14.2857142857}, {'Keywords (m)': 'efficacy,weight,', 'Product': 'saxenda', 'Document Name': 'Weight (SAX 004) (v6.0)', 'DOC ID': 'SAX 004', 'extracted_words': \"{'pediatric', 'adolescent', 'medications', 'medication', 'weight', 'obesity'}\", 'new_keywords': ',efficacy,weight', 'score': 14.2857142857}]\n",
      "[{'Keywords (m)': 'regain', 'Product': 'saxenda', 'Document Name': 'Weight Regain After Discontinuation (SAX 051) (v5.0)', 'DOC ID': 'SAX 051', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',regain', 'score': 9.0909090909}, {'Keywords (m)': 'efficacy,weight,', 'Product': 'saxenda', 'Document Name': 'Weight (SAX 004) (v6.0)', 'DOC ID': 'SAX 004', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',efficacy,weight', 'score': 8.3333333333}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'data', 'long', 'regain', 'longterm', 'dr', 'wegovy', 'therapy', 'long term', 'weight', 'longest', 'term'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 7.1428571429}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'egfr', 'rybelsus', 'information', 'safety'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 33.3333333333}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'egfr', 'rybelsus', 'information', 'safety'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 12.5}, {'Keywords (m)': 'glp-1 ra,glucagon-like peptide,safety,hypoglycemia,gastrointestinal,glutide,exenatide,victoza,trulicity,byetta,bydureon,ozempic,adlyxin', 'Product': 'rybelsus', 'Document Name': 'Safety vs Other GLP-1 RAs (OSEM 086) (v5.0)', 'DOC ID': 'OSEM 086', 'extracted_words': \"{'egfr', 'rybelsus', 'information', 'safety'}\", 'new_keywords': ',ozempic,victoza,safety,byetta,exenatide,glp-1 ra,glucagon-like peptide,bydureon,glutide,adlyxin,trulicity,hypoglycemia,gi', 'score': 6.25}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'sustain,phase,trials,trial,clinical,overview', 'Product': 'ozempic', 'Document Name': 'SUSTAIN Overview (All Phase 3) (SEM 111) (v10.0)', 'DOC ID': 'SEM 111', 'extracted_words': \"{'data', 'clinical', 'ozempic', 'trial', 'retinopathy', 'diabetic retinopathy', 'hcp', 'diabetic', 'trials', 'information'}\", 'new_keywords': ',clinical,phase,trial,sustain,overview,trials', 'score': 23.0769230769}, {'Keywords (m)': 'retinopathy,eye,drc,diabetic retinopathy complications,diabetic retinopathy,blindness,blind,vitreous hemorrhage,retina,visual,microvascular', 'Product': 'ozempic', 'Document Name': 'Retinopathy (SEM 004) (v16.0)', 'DOC ID': 'SEM 004', 'extracted_words': \"{'data', 'clinical', 'ozempic', 'trial', 'retinopathy', 'diabetic retinopathy', 'hcp', 'diabetic', 'trials', 'information'}\", 'new_keywords': ',visual,microvascular,diabetic retinopathy,drc,blindness,blind,vitreous hemorrhage,retinopathy,eye,diabetic retinopathy complications,retina', 'score': 10.5263157895}, {'Keywords (m)': 'sustain,overview,slide,slides,clinical', 'Product': 'ozempic', 'Document Name': 'Cover to Ozempic Clinical Overview Deck (SEM 600) (v5.0)', 'DOC ID': 'SEM 600', 'extracted_words': \"{'data', 'clinical', 'ozempic', 'trial', 'retinopathy', 'diabetic retinopathy', 'hcp', 'diabetic', 'trials', 'information'}\", 'new_keywords': ',sustain,clinical,slide,overview', 'score': 7.6923076923}]\n",
      "[{'Keywords (m)': 'cv,cardiovascular', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-CV Outcomes in Subgroup of Patients with CV Risk Factors (SEM 165) (v3.0)', 'DOC ID': 'SEM 165', 'extracted_words': \"{'study', 'ozempic', 'cardiovascular', 'cv benefit', 'moa'}\", 'new_keywords': ',cardiovascular', 'score': 20.0}, {'Keywords (m)': 'cardiovascular,indication,cv', 'Product': 'ozempic', 'Document Name': 'CV Indication (SEM 153) (v6.0)', 'DOC ID': 'SEM 153', 'extracted_words': \"{'study', 'ozempic', 'cardiovascular', 'cv benefit', 'moa'}\", 'new_keywords': ',indication,cardiovascular', 'score': 16.6666666667}, {'Keywords (m)': 'cv,cv indication,cv risk reduction,cardiovascular', 'Product': 'ozempic', 'Document Name': 'Rationale for CV Indication (SEM 162) (v3.0)', 'DOC ID': 'SEM 162', 'extracted_words': \"{'study', 'ozempic', 'cardiovascular', 'cv benefit', 'moa'}\", 'new_keywords': ',cardiovascular,cv indication,cv risk reduction', 'score': 14.2857142857}]\n",
      "[{'Keywords (m)': 'transplant,solid organ transplant,kidney transplant,liver transplant', 'Product': 'ozempic', 'Document Name': 'Transplant (SEM 027) (v5.0)', 'DOC ID': 'SEM 027', 'extracted_words': \"{'data', 'ozempic', 'safety', 'kidney transplant', 'transplant', 'kidney'}\", 'new_keywords': ',transplant,liver transplant,solid organ transplant,kidney transplant', 'score': 25.0}, {'Keywords (m)': 'renal,kidney,dialysis,esrd,gfr,egfr,creatinine,clearance,crcl,nephrotic,transplant', 'Product': 'ozempic', 'Document Name': 'Renal Impairment (SEM 125) (v13.0)', 'DOC ID': 'SEM 125', 'extracted_words': \"{'data', 'ozempic', 'safety', 'kidney transplant', 'transplant', 'kidney'}\", 'new_keywords': ',creatinine,clearance,nephrotic,dialysis,renal,gfr,kidney,egfr,transplant,crcl,esrd', 'score': 13.3333333333}, {'Keywords (m)': 'hypoglycemia,hypo,safety', 'Product': 'ozempic', 'Document Name': 'Hypoglycemia (SEM 120) (v9.0)', 'DOC ID': 'SEM 120', 'extracted_words': \"{'data', 'ozempic', 'safety', 'kidney transplant', 'transplant', 'kidney'}\", 'new_keywords': ',hypo,hypoglycemia,safety', 'score': 12.5}]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'vs', 'information', 'rybelsus', 'geriatric'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 14.2857142857}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'vs', 'information', 'rybelsus', 'geriatric'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 12.5}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, ozempic, rybelsus', 'Document Name': 'NIOSH Classification (Sema) (SEM 300) (v6.0)', 'DOC ID': 'SEM 300', 'extracted_words': \"{'vs', 'information', 'rybelsus', 'geriatric'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'ozempic,semaglutide injection,drug,interaction', 'Product': 'ozempic', 'Document Name': 'Drug Interactions (SEM 158) (v10.0)', 'DOC ID': 'SEM 158', 'extracted_words': \"{'dialysis', 'ozempic', 'information'}\", 'new_keywords': ',interaction,drug,semaglutide injection,ozempic', 'score': 16.6666666667}, {'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'dialysis', 'ozempic', 'information'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 12.5}, {'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'dialysis', 'ozempic', 'information'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'ozempic,versus,vs', 'Product': 'wegovy', 'Document Name': 'vs Ozempic (SEOB 026) (v5.0)', 'DOC ID': 'SEOB 026', 'extracted_words': \"{'difference', 'clinical', 'ozempic'}\", 'new_keywords': ',vs,ozempic,versus', 'score': 20.0}, {'Keywords (m)': 'ozempic,switch,transition', 'Product': 'wegovy', 'Document Name': 'Switching from Ozempic (SEOB 065) (v7.0)', 'DOC ID': 'SEOB 065', 'extracted_words': \"{'difference', 'clinical', 'ozempic'}\", 'new_keywords': ',transition,ozempic,switch', 'score': 20.0}, {'Keywords (m)': '2 mg,2.0 mg,ozempic,sustain forte', 'Product': 'wegovy', 'Document Name': 'vs Ozempic 2 mg (SEOB 008) (v6.0)', 'DOC ID': 'SEOB 008', 'extracted_words': \"{'difference', 'clinical', 'ozempic'}\", 'new_keywords': ',2 mg,sustain forte,ozempic,2.0 mg', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'pipeline', 'Product': 'all products, general', 'Document Name': 'Pipeline (GEN 090) (v6.0)', 'DOC ID': 'GEN 090', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',pipeline', 'score': 50.0}, {'Keywords (m)': 'hcp,additional information required,credentials,clarification,clarify,information', 'Product': 'general', 'Document Name': 'HCP Additional Information Required (GEN 130) (v2.0)', 'DOC ID': 'GEN 130', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',clarification,credentials,hcp,additional information required,information,clarify', 'score': 14.2857142857}, {'Keywords (m)': 'product information,pi,package insert', 'Product': 'all products, concizumab, devices - insulin, esperoct, fiasp, flextouch device, gen glp-1, general, glucagen, growth hormone, hemostasis disease state, insulin aspart (nnpi), insulin aspart mix 70/30 (nnpi), insulin portfolio, levemir, macrilen, needles/devices, norditropin, novoeight, sogroya', 'Document Name': 'PI Discussion (Verbal Response Only) (GEN 1001) (v2.0)', 'DOC ID': 'GEN 1001', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',package insert,product information,pi', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'pipeline', 'Product': 'all products, general', 'Document Name': 'Pipeline (GEN 090) (v6.0)', 'DOC ID': 'GEN 090', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',pipeline', 'score': 50.0}, {'Keywords (m)': 'hcp,additional information required,credentials,clarification,clarify,information', 'Product': 'general', 'Document Name': 'HCP Additional Information Required (GEN 130) (v2.0)', 'DOC ID': 'GEN 130', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',clarification,credentials,hcp,additional information required,information,clarify', 'score': 14.2857142857}, {'Keywords (m)': 'product information,pi,package insert', 'Product': 'all products, concizumab, devices - insulin, esperoct, fiasp, flextouch device, gen glp-1, general, glucagen, growth hormone, hemostasis disease state, insulin aspart (nnpi), insulin aspart mix 70/30 (nnpi), insulin portfolio, levemir, macrilen, needles/devices, norditropin, novoeight, sogroya', 'Document Name': 'PI Discussion (Verbal Response Only) (GEN 1001) (v2.0)', 'DOC ID': 'GEN 1001', 'extracted_words': \"{'pipeline', 'hcp'}\", 'new_keywords': ',package insert,product information,pi', 'score': 0.0}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'binge eating disorder,binge eating,bed,bulimia', 'Product': 'saxenda', 'Document Name': 'Binge Eating Disorder (SAX 093) (v7.0)', 'DOC ID': 'SAX 093', 'extracted_words': \"{'3', 'treatment', 'obese', 'hcp', 'bed', 'disorder', 'information'}\", 'new_keywords': ',bed,bulimia', 'score': 12.5}, {'Keywords (m)': 'summary,overview,information,monograph', 'Product': 'saxenda', 'Document Name': 'Product Overview (SAX 025) (v7.0)', 'DOC ID': 'SAX 025', 'extracted_words': \"{'3', 'treatment', 'obese', 'hcp', 'bed', 'disorder', 'information'}\", 'new_keywords': ',information,summary,overview,monograph', 'score': 10.0}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'3', 'treatment', 'obese', 'hcp', 'bed', 'disorder', 'information'}\", 'new_keywords': ',excursion', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'pregnancy,pregnant,breastfeed,breastfed,lactation,fertility,fertile,teratogenicity,fetal,fetus,contraception,contraceptive', 'Product': 'wegovy', 'Document Name': 'Pregnancy (SEOB 072) (v2.0)', 'DOC ID': 'SEOB 072', 'extracted_words': \"{'hcp', 'pregnancy'}\", 'new_keywords': ',contraception,fertile,pregnant,breastfeeding,lactation,teratogenicity,fetus,pregnancy,fetal', 'score': 10.0}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'hcp', 'pregnancy'}\", 'new_keywords': ',excursion', 'score': 0.0}, {'Keywords (m)': 'bariatric surgery,anti-obesity medications,saxenda,wegovy', 'Product': 'gen obesity, saxenda, wegovy', 'Document Name': 'Bariatric Surgery (GOBS 001) (v1.0)', 'DOC ID': 'GOBS 001', 'extracted_words': \"{'hcp', 'pregnancy'}\", 'new_keywords': ',saxenda,anti-obesity medications,wegovy,bariatric surgery', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'moa,absorption,mechanism,snac,bioavailability', 'Product': 'rybelsus', 'Document Name': 'Media-Mechanism of Absorption (OSEM 3011) (v2.0)', 'DOC ID': 'OSEM 3011', 'extracted_words': \"{'gastric', 'mechanism', 'information', 'rybelsus', 'efficacy', 'bypass', 'absorption', 'gastric bypass'}\", 'new_keywords': ',mechanism,snac,moa,absorption,bioavailability', 'score': 18.1818181818}, {'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'gastric', 'mechanism', 'information', 'rybelsus', 'efficacy', 'bypass', 'absorption', 'gastric bypass'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 9.0909090909}, {'Keywords (m)': 'moa,action,mechanism,insulin,glucagon', 'Product': 'rybelsus', 'Document Name': 'Media-Mechanism of Action (OSEM 3012) (v2.0)', 'DOC ID': 'OSEM 3012', 'extracted_words': \"{'gastric', 'mechanism', 'information', 'rybelsus', 'efficacy', 'bypass', 'absorption', 'gastric bypass'}\", 'new_keywords': ',insulin,mechanism,glucagon,moa,action', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'weight,pound,kilogram,mechanism,weight loss', 'Product': 'rybelsus', 'Document Name': 'Mechanism of Weight Loss (OSEM 082) (v3.0)', 'DOC ID': 'OSEM 082', 'extracted_words': \"{'weight loss', 'indication', 'weight', 'oral', 'semaglutide', 'information'}\", 'new_keywords': ',pound,mechanism,kilogram,weight loss,weight', 'score': 22.2222222222}, {'Keywords (m)': 'oral,tablet,oasis,formulation', 'Product': 'rybelsus, wegovy', 'Document Name': 'Oral Formulation (SEOB 025) (v5.0)', 'DOC ID': 'SEOB 025', 'extracted_words': \"{'weight loss', 'indication', 'weight', 'oral', 'semaglutide', 'information'}\", 'new_keywords': ',oral,formulation,oasis,tablet', 'score': 11.1111111111}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'weight loss', 'indication', 'weight', 'oral', 'semaglutide', 'information'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'ozempic,glucose,semaglutide,fasting,fpg,preprandial', 'Product': 'ozempic', 'Document Name': 'Fasting Plasma Glucose (FPG) (SEM 025) (v9.0)', 'DOC ID': 'SEM 025', 'extracted_words': \"{'ozempic', 'mi', 'send', 'metabolism', 'diabetic retinopathy', 'diabetes', 'glucose', 'diabetic', 'retinopathy', 'rapid', 'early'}\", 'new_keywords': ',fpg,ozempic,preprandial,glucose,fasting,semaglutide', 'score': 13.3333333333}, {'Keywords (m)': 'ozempic,semaglutide injection,glycemic,control,0.25,initial,early,switching,initiation,hyperglycemia', 'Product': 'ozempic', 'Document Name': 'Initial Glycemic Control (SEM 021) (v7.0)', 'DOC ID': 'SEM 021', 'extracted_words': \"{'ozempic', 'mi', 'send', 'metabolism', 'diabetic retinopathy', 'diabetes', 'glucose', 'diabetic', 'retinopathy', 'rapid', 'early'}\", 'new_keywords': ',hyperglycemia,ozempic,semaglutide injection,glycemic,switching,initiation,initial,0.25,control,early', 'score': 10.5263157895}, {'Keywords (m)': 'retinopathy,eye,drc,diabetic retinopathy complications,diabetic retinopathy,blindness,blind,vitreous hemorrhage,retina,visual,microvascular', 'Product': 'ozempic', 'Document Name': 'Retinopathy (SEM 004) (v16.0)', 'DOC ID': 'SEM 004', 'extracted_words': \"{'ozempic', 'mi', 'send', 'metabolism', 'diabetic retinopathy', 'diabetes', 'glucose', 'diabetic', 'retinopathy', 'rapid', 'early'}\", 'new_keywords': ',visual,microvascular,diabetic retinopathy,drc,blindness,blind,vitreous hemorrhage,retinopathy,eye,diabetic retinopathy complications,retina', 'score': 10.0}]\n",
      "[{'Keywords (m)': 'mechanism,weight,weight loss', 'Product': 'ozempic', 'Document Name': 'Mechanism of Weight Loss (SEM 141) (v6.0)', 'DOC ID': 'SEM 141', 'extracted_words': \"{'data', 'ozempic', 'longterm', 'weight loss', 'weight'}\", 'new_keywords': ',weight loss,mechanism,weight', 'score': 33.3333333333}, {'Keywords (m)': 'weight,victoza', 'Product': 'ozempic', 'Document Name': 'Weight vs. Victoza (SEM 142) (v6.0)', 'DOC ID': 'SEM 142', 'extracted_words': \"{'data', 'ozempic', 'longterm', 'weight loss', 'weight'}\", 'new_keywords': ',weight,victoza', 'score': 16.6666666667}, {'Keywords (m)': 'obesity,weight', 'Product': 'ozempic', 'Document Name': 'Obesity Indication (SEM 155) (v13.0)', 'DOC ID': 'SEM 155', 'extracted_words': \"{'data', 'ozempic', 'longterm', 'weight loss', 'weight'}\", 'new_keywords': ',weight,obesity', 'score': 16.6666666667}]\n",
      "[{'Keywords (m)': 'thyroid,thyroid neoplasms,mtc,men 2,calcitonin', 'Product': 'saxenda', 'Document Name': 'Thyroid Neoplasms (SAX 018) (v1.0)', 'DOC ID': 'SAX 018', 'extracted_words': \"{'cancer', 'contraindication', 'follicular', 'thyroid cancer', 'thyroid', 'follicular thyroid cancer'}\", 'new_keywords': ',men 2,calcitonin,mtc,thyroid,thyroid neoplasms', 'score': 10.0}, {'Keywords (m)': 'cancer,tumor,oncology,neoplasm,carcinoma,breast', 'Product': 'saxenda', 'Document Name': 'Breast Neoplasms (SAX 010) (v7.0)', 'DOC ID': 'SAX 010', 'extracted_words': \"{'cancer', 'contraindication', 'follicular', 'thyroid cancer', 'thyroid', 'follicular thyroid cancer'}\", 'new_keywords': ',tumor,breast,cancer,neoplasm,oncology,carcinoma', 'score': 9.0909090909}, {'Keywords (m)': 'pancreas,cancer,pancreatic,tumor,oncology,neoplasm,carcinoma', 'Product': 'saxenda', 'Document Name': 'Pancreatic Cancer (SAX 015) (v7.0)', 'DOC ID': 'SAX 015', 'extracted_words': \"{'cancer', 'contraindication', 'follicular', 'thyroid cancer', 'thyroid', 'follicular thyroid cancer'}\", 'new_keywords': ',tumor,cancer,neoplasm,pancreas,pancreatic,oncology,carcinoma', 'score': 8.3333333333}]\n",
      "[{'Keywords (m)': 'thyroid,thyroid neoplasms,mtc,men 2,calcitonin', 'Product': 'saxenda', 'Document Name': 'Thyroid Neoplasms (SAX 018) (v1.0)', 'DOC ID': 'SAX 018', 'extracted_words': \"{'monitor', 'regular', 'cancer', 'thyroidectomy', 'thyroid cancer', 'thyroid'}\", 'new_keywords': ',men 2,calcitonin,mtc,thyroid,thyroid neoplasms', 'score': 10.0}, {'Keywords (m)': 'cancer,tumor,oncology,neoplasm,carcinoma,breast', 'Product': 'saxenda', 'Document Name': 'Breast Neoplasms (SAX 010) (v7.0)', 'DOC ID': 'SAX 010', 'extracted_words': \"{'monitor', 'regular', 'cancer', 'thyroidectomy', 'thyroid cancer', 'thyroid'}\", 'new_keywords': ',tumor,breast,cancer,neoplasm,oncology,carcinoma', 'score': 9.0909090909}, {'Keywords (m)': 'pancreas,cancer,pancreatic,tumor,oncology,neoplasm,carcinoma', 'Product': 'saxenda', 'Document Name': 'Pancreatic Cancer (SAX 015) (v7.0)', 'DOC ID': 'SAX 015', 'extracted_words': \"{'monitor', 'regular', 'cancer', 'thyroidectomy', 'thyroid cancer', 'thyroid'}\", 'new_keywords': ',tumor,cancer,neoplasm,pancreas,pancreatic,oncology,carcinoma', 'score': 8.3333333333}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 28.5714285714}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 25.0}, {'Keywords (m)': 'ozempic,comparison,semaglutide injection,semaglutide sq,semaglutide sc,semaglutide subcutaneous,semaglutide comparison', 'Product': 'rybelsus', 'Document Name': 'vs Ozempic (OSEM 040) (v16.0)', 'DOC ID': 'OSEM 040', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',semaglutide subcutaneous,ozempic,semaglutide injection,semaglutide comparison,compare,semaglutide sc,semaglutide sq', 'score': 9.0909090909}]\n",
      "[{'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 28.5714285714}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 25.0}, {'Keywords (m)': 'ozempic,comparison,semaglutide injection,semaglutide sq,semaglutide sc,semaglutide subcutaneous,semaglutide comparison', 'Product': 'rybelsus', 'Document Name': 'vs Ozempic (OSEM 040) (v16.0)', 'DOC ID': 'OSEM 040', 'extracted_words': \"{'data', 'rybelsus', 'ozempic', 'use', 'semaglutide'}\", 'new_keywords': ',semaglutide subcutaneous,ozempic,semaglutide injection,semaglutide comparison,compare,semaglutide sc,semaglutide sq', 'score': 9.0909090909}]\n",
      "[{'Keywords (m)': 'triglyceride,hypertriglyceridemia,pancreatitis', 'Product': 'rybelsus', 'Document Name': 'High Triglycerides and Pancreatitis (OSEM 079) (v5.0)', 'DOC ID': 'OSEM 079', 'extracted_words': \"{'rybelsus', 'send', 'mi', 'information', 'pancreatitis'}\", 'new_keywords': ',hypertriglyceridemia,triglyceride,pancreatitis', 'score': 14.2857142857}, {'Keywords (m)': 'safety,rybelsus,ozempic,ae', 'Product': 'rybelsus', 'Document Name': 'Safety vs Ozempic (OSEM 143) (v5.0)', 'DOC ID': 'OSEM 143', 'extracted_words': \"{'rybelsus', 'send', 'mi', 'information', 'pancreatitis'}\", 'new_keywords': ',ae,rybelsus,ozempic,safety', 'score': 12.5}, {'Keywords (m)': 'cv,rybelsus,ozempic,semglutide,indication', 'Product': 'rybelsus', 'Document Name': 'Rybelsus vs Ozempic-CV Indication (OSEM 133) (v5.0)', 'DOC ID': 'OSEM 133', 'extracted_words': \"{'rybelsus', 'send', 'mi', 'information', 'pancreatitis'}\", 'new_keywords': ',ozempic,rybelsus,semglutide,cardiovascular,indication', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'summary,overview,information,monograph', 'Product': 'saxenda', 'Document Name': 'Product Overview (SAX 025) (v7.0)', 'DOC ID': 'SAX 025', 'extracted_words': \"{'stable', 'storage', 'hcp', 'information'}\", 'new_keywords': ',information,summary,overview,monograph', 'score': 14.2857142857}, {'Keywords (m)': 'in-use,storage,stability,expiration,fridge,frozen,freeze,heat,hot,refrigerate,refrigeration,refrigerator,stable,store,temp,temperature,unopen,unopened,warm,room,cool,stored', 'Product': 'saxenda', 'Document Name': 'Storage and Stability (SAX 080) (v4.0)', 'DOC ID': 'SAX 080', 'extracted_words': \"{'stable', 'storage', 'hcp', 'information'}\", 'new_keywords': ',refrigerator,temp,hot,temperature,freeze,warm,room,frozen,unopen,stored,expiration,fridge,heat,store,stable,cool,storage,in-use', 'score': 10.0}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'stable', 'storage', 'hcp', 'information'}\", 'new_keywords': ',excursion', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'neoplasms,cancer,neoplasm', 'Product': 'ozempic', 'Document Name': 'Neoplasms  (SEM 134) (v7.0)', 'DOC ID': 'SEM 134', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',neoplasm,cancer', 'score': 20.0}, {'Keywords (m)': 'thyroid,neoplasms,carcinoma,cancer,thyroid cancer,ptc,papillary thyroid carcinoma,mtc,medullary thyroid carcinoma,men2,men 2,multiple endocrine neoplasia syndrome type 2,neoplasia,follicular thyroid cancer,ftc', 'Product': 'ozempic', 'Document Name': 'Thyroid Neoplasms (SEM 016) (v10.0)', 'DOC ID': 'SEM 016', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',cancer,ptc,men 2,multiple endocrine neoplasia syndrome type 2,men2,neoplasm,mtc,ftc,neoplasia,thyroid cancer,medullary thyroid carcinoma,thyroid,follicular thyroid cancer,papillary thyroid carcinoma,carcinoma', 'score': 18.75}, {'Keywords (m)': 'thyroid cancer,hypothyroidism,hyperthyroidism,goiter,thyroid,nodules,thyroidectomy,ptc,papillary thyroid carcinoma,mtc,medullary thyroid carcinoma,men2,men2,multiple endocrine neoplasia syndrome type 2', 'Product': 'ozempic', 'Document Name': 'Thyroid Conditions (SEM 012) (v5.0)', 'DOC ID': 'SEM 012', 'extracted_words': \"{'thyroid', 'medullary', 'cancer', 'thyroid cancer'}\", 'new_keywords': ',hypothyroidism,goiter,ptc,multiple endocrine neoplasia syndrome type 2,thyroidectomy,men2,nodules,hyperthyroidism,mtc,thyroid cancer,medullary thyroid carcinoma,thyroid,papillary thyroid carcinoma', 'score': 13.3333333333}]\n",
      "[{'Keywords (m)': 'allergic,allergies,allergy,hypersensitivity,angioedema,anaphylactic,anaphylaxis,immunogenicity,reaction,reactions,skin,', 'Product': 'ozempic', 'Document Name': 'Allergic Reactions (SEM 008) (v7.0)', 'DOC ID': 'SEM 008', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',immunogenic,hypersensitivity,anaphylaxis,angioedema,anaphylactic,allergy,reaction,skin', 'score': 18.1818181818}, {'Keywords (m)': 'antibody,antibodies,immunogenicity', 'Product': 'ozempic', 'Document Name': 'Antibodies (SEM 007) (v8.0)', 'DOC ID': 'SEM 007', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',immunogenic,antibody', 'score': 16.6666666667}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',excursion', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'allergic,allergies,allergy,hypersensitivity,angioedema,anaphylactic,anaphylaxis,immunogenicity,reaction,reactions,skin,', 'Product': 'ozempic', 'Document Name': 'Allergic Reactions (SEM 008) (v7.0)', 'DOC ID': 'SEM 008', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',immunogenic,hypersensitivity,anaphylaxis,angioedema,anaphylactic,allergy,reaction,skin', 'score': 18.1818181818}, {'Keywords (m)': 'antibody,antibodies,immunogenicity', 'Product': 'ozempic', 'Document Name': 'Antibodies (SEM 007) (v8.0)', 'DOC ID': 'SEM 007', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',immunogenic,antibody', 'score': 16.6666666667}, {'Keywords (m)': 'excursion', 'Product': 'all products, fiasp, gen glp-1, general, insulin portfolio, levemir, novolog, novolog mix 70/30, novolin 70/30, novolin n, novolin r, other, ozempic, saxenda, tresiba, victoza, wegovy, xultophy 100/3.6', 'Document Name': 'Cover to Excursion Data for Novo Nordisk Products (GEN 123) (v6.0)', 'DOC ID': 'GEN 123', 'extracted_words': \"{'send', 'mi', 'allergy', 'reaction', 'antibody'}\", 'new_keywords': ',excursion', 'score': 0.0}]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Keywords (m)': 'cv,cardiovascular,mace,heart attack,mi,stroke,death,indication', 'Product': 'rybelsus', 'Document Name': 'CV Indication (OSEM 093) (v9.0)', 'DOC ID': 'OSEM 093', 'extracted_words': \"{'reaction', 'send', 'mi', 'allergy'}\", 'new_keywords': ',stroke,mace,mi,cardiovascular,indication,heart attack,death', 'score': 10.0}, {'Keywords (m)': 'allergic,allergy,hypersensitivity,sensitivity,anaphylaxis,anaphylactic,urticaria,rash,immunogenic,immunogenicity', 'Product': 'rybelsus', 'Document Name': 'Allergic Reactions (OSEM 044) (v8.0)', 'DOC ID': 'OSEM 044', 'extracted_words': \"{'reaction', 'send', 'mi', 'allergy'}\", 'new_keywords': ',immunogenic,hypersensitivity,anaphylaxis,anaphylactic,allergy,urticaria,sensitivity,rash', 'score': 9.0909090909}, {'Keywords (m)': 'niosh,hazardous', 'Product': 'gen glp-1, ozempic, rybelsus', 'Document Name': 'NIOSH Classification (Sema) (SEM 300) (v6.0)', 'DOC ID': 'SEM 300', 'extracted_words': \"{'reaction', 'send', 'mi', 'allergy'}\", 'new_keywords': ',hazardous,niosh', 'score': 0.0}]\n",
      "[{'Keywords (m)': 'step,sustain,forte,diabetes,t2d', 'Product': 'ozempic, wegovy', 'Document Name': 'STEP 2 vs SUSTAIN FORTE (SEOB 057) (v1.0)', 'DOC ID': 'SEOB 057', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',step,forte,t2d,sustain,diabetes', 'score': 15.3846153846}, {'Keywords (m)': 'cv,cardiovascular', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-CV Outcomes in Subgroup of Patients with CV Risk Factors (SEM 165) (v3.0)', 'DOC ID': 'SEM 165', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',cardiovascular', 'score': 10.0}, {'Keywords (m)': 'cvot,glp-1,glp-1 ra,glp1,rewind,sustain 6,pioneer 6,excel,elixa,harmony,cv,outcomes,mace,leader', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Overview of CVOTs  (GLP1 123) (v12.0)', 'DOC ID': 'GLP1 123', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',mace,cvot,glp-1 ra,cardiovascular,excel,sustain 6,outcomes,leader,rewind,harmony,glp-1,elixa,pioneer 6', 'score': 9.5238095238}]\n",
      "[{'Keywords (m)': 'sustain,sglt-2,sglt2,add,sustain 9,sustain 9', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 9 (add-on SGLT-2i) (SEM 109) (v5.0)', 'DOC ID': 'SEM 109', 'extracted_words': \"{'study', '9', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',sglt2,sustain,sglt-2,add,sustain 9', 'score': 25.0}, {'Keywords (m)': 'sustain,trulicity,dulaglutide', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 7 (vs dulaglutide) (SEM 107) (v5.0)', 'DOC ID': 'SEM 107', 'extracted_words': \"{'study', '9', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',dulaglutide,sustain,trulicity', 'score': 14.2857142857}, {'Keywords (m)': 'sustain,monotherapy,naive,treatment-naive', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 1 (monotherapy)  (SEM 101) (v6.0)', 'DOC ID': 'SEM 101', 'extracted_words': \"{'study', '9', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',naive,sustain,monotherapy,treatment-naive', 'score': 12.5}]\n",
      "[{'Keywords (m)': 'step,sustain,forte,diabetes,t2d', 'Product': 'ozempic, wegovy', 'Document Name': 'STEP 2 vs SUSTAIN FORTE (SEOB 057) (v1.0)', 'DOC ID': 'SEOB 057', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',step,forte,t2d,sustain,diabetes', 'score': 15.3846153846}, {'Keywords (m)': 'cv,cardiovascular', 'Product': 'ozempic', 'Document Name': 'SUSTAIN 6-CV Outcomes in Subgroup of Patients with CV Risk Factors (SEM 165) (v3.0)', 'DOC ID': 'SEM 165', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',cardiovascular', 'score': 10.0}, {'Keywords (m)': 'cvot,glp-1,glp-1 ra,glp1,rewind,sustain 6,pioneer 6,excel,elixa,harmony,cv,outcomes,mace,leader', 'Product': 'gen glp-1, ozempic, rybelsus, victoza', 'Document Name': 'Overview of CVOTs  (GLP1 123) (v12.0)', 'DOC ID': 'GLP1 123', 'extracted_words': \"{'study', 'cardiovascular', 'oral', 'baseline', 'sustain', 'sustain 6', 'medications', 'medication', 'diabetes', 'antidiabetic'}\", 'new_keywords': ',mace,cvot,glp-1 ra,cardiovascular,excel,sustain 6,outcomes,leader,rewind,harmony,glp-1,elixa,pioneer 6', 'score': 9.5238095238}]\n",
      "[{'Keywords (m)': 'sustain,sglt-2,sglt2,add,sustain 9,sustain 9', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 9 (add-on SGLT-2i) (SEM 109) (v5.0)', 'DOC ID': 'SEM 109', 'extracted_words': \"{'9', 'ozempic', 'sglt2', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',sglt2,sustain,sglt-2,add,sustain 9', 'score': 37.5}, {'Keywords (m)': 'sustain,trulicity,dulaglutide', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 7 (vs dulaglutide) (SEM 107) (v5.0)', 'DOC ID': 'SEM 107', 'extracted_words': \"{'9', 'ozempic', 'sglt2', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',dulaglutide,sustain,trulicity', 'score': 12.5}, {'Keywords (m)': 'sustain,monotherapy,naive,treatment-naive', 'Product': 'ozempic', 'Document Name': 'Cover to SUSTAIN 1 (monotherapy)  (SEM 101) (v6.0)', 'DOC ID': 'SEM 101', 'extracted_words': \"{'9', 'ozempic', 'sglt2', 'send', 'sustain', 'sustain 9'}\", 'new_keywords': ',naive,sustain,monotherapy,treatment-naive', 'score': 11.1111111111}]\n",
      "[{'Keywords (m)': 'contact,reach', 'Product': 'all products, general', 'Document Name': 'Unable to Reach (GEN 104) (v6.0)', 'DOC ID': 'GEN 104', 'extracted_words': \"{'study', 'investigator', 'contact'}\", 'new_keywords': ',reach,contact', 'score': 25.0}, {'Keywords (m)': 'trial,site,investigator,clinical trial site', 'Product': 'all products, general', 'Document Name': 'Potential NNI Clinical Trial Investigator (GEN 032) (v5.0)', 'DOC ID': 'GEN 032', 'extracted_words': \"{'study', 'investigator', 'contact'}\", 'new_keywords': ',investigator,trial,site,clinical trial site', 'score': 16.6666666667}, {'Keywords (m)': 'product information,pi,package insert', 'Product': 'all products, concizumab, devices - insulin, esperoct, fiasp, flextouch device, gen glp-1, general, glucagen, growth hormone, hemostasis disease state, insulin aspart (nnpi), insulin aspart mix 70/30 (nnpi), insulin portfolio, levemir, macrilen, needles/devices, norditropin, novoeight, sogroya', 'Document Name': 'PI Discussion (Verbal Response Only) (GEN 1001) (v2.0)', 'DOC ID': 'GEN 1001', 'extracted_words': \"{'study', 'investigator', 'contact'}\", 'new_keywords': ',package insert,product information,pi', 'score': 0.0}]\n"
     ]
    }
   ],
   "source": [
    "#to calculate accuracy of data\n",
    "df_accuracy = pd.read_excel (r'./data_to_test.xlsx')\n",
    "for idx_acc,sentence_acc in df_accuracy['Question'].iteritems() :\n",
    "    df_accuracy.at[idx_acc, 'accuracy'] = 'not accurate'\n",
    "    output_sentence = extract_documents(sentence_acc,df_accuracy.at[idx_acc,'Product'])\n",
    "    df_accuracy.at[idx_acc, 'extracted_keywords_'+ str(count)] = dj['extracted_words']\n",
    "    json_data = json.loads(output_sentence)\n",
    "    count = 1\n",
    "    for dj in json_data:\n",
    "        if dj['DOC ID'] == df_accuracy.at[idx_acc,'DOC ID']:\n",
    "            df_accuracy.at[idx_acc, 'accuracy'] = 'accurate with one of docID'\n",
    "        df_accuracy.at[idx_acc, 'keywords_'+ str(count)] = dj['Keywords (m)']\n",
    "        df_accuracy.at[idx_acc, 'Document_Name_'+ str(count)] = dj['Document Name']\n",
    "        df_accuracy.at[idx_acc, 'DOC_ID_'+ str(count)] = dj['DOC ID']\n",
    "        df_accuracy.at[idx_acc, 'new_keywords_'+ str(count)] = dj['new_keywords']\n",
    "        df_accuracy.at[idx_acc, 'score_'+ str(count)] = dj['score']\n",
    "        count+=1\n",
    "df_accuracy.to_csv('accuracy.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "2a96dd97",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3447228549734245\n"
     ]
    }
   ],
   "source": [
    "df_tocheck = pd.read_csv(r'./accuracy.csv')\n",
    "df_tocheck['accuracy'].value_counts()['accurate']\n",
    "df_tocheck['accuracy'].count()\n",
    "accuracy = df_tocheck['accuracy'].value_counts()['accurate']/df_tocheck['accuracy'].count()\n",
    "print(accuracy)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "5194f7d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "end_json = {\n",
    "    \"low\": [\"low\",\"lowest\",\"lower\"],\n",
    "    \"low-dose\": [\"low-dose\"],\n",
    "    \"0.25\": [\"0.25\"],\n",
    "    \"initiation\": [\"initiation\"],\n",
    "    \"starting dose\": [\"starting dose\"],\n",
    "    \"cutoff\": [\"cutoff\"],\n",
    "    \"2.8\": [\"2.8\"],\n",
    "    \"sensitivity\": [\"sensitivity\"],\n",
    "    \"specificity\": [\"specificity\"],\n",
    "    \"3 mg\": [\"3 mg\"],\n",
    "    \"start\": [\"start\",\"starting\",\"starter\"],\n",
    "    \"usp\": [\"usp\"],\n",
    "    \"797\": [\"797\"],\n",
    "    \"sterile\": [\"sterile\",\"sterility\"],\n",
    "    \"stable\": [\"stable\",\"stability\"],\n",
    "    \"test\": [\"test\"],\n",
    "    \"stress\": [\"stress\"],\n",
    "    \"iso\": [\"iso\"],\n",
    "    \"accurate\": [\"accurate\",\"accuracy\"],\n",
    "    \"volume\": [\"volume\",\"volumes\"],\n",
    "    \"international organization for standardization\": [\n",
    "        \"international organization for standardization\"\n",
    "    ],\n",
    "    \"deliver\": [\"deliver\",\"delivery\"],\n",
    "    \"international\": [\"international\"],\n",
    "    \"standardidization\": [\"standardidization\"],\n",
    "    \"international organization\": [\"international organization\"],\n",
    "    \"organization\": [\"organization\"],\n",
    "    \"gi disease\": [\"gi disease\"],\n",
    "    \"gi conditions\": [\"gi conditions\"],\n",
    "    \"gerd\": [\"gerd\"],\n",
    "    \"gastritis\": [\"gastritis\"],\n",
    "    \"ulcerative colitis\": [\"ulcerative colitis\"],\n",
    "    \"ibs\": [\"ibs\",\"irritable bowel syndrome\"],\n",
    "    \"crohn's disease\": [\"crohn's disease\"],\n",
    "    \"acute\": [\"acute\"],\n",
    "    \"chronic\": [\"chronic\"],\n",
    "    \"gi\": [\"gi\",\"gastrointestinal\"],\n",
    "    \"colitis\": [\"colitis\"],\n",
    "    \"crohn's\": [\"crohn's\"],\n",
    "    \"adolescent\": [\"adolescent\",\"adolescents\"],\n",
    "    \"teens\": [\"teens\"],\n",
    "    \"adverse event\": [\"adverse event\",\"adverse events\"],\n",
    "    \"reporting\": [\"reporting\"],\n",
    "    \"fda\": [\"fda\"],\n",
    "    \"adverse\": [\"adverse\"],\n",
    "    \"events\": [\"events\"],\n",
    "    \"safety\": [\"safe\",\"safety\"],\n",
    "    \"ae\": [\"ae\"],\n",
    "    \"common\": [\"common\"],\n",
    "    \"adverse reaction\": [\"adverse reaction\"],\n",
    "    \"side effect\": [\"side effect\"],\n",
    "    \"air\": [\"air\"],\n",
    "    \"bubble\": [\"bubble\",\"bubbles\"],\n",
    "    \"foam\": [\"foam\",\"foams\"],\n",
    "    \"xray\": [\"xray\",\"x-ray\",\"x-rays\",\"xrays\"],\n",
    "    \"airport\": [\"airport\"],\n",
    "    \"security\": [\"security\"],\n",
    "    \"tsa\": [\"tsa\",\"transportation security administration\"],\n",
    "    \"transportation\": [\"transportation\"],\n",
    "    \"radiation\": [\"radiation\"],\n",
    "    \"albumin\": [\"albumin\"],\n",
    "    \"hypoalbuminemia\": [\"hypoalbuminemia\"],\n",
    "    \"protein\": [\"protein\"],\n",
    "    \"alcohol\": [\"alcohol\"],\n",
    "    \"alcohol use\": [\"alcohol use\"],\n",
    "    \"alcohol dependency\": [\"alcohol dependency\"],\n",
    "    \"consumption\": [\"consumption\"],\n",
    "    \"pancreatitis\": [\"pancreatitis\"],\n",
    "    \"amylase\": [\"amylase\"],\n",
    "    \"lipase\": [\"lipase\"],\n",
    "    \"allergy\": [\"allergic\",\"allergies\",\"allergy\"],\n",
    "    \"amyloidosis\": [\"amyloidosis\"],\n",
    "    \"hypersensitivity\": [\"hypersensitivity\"],\n",
    "    \"angioedema\": [\"angioedema\"],\n",
    "    \"anaphylactic\": [\"anaphylactic\"],\n",
    "    \"anaphylaxis\": [\"anaphylaxis\"],\n",
    "    \"reaction\": [\"reaction\",\"reactions\"],\n",
    "    \"skin\": [\"skin\"],\n",
    "    \"iasp\": [\"iasp\"],\n",
    "    \"nnpi\": [\"nnpi\"],\n",
    "    \"unbranded biologic\": [\"unbranded biologic\"],\n",
    "    \"urticaria\": [\"urticaria\"],\n",
    "    \"rash\": [\"rash\"],\n",
    "    \"immunogenic\": [\"immunogenic\",\"immunogenicity\"],\n",
    "    \"immune complex disease\": [\"immune complex disease\"],\n",
    "    \"antibody\": [\"antibody\",\"antibodies\"],\n",
    "    \"injection\": [\"injection\"],\n",
    "    \"contraindication\": [\"contraindication\",\"contraindicated\"],\n",
    "    \"niacin\": [\"niacin\"],\n",
    "    \"alopecia\": [\"alopecia\"],\n",
    "    \"hair\": [\"hair\"],\n",
    "    \"hair loss\": [\"hair loss\"],\n",
    "    \"alzheimer\": [\"alzheimer\"],\n",
    "    \"dementia\": [\"dementia\"],\n",
    "    \"cognition\": [\"cognition\",\"cognitive\"],\n",
    "    \"answer registry\": [\"answer registry\"],\n",
    "    \"template\": [\"template\"],\n",
    "    \"anti-liraglutide\": [\"anti-liraglutide\",\"anti liraglutide\"],\n",
    "    \"neutralizing\": [\"neutralizing\"],\n",
    "    \"pharmacokinetics\": [\"pharmacokinetics\",\"pk\"],\n",
    "    \"pharmacology\": [\"pharmacology\"],\n",
    "    \"absorption\": [\"absorption\"],\n",
    "    \"distribution\": [\"distribution\"],\n",
    "    \"metabolism\": [\"metabolism\"],\n",
    "    \"excretion\": [\"excretion\"],\n",
    "    \"elimination\": [\"elimination\"],\n",
    "    \"half-life\": [\"half-life\"],\n",
    "    \"steady\": [\"steady\"],\n",
    "    \"step\": [\"step\"],\n",
    "    \"phase\": [\"phase\"],\n",
    "    \"trial\": [\"trial\",\"trials\"],\n",
    "    \"study\": [\"study\",\"studies\"],\n",
    "    \"program\": [\"program\"],\n",
    "    \"approval\": [\"approval\"],\n",
    "    \"available\": [\"available\",\"availability\"],\n",
    "    \"overview\": [\"overview\"],\n",
    "    \"launch\": [\"launch\"],\n",
    "    \"date\": [\"date\"],\n",
    "    \"macrilen\": [\"macrilen\"],\n",
    "    \"approval and product overview\": [\"approval and product overview\"],\n",
    "    \"prescribing information\": [\"prescribing information\"],\n",
    "    \"glp-1\": [\"glp-1\",\"glp 1\",\"glp1\"],\n",
    "    \"summary\": [\"summary\"],\n",
    "    \"bariatric surgery glp-1 ras victoza ozempic rybelsus\": [\n",
    "        \"bariatric surgery glp-1 ras victoza ozempic rybelsus\"\n",
    "    ],\n",
    "    \"bariatric surgery\": [\"bariatric surgery\"],\n",
    "    \"anti-obesity medications\": [\"anti-obesity medications\"],\n",
    "    \"saxenda\": [\"saxenda\"],\n",
    "    \"wegovy\": [\"wegovy\"],\n",
    "    \"bariatric\": [\"bariatric\"],\n",
    "    \"gastric bypass\": [\"gastric bypass\"],\n",
    "    \"roux\": [\"roux\"],\n",
    "    \"roux-en-y\": [\"roux-en-y\"],\n",
    "    \"banding\": [\"banding\"],\n",
    "    \"surgery\": [\"surgery\"],\n",
    "    \"stapling\": [\"stapling\",\"stapled\"],\n",
    "    \"obesity-related surgery\": [\"obesity-related surgery\",\"obesity related surgery\"],\n",
    "    \"sleeve\": [\"sleeve\"],\n",
    "    \"gastric\": [\"gastric\"],\n",
    "    \"bypass\": [\"bypass\"],\n",
    "    \"lap banding\": [\"lap banding\"],\n",
    "    \"battery\": [\"battery\"],\n",
    "    \"life\": [\"life\"],\n",
    "    \"novopen echo\": [\"novopen echo\"],\n",
    "    \"echo\": [\"echo\"],\n",
    "    \"expire\": [\"expire\"],\n",
    "    \"duration\": [\"duration\"],\n",
    "    \"last\": [\"last\"],\n",
    "    \"dead\": [\"dead\"],\n",
    "    \"novopen\": [\"novopen\"],\n",
    "    \"beta cell\": [\"beta cell\",\"beta-cell\"],\n",
    "    \"function\": [\"function\"],\n",
    "    \"preservation\": [\"preservation\"],\n",
    "    \"homa-b\": [\"homa-b\",\"homab\",\"homa b\"],\n",
    "    \"c-peptide\": [\"c-peptide\",\"c peptide\"],\n",
    "    \"beta\": [\"beta\"],\n",
    "    \"cell\": [\"cell\"],\n",
    "    \"insulin\": [\"insulin\"],\n",
    "    \"secretion\": [\"secretion\"],\n",
    "    \"glucagon\": [\"glucagon\"],\n",
    "    \"infusion\": [\"infusion\"],\n",
    "    \"pancreas\": [\"pancreas\"],\n",
    "    \"rate\": [\"rate\"],\n",
    "    \"isr\": [\"isr\"],\n",
    "    \"igtt\": [\"igtt\"],\n",
    "    \"homa ir\": [\"homa ir\",\"homa-ir\",\"homair\"],\n",
    "    \"homa\": [\"homa\"],\n",
    "    \"proinsulin\": [\"proinsulin\"],\n",
    "    \"apoptosis\": [\"apoptosis\"],\n",
    "    \"apoptotic\": [\"apoptotic\"],\n",
    "    \"bed\": [\"bed\",\"binge eating disorder\",\"binge eating\"],\n",
    "    \"bulimia\": [\"bulimia\"],\n",
    "    \"blood brain barrier\": [\"blood brain barrier\",\"bbb\",\"blood-brain-barrier\",\"blood-brain barrier\"],\n",
    "    \"bp\": [\"bp\",\"blood pressure\"],\n",
    "    \"pressure\": [\"pressure\"],\n",
    "    \"systolic\": [\"systolic\"],\n",
    "    \"sbp\": [\"sbp\"],\n",
    "    \"diastolic\": [\"diastolic\"],\n",
    "    \"dbp\": [\"dbp\"],\n",
    "    \"hypertension\": [\"hypertension\",\"hypertensive\"],\n",
    "    \"pulse\": [\"pulse\"],\n",
    "    \"hr\": [\"hr\"],\n",
    "    \"blood\": [\"blood\"],\n",
    "    \"heart\": [\"heart\"],\n",
    "    \"cardiovascular\": [\"cardiovascular\",\"cv\"],\n",
    "    \"bpm\": [\"bpm\"],\n",
    "    \"high blood pressure\": [\"high blood pressure\",\"hbp\"],\n",
    "    \"systolic blood pressure\": [\"systolic blood pressure\",\"sbp\"],\n",
    "    \"diastolic blood pressure\": [\"diastolic blood pressure\",\"dbp\"],\n",
    "    \"heart rate\": [\"heart rate\",\"hr\"],\n",
    "    \"body composition\": [\"body composition\"],\n",
    "    \"obesity\": [\"obesity\"],\n",
    "    \"type 2 diabetes\": [\"type 2 diabetes\"],\n",
    "    \"fat tissue\": [\"fat tissue\"],\n",
    "    \"lean tissue\": [\"lean tissue\"],\n",
    "    \"visceral fat\": [\"visceral fat\"],\n",
    "    \"subcutaneous fat\": [\"subcutaneous fat\"],\n",
    "    \"fat\": [\"fat\"],\n",
    "    \"lean\": [\"lean\"],\n",
    "    \"visceral\": [\"visceral\"],\n",
    "    \"dxa\": [\"dxa\"],\n",
    "    \"dexa\": [\"dexa\"],\n",
    "    \"body mass\": [\"body mass\",\"body-mass\"],\n",
    "    \"breast\": [\"breast\"],\n",
    "    \"cancer\": [\"cancer\"],\n",
    "    \"neoplasm\": [\"neoplasm\",\"neoplasms\"],\n",
    "    \"carcinoma\": [\"carcinoma\",\"carcunimas\"],\n",
    "    \"tumor\": [\"tumor\",\"tumors\"],\n",
    "    \"oncology\": [\"oncology\"],\n",
    "    \"naive\": [\"naive\"],\n",
    "    \"type 2\": [\"type 2\",\"type-2\",\"type2\"],\n",
    "    \"amylin\": [\"amylin\"],\n",
    "    \"carcinomia\": [\"carcinomia\"],\n",
    "    \"carcinogen\": [\"carcinogen\",\"carcinogenicity\"],\n",
    "    \"tumors\": [\"tumors\"],\n",
    "    \"carcinomas\": [\"carcinomas\"],\n",
    "    \"arterial\": [\"arterial\",\"artery\",\"atrial\"],\n",
    "    \"atrioventricular\": [\"atrioventricular\"],\n",
    "    \"cardiac\": [\"cardiac\",\"cardiology\"],\n",
    "    \"coronary\": [\"coronary\"],\n",
    "    \"cpb\": [\"cpb\"],\n",
    "    \"implant\": [\"implant\",\"implantation\"],\n",
    "    \"lvad\": [\"lvad\"],\n",
    "    \"septal\": [\"septal\"],\n",
    "    \"valve\": [\"valve\"],\n",
    "    \"ventricle\": [\"ventricle\",\"ventricular\"],\n",
    "    \"cabg\": [\"cabg\"],\n",
    "    \"ecmo\": [\"ecmo\"],\n",
    "    \"extracorporeal\": [\"extracorporeal\"],\n",
    "    \"cardiopulmonary\": [\"cardiopulmonary\"],\n",
    "    \"cardiothoracic\": [\"cardiothoracic\"],\n",
    "    \"cvd\":[\"cardiovascular disease\",\"cvd\"],\n",
    "    \"ascvd\":[\"atherosclerotic cardiovascular disease\",\"ascvd\"],\n",
    "    \"mace\":[\"major adverse cardiovascular events\",\"mace\"],\n",
    "    \"myocardial\": [\"myocardial\"],\n",
    "    \"infarction\": [\"infarction\",\"infarctions\"],\n",
    "    \"mi\": [\"mi\",\"myocardial infarction\"],\n",
    "    \"heart attack\": [\"heart attack\"],\n",
    "    \"stroke\": [\"stroke\"],\n",
    "    \"ischemia\": [\"ischemia\"],\n",
    "    \"ischemic\": [\"ischemic\"],\n",
    "    \"cvot\": [\"cardiovascular outcome trial\",\"cvot\"],\n",
    "    \"outcome\": [\"outcome\"],\n",
    "    \"select\": [\"select\"],\n",
    "    \"sustain 6\": [\"sustain 6\"],\n",
    "    \"heart failure\": [\"heart failure\"],\n",
    "    \"hf\": [\"hf\",\"hear failure\"],\n",
    "    \"categorical\": [\"categorical\"],\n",
    "    \"proportion\": [\"proportion\"],\n",
    "    \"5%\": [\"5%\"],\n",
    "    \"10%\": [\"10%\"],\n",
    "    \"15%\": [\"15%\"],\n",
    "    \"20%\": [\"20%\"],\n",
    "    \"cgm\": [\"cgm\"],\n",
    "    \"concomitant\": [\"concomitant\"],\n",
    "    \"oad\": [\"obstructive airway disease\",\"oad\"],\n",
    "    \"antidiabetic\": [\"antidiabetic\"],\n",
    "    \"diabetic\": [\"diabetic\"],\n",
    "    \"lipid lowering\": [\"lipid lowering\",\"lipid-lowering\"],\n",
    "    \"antihypertensive\": [\"antihypertensive\"],\n",
    "    \"medication\": [\"medication\",\"medications\"],\n",
    "    \"drug\": [\"drug\"],\n",
    "    \"chrohn's disease\": [\"chrohn's disease\"],\n",
    "    \"chrohn's\": [\"chrohn's\"],\n",
    "    \"ulcer\": [\"ulcer\"],\n",
    "    \"peptic\": [\"peptic\"],\n",
    "    \"question\": [\"question\"],\n",
    "    \"clarification\": [\"clarification\"],\n",
    "    \"monograph\": [\"monograph\"],\n",
    "    \"dossier\": [\"dossier\"],\n",
    "    \"trials\": [\"trials\"],\n",
    "    \"data\": [\"data\"],\n",
    "    \"phase 3\": [\"phase 3\",\"phase3\",\"phase-3\"],\n",
    "    \"clinical\": [\"clinical\"],\n",
    "    \"slide\": [\"slide\",\"slides\"],\n",
    "    \"deck\": [\"deck\"],\n",
    "    \"pi\": [\"pi\"],\n",
    "    \"trial participation\": [\"trial participation\"],\n",
    "    \"study participation\": [\"study participation\"],\n",
    "    \"combination\": [\"combination\",\"combinations\",\"combine\",\"combo\",\"combining\"],\n",
    "    \"two\": [\"two\"],\n",
    "    \"duplicate\": [\"duplicate\",\"duplicates\"],\n",
    "    \"basal\": [\"basal\"],\n",
    "    \"long-acting\": [\"long-acting\",\"long acting\"],\n",
    "    \"dpp4\": [\"dpp4\",\"dpp-4i\",\"dpp-4\",\"dipeptidyl peptidase-4\"],\n",
    "    \"sitagliptin\": [\"sitagliptin\"],\n",
    "    \"dipeptidyl peptidase inhibitor\": [\"dipeptidyl peptidase inhibitor\"],\n",
    "    \"gliptin\": [\"gliptin\"],\n",
    "    \"dipeptydl peptidase\": [\"dipeptydl peptidase\"],\n",
    "    \"januvia\": [\"januvia\"],\n",
    "    \"saxagliptin\": [\"saxagliptin\"],\n",
    "    \"onglyza\": [\"onglyza\"],\n",
    "    \"linagliptin\": [\"linagliptin\"],\n",
    "    \"tradjenta\": [\"tradjenta\"],\n",
    "    \"fasting\": [\"fasting\"],\n",
    "    \"linaclotide\": [\"linaclotide\"],\n",
    "    \"bisphosphonate\": [\"bisphosphonate\"],\n",
    "    \"fosamax\": [\"fosamax\"],\n",
    "    \"linzess\": [\"linzess\"],\n",
    "    \"synthroid\": [\"synthroid\"],\n",
    "    \"levothyroxine\": [\"levothyroxine\"],\n",
    "    \"feiba\": [\"feiba\"],\n",
    "    \"apcc\": [\"apcc\"],\n",
    "    \"sequential\": [\"sequential\"],\n",
    "    \"hemlibra\": [\"hemlibra\"],\n",
    "    \"emicizumab\": [\"emicizumab\"],\n",
    "    \"roche\": [\"roche\"],\n",
    "    \"fviii mimetic\": [\"fviii mimetic\"],\n",
    "    \"concurrent\": [\"concurrent\"],\n",
    "    \"scale insulin\": [\"scale insulin\"],\n",
    "    \"glargine\": [\"glargine\"],\n",
    "    \"degludec\": [\"degludec\"],\n",
    "    \"tresiba\": [\"tresiba\"],\n",
    "    \"nph\": [\"nph\"],\n",
    "    \"lantus\": [\"lantus\"],\n",
    "    \"aspart\": [\"aspart\"],\n",
    "    \"mdi\": [\"mdi\"],\n",
    "    \"transition-t2d\": [\"transition-t2d\"],\n",
    "    \"detemir\": [\"detemir\"],\n",
    "    \"glulisine\": [\"glulisine\"],\n",
    "    \"lispro\": [\"lispro\"],\n",
    "    \"levemir\": [\"levemir\"],\n",
    "    \"basaglar\": [\"basaglar\"],\n",
    "    \"toujeo\": [\"toujeo\"],\n",
    "    \"novolog\": [\"novolog\"],\n",
    "    \"humalog\": [\"humalog\"],\n",
    "    \"apidra\": [\"apidra\"],\n",
    "    \"fiasp\": [\"fiasp\"],\n",
    "    \"niad\": [\"niad\"],\n",
    "    \"oral\": [\"oral\"],\n",
    "    \"oads\": [\"oads\"],\n",
    "    \"metformin\": [\"metformin\"],\n",
    "    \"sulfonylurea\": [\"sulfonylurea\"],\n",
    "    \"dpp-4i\": [\"dpp-4i\",\"dpp4i\"],\n",
    "    \"tzd\": [\"tzd\",\"tzds\"],\n",
    "    \"thiazolidinedione\": [\"thiazolidinedione\"],\n",
    "    \"contraception\": [\"contraception\",\"contraceptive\"],\n",
    "    \"birth control\": [\"birth control\"],\n",
    "    \"discontinuation\": [\"discontinuation\"],\n",
    "    \"reproduction\": [\"reproduction\"],\n",
    "    \"reproduce\": [\"reproduce\"],\n",
    "    \"pregnant\": [\"pregnant\"],\n",
    "    \"pregnancy\": [\"pregnancy\"],\n",
    "    \"antiobesity medications\": [\"antiobesity medications\"],\n",
    "    \"phentermine\": [\"phentermine\"],\n",
    "    \"qsymia\": [\"qsymia\"],\n",
    "    \"liraglutide\": [\"liraglutide\"],\n",
    "    \"weight loss\": [\"weight loss\"],\n",
    "    \"aom\": [\"aom\"],\n",
    "    \"contrave\": [\"contrave\"],\n",
    "    \"bupropion\": [\"bupropion\"],\n",
    "    \"naltrexone\": [\"naltrexone\"],\n",
    "    \"topiramate\": [\"topiramate\"],\n",
    "    \"orlistat\": [\"orlistat\"],\n",
    "    \"xenical\": [\"xenical\"],\n",
    "    \"anti-obesity\": [\"anti-obesity\",\"anti obesity\"],\n",
    "    \"alli\": [\"alli\"],\n",
    "    \"ozempic\": [\"ozempic\"],\n",
    "    \"victoza\": [\"victoza\"],\n",
    "    \"trulicity\": [\"trulicity\"],\n",
    "    \"bydureon\": [\"bydureon\"],\n",
    "    \"byetta\": [\"byetta\"],\n",
    "    \"adlyxin\": [\"adlyxin\"],\n",
    "    \"dulaglutide\": [\"dulaglutide\"],\n",
    "    \"exenatide\": [\"exenatide\"],\n",
    "    \"lixisenatide\": [\"lixisenatide\"],\n",
    "    \"bolus\": [\"bolus\"],\n",
    "    \"prandial\": [\"prandial\"],\n",
    "    \"mealtime\": [\"mealtime\"],\n",
    "    \"short-acting\": [\"short-acting\",\"short acting\"],\n",
    "    \"rapid-acting\": [\"rapid-acting\"],\n",
    "    \"sglt2\": [\"sglt2\"],\n",
    "    \"jardiance\": [\"jardiance\"],\n",
    "    \"empagliflozin\": [\"empagliflozin\"],\n",
    "    \"sodium glucose co-transporter\": [\"sodium glucose co-transporter\"],\n",
    "    \"7 mg\": [\"7 mg\"],\n",
    "    \"14 mg\": [\"14 mg\"],\n",
    "    \"compare\": [\"compare\",\"compared\",\"comparison\"],\n",
    "    \"vs\": [\"vs\"],\n",
    "    \"versus\": [\"versus\"],\n",
    "    \"fix\": [\"fix\"],\n",
    "    \"factor\": [\"factor\"],\n",
    "    \"ix\": [\"ix\"],\n",
    "    \"factor ix\": [\"factor ix\"],\n",
    "    \"rfviii\": [\"rfviii\"],\n",
    "    \"fviii\": [\"fviii\"],\n",
    "    \"viii\": [\"viii\"],\n",
    "    \"connected devices\": [\"connected devices\"],\n",
    "    \"nni insulins\": [\"nni insulins\"],\n",
    "    \"inpen\": [\"inpen\"],\n",
    "    \"humapen luxura\": [\"humapen luxura\"],\n",
    "    \"compound\": [\"compound\"],\n",
    "    \"carnitine\": [\"carnitine\"],\n",
    "    \"b12\": [\"b12\"],\n",
    "    \"chf\": [\"chf\"],\n",
    "    \"congestive\": [\"congestive\"],\n",
    "    \"devote\": [\"devote\"],\n",
    "    \"dialoq\": [\"dialoq\"],\n",
    "    \"connected\": [\"connected\"],\n",
    "    \"smart\": [\"smart\"],\n",
    "    \"device\": [\"device\"],\n",
    "    \"attachment\": [\"attachment\"],\n",
    "    \"pen\": [\"pen\"],\n",
    "    \"novopen 6\": [\"novopen 6\"],\n",
    "    \"novopen echo plus\": [\"novopen echo plus\"],\n",
    "    \"continuous\": [\"continuous\"],\n",
    "    \"ci\": [\"ci\"],\n",
    "    \"pump\": [\"pump\"],\n",
    "    \"cost\": [\"cost\"],\n",
    "    \"price\": [\"price\"],\n",
    "    \"coverage\": [\"coverage\"],\n",
    "    \"cost price\": [\"cost price\"],\n",
    "    \"formulary\": [\"formulary\"],\n",
    "    \"savings\": [\"savings\"],\n",
    "    \"copay\": [\"copay\"],\n",
    "    \"insurance\": [\"insurance\"],\n",
    "    \"pricing\": [\"pricing\"],\n",
    "    \"confirm\": [\"confirm\"],\n",
    "    \"rwe\": [\"rwe\"],\n",
    "    \"world\": [\"world\"],\n",
    "    \"dual studies\": [\"dual studies\"],\n",
    "    \"insulin degludec\": [\"insulin degludec\"],\n",
    "    \"faster aspart\": [\"faster aspart\"],\n",
    "    \"onset studies\": [\"onset studies\"],\n",
    "    \"aace\": [\"aace\"],\n",
    "    \"ace\": [\"ace\"],\n",
    "    \"guidelines\": [\"guidelines\"],\n",
    "    \"ada\": [\"ada\"],\n",
    "    \"standards of care\": [\"standards of care\"],\n",
    "    \"ellipse\": [\"ellipse\"],\n",
    "    \"children\": [\"children\"],\n",
    "    \"lead-1\": [\"lead-1\"],\n",
    "    \"rosiglitazone\": [\"rosiglitazone\"],\n",
    "    \"lead-2\": [\"lead-2\"],\n",
    "    \"lead-3\": [\"lead-3\"],\n",
    "    \"lead-4\": [\"lead-4\"],\n",
    "    \"lead-5\": [\"lead-5\"],\n",
    "    \"lead-6\": [\"lead-6\"],\n",
    "    \"switch\": [\"switch\"],\n",
    "    \"1860\": [\"1860\"],\n",
    "    \"pratley\": [\"pratley\"],\n",
    "    \"52-week data\": [\"52-week data\"],\n",
    "    \"vs januvia\": [\"vs januvia\"],\n",
    "    \"cover\": [\"cover\"],\n",
    "    \"wfh guidelines\": [\"wfh guidelines\"],\n",
    "    \"hemophilia\": [\"hemophilia\"],\n",
    "    \"3rd edition\": [\"3rd edition\"],\n",
    "    \"esperoct \\namcp dossier\": [\"esperoct \\namcp dossier\"],\n",
    "    \"conclude\": [\"conclude\"],\n",
    "    \"hypo\": [\"hypo\"],\n",
    "    \"u300\": [\"u300\"],\n",
    "    \"excursion\": [\"excursion\"],\n",
    "    \"kapitza\": [\"kapitza\"],\n",
    "    \"response\": [\"response\"],\n",
    "    \"poster\": [\"poster\"],\n",
    "    \"phase 2\": [\"phase 2\"],\n",
    "    \"o'neil\": [\"o'neil\"],\n",
    "    \"dose-finding\": [\"dose-finding\",\"dose finding\"],\n",
    "    \"dose-ranging\": [\"dose-ranging\",\"dose ranging\"],\n",
    "    \"exposure\": [\"exposure\"],\n",
    "    \"pharmacokinetic\": [\"pharmacokinetic\"],\n",
    "    \"dose-response\": [\"dose-response\"],\n",
    "    \"sustain\": [\"sustain\"],\n",
    "    \"gilead\": [\"gilead\"],\n",
    "    \"cilofexor\": [\"cilofexor\"],\n",
    "    \"firsocostat\": [\"firsocostat\"],\n",
    "    \"2022\": [\"2022\"],\n",
    "    \"nash\": [\"nash\"],\n",
    "    \"nafld\": [\"nafld\"],\n",
    "    \"non-alcoholic\": [\"non-alcoholic\"],\n",
    "    \"steatohepatitis\": [\"steatohepatitis\"],\n",
    "    \"fatty liver\": [\"fatty liver\"],\n",
    "    \"scale\": [\"scale\"],\n",
    "    \"real 1\": [\"real 1\"],\n",
    "    \"treatment-naive\": [\"treatment-naive\"],\n",
    "    \"sogroya\": [\"sogroya\"],\n",
    "    \"aghd\": [\"aghd\"],\n",
    "    \"real 4\": [\"real 4\"],\n",
    "    \"ghd\": [\"ghd\"],\n",
    "    \"pediatric ghd\": [\"pediatric ghd\"],\n",
    "    \"weekly\": [\"weekly\"],\n",
    "    \"pivotal\": [\"pivotal\"],\n",
    "    \"ibt\": [\"ibt\",\"intensive behavior therapy\"],\n",
    "    \"cms\": [\"cms\"],\n",
    "    \"phase 3b\": [\"phase 3b\"],\n",
    "    \"step 5\": [\"step 5\"],\n",
    "    \"long term\": [\"long term\"],\n",
    "    \"2 year\": [\"2 year\"],\n",
    "    \"104 weeks\": [\"104 weeks\"],\n",
    "    \"sustained\": [\"sustained\"],\n",
    "    \"step 8\": [\"step 8\"],\n",
    "    \"monotherapy\": [\"monotherapy\"],\n",
    "    \"sustain 10\": [\"sustain 10\"],\n",
    "    \"sustain 2\": [\"sustain 2\"],\n",
    "    \"sustain 3\": [\"sustain 3\"],\n",
    "    \"glp-1 ra\": [\"glp-1 ra\"],\n",
    "    \"sglt-2; canagliflozin\": [\"sglt-2; canagliflozin\"],\n",
    "    \"invokana\": [\"invokana\"],\n",
    "    \"sglt-2\": [\"sglt-2\"],\n",
    "    \"add\": [\"add\"],\n",
    "    \"sustain 9\": [\"sustain 9\"],\n",
    "    \"sustain forte\": [\"sustain forte\"],\n",
    "    \"forte\": [\"forte\"],\n",
    "    \"2\": [\"2\"],\n",
    "    \"2 mg\": [\"2 mg\"],\n",
    "    \"ozempic 2 mg\": [\"ozempic 2 mg\",\"ozempic 2mg\",\"ozempic 2\"],\n",
    "    \"semaglutide 2mg\": [\"semaglutide 2mg\",\"semaglutide 2 mg\"],\n",
    "    \"verma\": [\"verma\"],\n",
    "    \"established cvd\": [\"established cvd\"],\n",
    "    \"cv risk factors\": [\"cv risk factors\"],\n",
    "    \"rewind\": [\"rewind\"],\n",
    "    \"deg\": [\"deg\"],\n",
    "    \"begin\": [\"begin\"],\n",
    "    \"heller\": [\"heller\"],\n",
    "    \"bode\": [\"bode\"],\n",
    "    \"basal bolus\": [\"basal bolus\"],\n",
    "    \"davies\": [\"davies\"],\n",
    "    \"garber\": [\"garber\"],\n",
    "    \"hollander\": [\"hollander\"],\n",
    "    \"u100 vs u200\": [\"u100 vs u200\"],\n",
    "    \"flex\": [\"flex\"],\n",
    "    \"mathieu\": [\"mathieu\"],\n",
    "    \"meneghini\": [\"meneghini\"],\n",
    "    \"low volume\": [\"low volume\"],\n",
    "    \"gough\": [\"gough\"],\n",
    "    \"zinman\": [\"zinman\"],\n",
    "    \"rodbard\": [\"rodbard\"],\n",
    "    \"pediatric\": [\"pediatric\"],\n",
    "    \"ideglira\": [\"ideglira\"],\n",
    "    \"xultophy\": [\"xultophy\"],\n",
    "    \"dual i\": [\"dual i\"],\n",
    "    \"dual\": [\"dual\"],\n",
    "    \"dual ii\": [\"dual ii\"],\n",
    "    \"dual iii\": [\"dual iii\"],\n",
    "    \"dual iv\": [\"dual iv\"],\n",
    "    \"insulin naive\": [\"insulin naive\"],\n",
    "    \"9\": [\"9\"],\n",
    "    \"dual v\": [\"dual v\"],\n",
    "    \"dual ix\": [\"dual ix\"],\n",
    "    \"t2\": [\"t2\"],\n",
    "    \"diabetes\": [\"diabetes\"],\n",
    "    \"once\": [\"once\"],\n",
    "    \"twice\": [\"twice\"],\n",
    "    \"dual vii\": [\"dual vii\"],\n",
    "    \"durability\": [\"durability\"],\n",
    "    \"intensify\": [\"intensify\"],\n",
    "    \"intensification\": [\"intensification\"],\n",
    "    \"full\": [\"full\"],\n",
    "    \"publications\": [\"publications\"],\n",
    "    \"pubs\": [\"pubs\"],\n",
    "    \"pharmacodynamics\": [\"pharmacodynamics\"],\n",
    "    \"variability\": [\"variability\"],\n",
    "    \"iglar\": [\"iglar\"],\n",
    "    \"hypoglycemia\": [\"hypoglycemia\"],\n",
    "    \"meta-analysis\": [\"meta-analysis\"],\n",
    "    \"insulin glargine\": [\"insulin glargine\"],\n",
    "    \"lead 1-6\": [\"lead 1-6\"],\n",
    "    \"lead\": [\"lead\"],\n",
    "    \"postmeal\": [\"postmeal\"],\n",
    "    \"basal insulin\": [\"basal insulin\"],\n",
    "    \"insulin pump\": [\"insulin pump\"],\n",
    "    \"csii\": [\"csii\"],\n",
    "    \"onset 4\": [\"onset 4\"],\n",
    "    \"onset 5\": [\"onset 5\"],\n",
    "    \"insulin aspart\": [\"insulin aspart\"],\n",
    "    \"pioneer\": [\"pioneer\"],\n",
    "    \"pioneer 1\": [\"pioneer 1\",\"p1\"],\n",
    "    \"placebo\": [\"placebo\"],\n",
    "    \"pioneer 2\": [\"pioneer 2\",\"p2\"],\n",
    "    \"pioneer 3\": [\"pioneer 3\",\"p3\"],\n",
    "    \"pioneer 4\": [\"pioneer 4\",\"p4\"],\n",
    "    \"pioneer 5\": [\"pioneer 5\",\"p5\"],\n",
    "    \"renal\": [\"renal\"],\n",
    "    \"esrd\": [\"esrd\"],\n",
    "    \"dialysis\": [\"dialysis\"],\n",
    "    \"gfr\": [\"gfr\"],\n",
    "    \"pioneer 6\": [\"pioneer 6\",\"p6\"],\n",
    "    \"pioneer 7\": [\"pioneer 7\",\"p7\"],\n",
    "    \"flexible\": [\"flexible\"],\n",
    "    \"study 2\": [\"study 2\"],\n",
    "    \"study 3\": [\"study 3\"],\n",
    "    \"maintenance\": [\"maintenance\"],\n",
    "    \"study 1\": [\"study 1\"],\n",
    "    \"prediabetes\": [\"prediabetes\"],\n",
    "    \"3 years\": [\"3 years\"],\n",
    "    \"long-term\": [\"long-term\"],\n",
    "    \"sleep apnea\": [\"sleep apnea\"],\n",
    "    \"switch-2\": [\"switch-2\"],\n",
    "    \"custom\": [\"custom\"],\n",
    "    \"custom nash\": [\"custom nash\"],\n",
    "    \"custom letter\": [\"custom letter\"],\n",
    "    \"protamine\": [\"protamine\"],\n",
    "    \"mix 70/30\": [\"mix 70/30\"],\n",
    "    \"death\": [\"death\"],\n",
    "    \"indication\": [\"indication\"],\n",
    "    \"outcomes\": [\"outcomes\"],\n",
    "    \"thyroid\": [\"thyroid\"],\n",
    "    \"t3\": [\"t3\"],\n",
    "    \"t4\": [\"t4\"],\n",
    "    \"tsh\": [\"tsh\"],\n",
    "    \"demographic\": [\"demographic\"],\n",
    "    \"ethnicity\": [\"ethnicity\"],\n",
    "    \"race\": [\"race\"],\n",
    "    \"gender\": [\"gender\"],\n",
    "    \"age\": [\"age\"],\n",
    "    \"baseline\": [\"baseline\"],\n",
    "    \"sex\": [\"sex\"],\n",
    "    \"ethnic\": [\"ethnic\"],\n",
    "    \"female\": [\"female\"],\n",
    "    \"male\": [\"male\"],\n",
    "    \"year\": [\"year\"],\n",
    "    \"hispanic\": [\"hispanic\"],\n",
    "    \"latino\": [\"latino\"],\n",
    "    \"white\": [\"white\"],\n",
    "    \"black\": [\"black\"],\n",
    "    \"african\": [\"african\"],\n",
    "    \"asian\": [\"asian\"],\n",
    "    \"demo\": [\"demo\"],\n",
    "    \"pens\": [\"pens\"],\n",
    "    \"demonstration\": [\"demonstration\"],\n",
    "    \"psychiatric\": [\"psychiatric\"],\n",
    "    \"anxiety\": [\"anxiety\"],\n",
    "    \"depression\": [\"depression\"],\n",
    "    \"mood\": [\"mood\"],\n",
    "    \"devote cvd safety\": [\"devote cvd safety\"],\n",
    "    \"medications concomitant other devote\": [\"medications concomitant other devote\"],\n",
    "    \"alternative titration\": [\"alternative titration\"],\n",
    "    \"average dose\": [\"average dose\"],\n",
    "    \"titration devote\": [\"titration devote\"],\n",
    "    \"smbg\": [\"smbg\"],\n",
    "    \"smpg\": [\"smpg\"],\n",
    "    \"glucose\": [\"glucose\"],\n",
    "    \"monitor\": [\"monitoring\",\"monitor\"],\n",
    "    \"glycemic control\": [\"glycemic control\"],\n",
    "    \"devote blinding blinded\": [\"devote blinding blinded\"],\n",
    "    \"nocturnal\": [\"nocturnal\"],\n",
    "    \"severe\": [\"severe\"],\n",
    "    \"overall\": [\"overall\"],\n",
    "    \"nnt\": [\"nnt\"],\n",
    "    \"number needed to treat\": [\"number needed to treat\"],\n",
    "    \"cv benefit\": [\"cv benefit\"],\n",
    "    \"origin\": [\"origin\"],\n",
    "    \"dilute\": [\"dilute\",\"diluent\",\"dilution\",\"diluting\",\"dilutions\",\"dilutes\",\"diluents\",\"dilluting\"],\n",
    "    \"trissel's\": [\"trissel's\",\"trissel\"],\n",
    "    \"diluted\": [\"diluted\"],\n",
    "    \"compatible\": [\"compatible\"],\n",
    "    \"compatibility\": [\"compatibility\"],\n",
    "    \"disclaimer page\": [\"disclaimer page\",\"disclaimer\",\"disclaimer  page\"],\n",
    "    \"stop\": [\"stopping\",\"stop\"],\n",
    "    \"rule\": [\"rule\"],\n",
    "    \"degree\": [\"degree\"],\n",
    "    \"percentage\": [\"percentage\"],\n",
    "    \"d/c\": [\"d/c\"],\n",
    "    \"tolerability\": [\"tolerability\"],\n",
    "    \"efficacy\": [\"efficacy\"],\n",
    "    \"icd\": [\"icd\"],\n",
    "    \"employer\": [\"employer\"],\n",
    "    \"identification\": [\"identification\",\"id\"],\n",
    "    \"agents\": [\"agents\"],\n",
    "    \"medications\": [\"medications\"],\n",
    "    \"antihyperglycemic\": [\"antihyperglycemic\"],\n",
    "    \"class\": [\"class\",\"classes\"],\n",
    "    \"ominous\": [\"ominous\"],\n",
    "    \"octet\": [\"octet\"],\n",
    "    \"incretin\": [\"incretin\"],\n",
    "    \"sterilize\": [\"sterilize\"],\n",
    "    \"disinfect\": [\"disinfect\",\"disinfects\",\"disinfecting\"],\n",
    "    \"cleanse\": [\"cleanse\"],\n",
    "    \"germicide\": [\"germicide\"],\n",
    "    \"infection\": [\"infection\",\"infections\"],\n",
    "    \"sanitize\": [\"sanitize\"],\n",
    "    \"purify\": [\"purify\"],\n",
    "    \"decontaminate\": [\"decontaminate\",\"decontaminates\"],\n",
    "    \"sterilizes\": [\"sterilizes\"],\n",
    "    \"purifies\": [\"purifies\"],\n",
    "    \"sterilizing\": [\"sterilizing\"],\n",
    "    \"purifying\": [\"purifying\"],\n",
    "    \"clean\": [\"clean\"],\n",
    "    \"greater\": [\"greater\"],\n",
    "    \"max\": [\"max\"],\n",
    "    \"dose\": [\"dose\",\"doses\",\"dosing\"],\n",
    "    \"titrate\": [\"titrate\",\"titration\",\"titrations\",\"titrates\"],\n",
    "    \"initiate\": [\"initiate\"],\n",
    "    \"mg\": [\"mg\",\"milligram\",\"milligrams\"],\n",
    "    \"recommendation\": [\"recommendation\",\"recommendations\"],\n",
    "    \"dose escalation\": [\"dose escalation\"],\n",
    "    \"dose initiation\": [\"dose initiation\"],\n",
    "    \"escalation\": [\"escalation\"],\n",
    "    \"missed dose\": [\"missed dose\"],\n",
    "    \"dosing and administration\": [\"dosing and administration\"],\n",
    "    \"administration\": [\"administration\"],\n",
    "    \"stopping rule\": [\"stopping rule\"],\n",
    "    \"reinitiate\": [\"reinitiate\",\"reinitiation\",\"reinitiating\"],\n",
    "    \"naïve\": [\"naïve\"],\n",
    "    \"algorithim\": [\"algorithim\"],\n",
    "    \"initiates\": [\"initiates\"],\n",
    "    \"regimen\": [\"regimen\"],\n",
    "    \"transition\": [\"transition\"],\n",
    "    \"sliding\": [\"sliding\"],\n",
    "    \"carb\": [\"carb\"],\n",
    "    \"ratio\": [\"ratio\"],\n",
    "    \"supplemental\": [\"supplemental\"],\n",
    "    \"carbohydrate\": [\"carbohydrate\"],\n",
    "    \"count\": [\"count\",\"counting\"],\n",
    "    \"ss\": [\"ss\"],\n",
    "    \"average\": [\"average\"],\n",
    "    \"mean\": [\"mean\"],\n",
    "    \"fasted\": [\"fasted\"],\n",
    "    \"empty stomach\": [\"empty stomach\"],\n",
    "    \"qod\": [\"qod\"],\n",
    "    \"other\": [\"other\"],\n",
    "    \"fast\": [\"fast\",\"faster\"],\n",
    "    \"rapid\": [\"rapid\"],\n",
    "    \"convert\": [\"convert\",\"coverting\"],\n",
    "    \"switching\": [\"switching\"],\n",
    "    \"how to dose\": [\"how to dose\"],\n",
    "    \"unbranded\": [\"unbranded\"],\n",
    "    \"biologic\": [\"biologic\"],\n",
    "    \"guideline\": [\"guideline\"],\n",
    "    \"escalate\": [\"escalate\"],\n",
    "    \"missed\": [\"missed\"],\n",
    "    \"exercise\": [\"exercise\"],\n",
    "    \"physical activity\": [\"physical activity\"],\n",
    "    \"change\": [\"change\"],\n",
    "    \"vomit\": [\"vomit\"],\n",
    "    \"miss\": [\"miss\"],\n",
    "    \"vomiting\": [\"vomiting\"],\n",
    "    \"holiday\": [\"holiday\"],\n",
    "    \"preferred time\": [\"preferred time\"],\n",
    "    \"double\": [\"double\"],\n",
    "    \"qd\": [\"qd\"],\n",
    "    \"once-daily\": [\"once-daily\"],\n",
    "    \"daily\": [\"daily\"],\n",
    "    \"once-weekly\": [\"once-weekly\"],\n",
    "    \"qw\": [\"qw\"],\n",
    "    \"rationale\": [\"rationale\"],\n",
    "    \"halflife\": [\"halflife\",\"half-life\",\"half life\"],\n",
    "    \"steady-state\": [\"steady-state\",\"steady state\",\"steadystate\"],\n",
    "    \"split\": [\"split\",\"splitting\"],\n",
    "    \"divide\": [\"divide\",\"dividing\"],\n",
    "    \"tiw\": [\"tiw\"],\n",
    "    \"three\": [\"three\"],\n",
    "    \"3\": [\"3\"],\n",
    "    \"water\": [\"water\"],\n",
    "    \"ounce\": [\"ounce\"],\n",
    "    \"milliliter\": [\"milliliter\"],\n",
    "    \"liquid\": [\"liquid\"],\n",
    "    \"coffee\": [\"coffee\"],\n",
    "    \"milk\": [\"milk\"],\n",
    "    \"juice\": [\"juice\"],\n",
    "    \"tea\": [\"tea\"],\n",
    "    \"interactions\": [\"interactions\"],\n",
    "    \"ddi\": [\"ddi\"],\n",
    "    \"binding\": [\"binding\"],\n",
    "    \"cyp 450\": [\"cyp 450\"],\n",
    "    \"cytochrome\": [\"cytochrome\"],\n",
    "    \"semaglutide injection\": [\"semaglutide injection\"],\n",
    "    \"interaction\": [\"interaction\"],\n",
    "    \"di\": [\"di\"],\n",
    "    \"secretagogue\": [\"secretagogue\"],\n",
    "    \"drug-drug interaction\": [\"drug-drug interaction\",\"drug drug interaction\"],\n",
    "    \"wash out period\": [\"wash out period\"],\n",
    "    \"cyp\": [\"cyp\"],\n",
    "    \"length\": [\"length\"],\n",
    "    \"education\": [\"education\"],\n",
    "    \"charitable\": [\"charitable\"],\n",
    "    \"grant\": [\"grant\"],\n",
    "    \"discontinue\": [\"discontinue\"],\n",
    "    \"initial\": [\"initial\"],\n",
    "    \"old\": [\"old\"],\n",
    "    \"elderly\": [\"elderly\"],\n",
    "    \"geriatric\": [\"geriatric\"],\n",
    "    \"aged\": [\"aged\"],\n",
    "    \"older\": [\"older\"],\n",
    "    \"retired\": [\"retired\"],\n",
    "    \"frail\": [\"frail\"],\n",
    "    \"post-hoc\": [\"post-hoc\"],\n",
    "    \"65\": [\"65\"],\n",
    "    \"moa\": [\"moa\"],\n",
    "    \"mechanism\": [\"mechanism\"],\n",
    "    \"tfpi\": [\"tfpi\"],\n",
    "    \"anti-thrombin\": [\"anti-thrombin\"],\n",
    "    \"sirna\": [\"sirna\"],\n",
    "    \"serpin\": [\"serpin\"],\n",
    "    \"environment\": [\"environment\",\"environmental\"],\n",
    "    \"discard\": [\"discard\"],\n",
    "    \"recycle\": [\"recycle\"],\n",
    "    \"degradation\": [\"degradation\"],\n",
    "    \"dispose\": [\"dispose\",\"disposal\"],\n",
    "    \"biodegradeable\": [\"biodegradeable\"],\n",
    "    \"trash\": [\"trash\"],\n",
    "    \"ub\": [\"ub\"],\n",
    "    \"equivalent\": [\"equivalent\",\"equivalence\"],\n",
    "    \"substitute\": [\"substitute\",\"substitution\"],\n",
    "    \"purple book\": [\"purple book\"],\n",
    "    \"orange book\": [\"orange book\"],\n",
    "    \"biosimilar\": [\"biosimilar\"],\n",
    "    \"interchangeable\": [\"interchangeable\"],\n",
    "    \"amcp\": [\"amcp\"],\n",
    "    \"estimand\": [\"estimand\"],\n",
    "    \"primary\": [\"primary\"],\n",
    "    \"trial product\": [\"trial product\"],\n",
    "    \"treatment policy\": [\"treatment policy\"],\n",
    "    \"statistical analysis\": [\"statistical analysis\"],\n",
    "    \"statistics\": [\"statistics\"],\n",
    "    \"elad\": [\"elad\"],\n",
    "    \"aeorbic\": [\"aeorbic\"],\n",
    "    \"explorer\": [\"explorer\"],\n",
    "    \"explorer8\": [\"explorer8\"],\n",
    "    \"fvii\": [\"fvii\"],\n",
    "    \"factor vii deficiency\": [\"factor vii deficiency\"],\n",
    "    \"ster\": [\"ster\"],\n",
    "    \"semaglutide\": [\"semaglutide\"],\n",
    "    \"fpg\": [\"fpg\"],\n",
    "    \"preprandial\": [\"preprandial\"],\n",
    "    \"tandem pump\": [\"tandem pump\"],\n",
    "    \"medicaid\": [\"medicaid\"],\n",
    "    \"flextouch\": [\"flextouch\"],\n",
    "    \"prefilled\": [\"prefilled\"],\n",
    "    \"airshot\": [\"airshot\"],\n",
    "    \"prime\": [\"prime\",\"priming\"],\n",
    "    \"flow check\": [\"flow check\"],\n",
    "    \"shot\": [\"shot\"],\n",
    "    \"formulation\": [\"formulation\"],\n",
    "    \"ingredient\": [\"ingredient\",\"ingredients\"],\n",
    "    \"excipient\": [\"excipient\",\"excipients\"],\n",
    "    \"glycerol\": [\"glycerol\"],\n",
    "    \"phenol\": [\"phenol\"],\n",
    "    \"metacresol\": [\"metacresol\"],\n",
    "    \"zinc\": [\"zinc\"],\n",
    "    \"disodium\": [\"disodium\"],\n",
    "    \"phosphate\": [\"phosphate\"],\n",
    "    \"arginine\": [\"arginine\"],\n",
    "    \"l-arginine\": [\"l-arginine\"],\n",
    "    \"niacinamide\": [\"niacinamide\"],\n",
    "    \"b3\": [\"b3\"],\n",
    "    \"fasting plasma glucose\": [\"fasting plasma glucose\"],\n",
    "    \"correct\": [\"correct\"],\n",
    "    \"competitor\": [\"competitor\",\"competitiors\",\"competitors\"],\n",
    "    \"flexpen\": [\"flexpen\"],\n",
    "    \"features\": [\"features\"],\n",
    "    \"feature\": [\"feature\"],\n",
    "    \"difference\": [\"difference\",\"differences\"],\n",
    "    \"similarity\": [\"similarity\",\"similarities\"],\n",
    "    \"vial\": [\"vial\"],\n",
    "    \"syringe\": [\"syringe\"],\n",
    "    \"vials\": [\"vials\"],\n",
    "    \"syringes\": [\"syringes\"],\n",
    "    \"gallbladder\": [\"gallbladder\",\"gall-bladder\",\"gall bladder\"],\n",
    "    \"gallstone\": [\"gallstone\",\"gallstones\"],\n",
    "    \"cholelithiasis\": [\"cholelithiasis\"],\n",
    "    \"cholecystitis\": [\"cholecystitis\"],\n",
    "    \"cholecystectomy\": [\"cholecystectomy\"],\n",
    "    \"gallbladder disease\": [\"gallbladder disease\"],\n",
    "    \"gallbladder events\": [\"gallbladder events\"],\n",
    "    \"gall\": [\"gall\"],\n",
    "    \"gastroparesis\": [\"gastroparesis\"],\n",
    "    \"motility\": [\"motility\"],\n",
    "    \"gut\": [\"gut\"],\n",
    "    \"intestine\": [\"intestine\",\"intestinal\"],\n",
    "    \"delayed\": [\"delayed\"],\n",
    "    \"stomach\": [\"stomach\"],\n",
    "    \"gastric emptying\": [\"gastric emptying\"],\n",
    "    \"emptying\": [\"emptying\"],\n",
    "    \"durable\": [\"durable\"],\n",
    "    \"information\": [\"information\"],\n",
    "    \"nausea\": [\"nausea\"],\n",
    "    \"diarrhea\": [\"diarrhea\"],\n",
    "    \"constipation\": [\"constipation\"],\n",
    "    \"anti-emetic\": [\"anti-emetic\"],\n",
    "    \"emesis\": [\"emesis\"],\n",
    "    \"glucagon-like peptide-1\": [\"glucagon-like peptide-1\"],\n",
    "    \"level\": [\"level\",\"levels\"],\n",
    "    \"gluten\": [\"gluten\"],\n",
    "    \"food\": [\"food\"],\n",
    "    \"allergenicity\": [\"allergenicity\"],\n",
    "    \"content\": [\"content\"],\n",
    "    \"gluten-free\": [\"gluten-free\"],\n",
    "    \"sensitive\": [\"sensitive\"],\n",
    "    \"wheat\": [\"wheat\"],\n",
    "    \"celiac\": [\"celiac\",\"celiac's\",\"celiacs\"],\n",
    "    \"intolerant\": [\"intolerant\",\"intolerance\"],\n",
    "    \"a1c\": [\"a1c\"],\n",
    "    \"glycemic\": [\"glycemic\"],\n",
    "    \"hemoglobin\": [\"hemoglobin\"],\n",
    "    \"glycosylated\": [\"glycosylated\"],\n",
    "    \"glycated\": [\"glycated\"],\n",
    "    \"t2d\": [\"t2d\"],\n",
    "    \"doses under 2.4 mg\": [\"doses under 2.4 mg\"],\n",
    "    \"1.7 mg\": [\"1.7 mg\"],\n",
    "    \"plasma\": [\"plasma\"],\n",
    "    \"category\": [\"category\"],\n",
    "    \"hypoglycemic\": [\"hypoglycemic\"],\n",
    "    \"sus\": [\"sus\"],\n",
    "    \"oral antidiabetic medications\": [\"oral antidiabetic medications\"],\n",
    "    \"ppg\": [\"ppg\"],\n",
    "    \"hemoglobin a1c\": [\"hemoglobin a1c\"],\n",
    "    \"hcp\": [\"hcp\"],\n",
    "    \"additional information required\": [\"additional information required\"],\n",
    "    \"credentials\": [\"credentials\"],\n",
    "    \"clarify\": [\"clarify\"],\n",
    "    \"beat\": [\"beat\"],\n",
    "    \"tachycardia\": [\"tachycardia\"],\n",
    "    \"fibrillation\": [\"fibrillation\"],\n",
    "    \"racing\": [\"racing\"],\n",
    "    \"arrhythmia\": [\"arrhythmia\"],\n",
    "    \"ast\": [\"ast\"],\n",
    "    \"alt\": [\"alt\"],\n",
    "    \"asat\": [\"asat\"],\n",
    "    \"alat\": [\"alat\"],\n",
    "    \"hepatic\": [\"hepatic\"],\n",
    "    \"enzymes\": [\"enzymes\"],\n",
    "    \"liver aspartate\": [\"liver aspartate\"],\n",
    "    \"alanine\": [\"alanine\"],\n",
    "    \"aminotranferase\": [\"aminotranferase\"],\n",
    "    \"liver\": [\"liver\"],\n",
    "    \"impairment\": [\"impairment\"],\n",
    "    \"alanine aminotransferase\": [\"alanine aminotransferase\"],\n",
    "    \"aspartate aminotransferase\": [\"aspartate aminotransferase\"],\n",
    "    \"hepatic enzymes\": [\"hepatic enzymes\"],\n",
    "    \"cirrhotic\": [\"cirrhotic\"],\n",
    "    \"cirrhosis\": [\"cirrhosis\"],\n",
    "    \"child-pugh\": [\"child-pugh\"],\n",
    "    \"maximum\": [\"maximum\"],\n",
    "    \"highest\": [\"highest\"],\n",
    "    \"high\": [\"high\"],\n",
    "    \"triglyceride\": [\"triglyceride\"],\n",
    "    \"hypertriglyceridemia\": [\"hypertriglyceridemia\"],\n",
    "    \"triglycerides\": [\"triglycerides\"],\n",
    "    \"hyperlipidemia\": [\"hyperlipidemia\"],\n",
    "    \"hyperlipidaemia\": [\"hyperlipidaemia\"],\n",
    "    \"acute pancreatitis\": [\"acute pancreatitis\"],\n",
    "    \"chronic pancreatitis\": [\"chronic pancreatitis\"],\n",
    "    \"pancreatitis risk\": [\"pancreatitis risk\"],\n",
    "    \"high triglycerides\": [\"high triglycerides\"],\n",
    "    \"award 11\": [\"award 11\",\"award-11\"],\n",
    "    \"high-dose\": [\"high-dose\",\"high dose\"],\n",
    "    \"4.5\": [\"4.5\"],\n",
    "    \"hospital\": [\"hospital\",\"hospitals\"],\n",
    "    \"inpatient\": [\"inpatient\",\"inpatients\"],\n",
    "    \"npo\": [\"npo\"],\n",
    "    \"post-surgery\": [\"post-surgery\",\"post surgery\"],\n",
    "    \"post-op\": [\"post-op\"],\n",
    "    \"procedure\": [\"procedure\"],\n",
    "    \"colonoscopy\": [\"colonoscopy\"],\n",
    "    \"potassium\": [\"potassium\"],\n",
    "    \"hyperkalemia\": [\"hyperkalemia\"],\n",
    "    \"hypokalemia\": [\"hypokalemia\"],\n",
    "    \"hypoglycaemic\": [\"hypoglycaemic\"],\n",
    "    \"hypoglycaemia\": [\"hypoglycaemia\"],\n",
    "    \"nocturnal hypo\": [\"nocturnal hypo\"],\n",
    "    \"insulins\": [\"insulins\"],\n",
    "    \"u-300\": [\"u-300\"],\n",
    "    \"low blood sugar\": [\"low blood sugar\"],\n",
    "    \"sugar\": [\"sugar\"],\n",
    "    \"igf-1\": [\"igf-1\"],\n",
    "    \"affinity\": [\"affinity\"],\n",
    "    \"cutting\": [\"cutting\"],\n",
    "    \"crushing\": [\"crushing\"],\n",
    "    \"swallowing\": [\"swallowing\"],\n",
    "    \"tablets\": [\"tablets\"],\n",
    "    \"storage\": [\"storage\"],\n",
    "    \"refrigerator\": [\"refrigerator\",\"refrigeration\",\"refrigerate\",\"refrigerates\"],\n",
    "    \"room temperature\": [\"room temperature\"],\n",
    "    \"in-use\": [\"in-use\"],\n",
    "    \"inclusion criteria\": [\"inclusion criteria\"],\n",
    "    \"exclusion criteria\": [\"exclusion criteria\"],\n",
    "    \"inclusion\": [\"inclusion\"],\n",
    "    \"exclusion\": [\"exclusion\"],\n",
    "    \"leader\": [\"leader\"],\n",
    "    \"emp-reg outcome\": [\"emp-reg outcome\"],\n",
    "    \"control\": [\"control\"],\n",
    "    \"early\": [\"early\"],\n",
    "    \"hyperglycemia\": [\"hyperglycemia\"],\n",
    "    \"deltoid\": [\"deltoid\"],\n",
    "    \"arm\": [\"arm\"],\n",
    "    \"abdomen\": [\"abdomen\"],\n",
    "    \"thigh\": [\"thigh\"],\n",
    "    \"injection site\": [\"injection site\"],\n",
    "    \"chart\": [\"chart\"],\n",
    "    \"institutions\": [\"institutions\"],\n",
    "    \"long-term care\": [\"long-term care\"],\n",
    "    \"ltc\": [\"ltc\"],\n",
    "    \"backflow\": [\"backflow\"],\n",
    "    \"contamination\": [\"contamination\"],\n",
    "    \"pathogens\": [\"pathogens\"],\n",
    "    \"transmission\": [\"transmission\"],\n",
    "    \"blood-borne\": [\"blood-borne\"],\n",
    "    \"cresol\": [\"cresol\"],\n",
    "    \"preservative\": [\"preservative\",\"preservatives\"],\n",
    "    \"thimerosal\": [\"thimerosal\"],\n",
    "    \"buffer\": [\"buffer\"],\n",
    "    \"resistance\": [\"resistance\",\"resistant\"],\n",
    "    \"global\": [\"global\"],\n",
    "    \"foreign\": [\"foreign\"],\n",
    "    \"tissue factor\": [\"tissue factor\"],\n",
    "    \"investigational\": [\"investigational\"],\n",
    "    \"cagrisema dm\": [\"cagrisema dm\"],\n",
    "    \"cagrisema\": [\"cagrisema\"],\n",
    "    \"cagri\": [\"cagri\"],\n",
    "    \"cagrilintide\": [\"cagrilintide\"],\n",
    "    \"cagrilintide/semaglutide\": [\"cagrilintide/semaglutide\"],\n",
    "    \"icodec\": [\"icodec\"],\n",
    "    \"lai 287\": [\"lai 287\"],\n",
    "    \"development\": [\"development\"],\n",
    "    \"decitabine\": [\"decitabine\"],\n",
    "    \"tetrahydrouridine\": [\"tetrahydrouridine\"],\n",
    "    \"dec\": [\"dec\"],\n",
    "    \"thu\": [\"thu\"],\n",
    "    \"sickle cell\": [\"sickle cell\"],\n",
    "    \"scd\": [\"scd\"],\n",
    "    \"f4c\": [\"f4c\"],\n",
    "    \"fibrosis\": [\"fibrosis\"],\n",
    "    \"iss\": [\"iss\"],\n",
    "    \"intravenous\": [\"intravenous\"],\n",
    "    \"iv\": [\"iv\"],\n",
    "    \"perioperative\": [\"perioperative\"],\n",
    "    \"administer\": [\"administer\"],\n",
    "    \"adsorb\": [\"adsorb\",\"adsorption\"],\n",
    "    \"infusions\": [\"infusions\"],\n",
    "    \"administrate\": [\"administrate\",\"administrating\"],\n",
    "    \"lada\": [\"lada\"],\n",
    "    \"latent autoimmune diabetes in adults\": [\"latent autoimmune diabetes in adults\"],\n",
    "    \"type 1.5 diabetes\": [\"type 1.5 diabetes\"],\n",
    "    \"latent\": [\"latent\"],\n",
    "    \"1.5\": [\"1.5\"],\n",
    "    \"type 1.5\": [\"type 1.5\"],\n",
    "    \"latex\": [\"latex\"],\n",
    "    \"rubber\": [\"rubber\"],\n",
    "    \"allergen\": [\"allergen\"],\n",
    "    \"nonlatex\": [\"nonlatex\"],\n",
    "    \"polyisoprene\": [\"polyisoprene\"],\n",
    "    \"stopper\": [\"stopper\"],\n",
    "    \"biologics\": [\"biologics\"],\n",
    "    \"leader trial\": [\"leader trial\"],\n",
    "    \"cardiometabolic\": [\"cardiometabolic\"],\n",
    "    \"secondary\": [\"secondary\"],\n",
    "    \"prevention\": [\"prevention\"],\n",
    "    \"effect\": [\"effect\"],\n",
    "    \"retinopathy\": [\"retinopathy\"],\n",
    "    \"eye\": [\"eye\"],\n",
    "    \"drc\": [\"drc\"],\n",
    "    \"diabetic retinopathy complications\": [\"diabetic retinopathy complications\"],\n",
    "    \"diabetic retinopathy\": [\"diabetic retinopathy\"],\n",
    "    \"blindness\": [\"blindness\"],\n",
    "    \"blind\": [\"blind\"],\n",
    "    \"vitreous hemorrhage\": [\"vitreous hemorrhage\"],\n",
    "    \"retina\": [\"retina\"],\n",
    "    \"visual\": [\"visual\"],\n",
    "    \"microvascular\": [\"microvascular\"],\n",
    "    \"60\": [\"60\"],\n",
    "    \"risk factors\": [\"risk factors\"],\n",
    "    \"lifestyle\": [\"lifestyle\"],\n",
    "    \"diet\": [\"diet\"],\n",
    "    \"adherence\": [\"adherence\"],\n",
    "    \"lipids\": [\"lipids\"],\n",
    "    \"hdl\": [\"hdl\"],\n",
    "    \"ldl\": [\"ldl\"],\n",
    "    \"cholesterol\": [\"cholesterol\"],\n",
    "    \"lipid\": [\"lipid\"],\n",
    "    \"vldl\": [\"vldl\"],\n",
    "    \"ffa\": [\"ffa\"],\n",
    "    \"lipoprotein\": [\"lipoprotein\"],\n",
    "    \"fatty\": [\"fatty\"],\n",
    "    \"literature\": [\"literature\"],\n",
    "    \"search\": [\"search\"],\n",
    "    \"literature search\": [\"literature search\",\"lit search\",\"literature  search\"],\n",
    "    \"long\": [\"long\"],\n",
    "    \"term\": [\"term\"],\n",
    "    \"longterm\": [\"longterm\",\"long term\",\"long-term\"],\n",
    "    \"long-term use\": [\"long-term use\"],\n",
    "    \"scale obesity and prediabetes\": [\"scale obesity and prediabetes\"],\n",
    "    \"longest\": [\"longest\",\"long\",\"longer\"],\n",
    "    \"time\": [\"time\"],\n",
    "    \"attack\": [\"attack\"],\n",
    "    \"management\": [\"management\"],\n",
    "    \"snac\": [\"snac\"],\n",
    "    \"sodium n-[8-(2-hydroxybenzoyl) aminocaprilate]\": [\n",
    "        \"sodium n-[8-(2-hydroxybenzoyl) aminocaprilate]\"\n",
    "    ],\n",
    "    \"sodium n-(8-[2-hydroxybenzoyl] aminocaprilate)\": [\n",
    "        \"sodium n-(8-[2-hydroxybenzoyl] aminocaprilate)\"\n",
    "    ],\n",
    "    \"mechanism of action\": [\"mechanism of action\"],\n",
    "    \"action\": [\"action\"],\n",
    "    \"protraction\": [\"protraction\"],\n",
    "    \"mop\": [\"mop\"],\n",
    "    \"edema\": [\"edema\",\"edematous\"],\n",
    "    \"swelling\": [\"swelling\",\"swollen\"],\n",
    "    \"pitting\": [\"pitting\"],\n",
    "    \"heart rate increase\": [\"heart rate increase\"],\n",
    "    \"protract\": [\"protract\"],\n",
    "    \"weight\": [\"weight\"],\n",
    "    \"pound\": [\"pound\"],\n",
    "    \"kilogram\": [\"kilogram\"],\n",
    "    \"hunger\": [\"hunger\"],\n",
    "    \"appetite\": [\"appetite\"],\n",
    "    \"craving\": [\"craving\"],\n",
    "    \"preference\": [\"preference\"],\n",
    "    \"satiety\": [\"satiety\"],\n",
    "    \"multihexamer\": [\"multihexamer\"],\n",
    "    \"hexamer\": [\"hexamer\"],\n",
    "    \"monomer\": [\"monomer\"],\n",
    "    \"albumin-binding\": [\"albumin-binding\"],\n",
    "    \"long-acting growth hormone\": [\"long-acting growth hormone\"],\n",
    "    \"somapacitan-beco\": [\"somapacitan-beco\"],\n",
    "    \"omeprazole\": [\"omeprazole\"],\n",
    "    \"ppi\": [\"ppi\"],\n",
    "    \"bioavailability\": [\"bioavailability\"],\n",
    "    \"video\": [\"video\"],\n",
    "    \"pioneer 8\": [\"pioneer 8\"],\n",
    "    \"p8\": [\"p8\"],\n",
    "    \"pd\": [\"pd\"],\n",
    "    \"pharmacodynamic\": [\"pharmacodynamic\"],\n",
    "    \"tmax\": [\"tmax\"],\n",
    "    \"cmax\": [\"cmax\"],\n",
    "    \"menstrual\": [\"menstrual\",\"menstruation\"],\n",
    "    \"disruption\": [\"disruption\"],\n",
    "    \"disorder\": [\"disorder\"],\n",
    "    \"impact\": [\"impact\"],\n",
    "    \"metabolic syndrome\": [\"metabolic syndrome\"],\n",
    "    \"metabolize\": [\"metabolize\"],\n",
    "    \"eliminate\": [\"eliminate\"],\n",
    "    \"excrete\": [\"excrete\"],\n",
    "    \"mix\": [\"mix\",\"mixing\"],\n",
    "    \"neutral\": [\"neutral\"],\n",
    "    \"hagedorn\": [\"hagedorn\"],\n",
    "    \"mixture\": [\"mixture\",\"mixtures\"],\n",
    "    \"mtc\": [\"mtc\"],\n",
    "    \"men 2\": [\"men 2\"],\n",
    "    \"medullary thyroid carcinoma\": [\"medullary thyroid carcinoma\"],\n",
    "    \"multiple endocrine neoplasia type 2\": [\"multiple endocrine neoplasia type 2\"],\n",
    "    \"thyroid cancer\": [\"thyroid cancer\"],\n",
    "    \"glp-1 ras\": [\"glp-1 ras\"],\n",
    "    \"medullary\": [\"medullary\"],\n",
    "    \"calcitonin parafollicular\": [\"calcitonin parafollicular\"],\n",
    "    \"c-cell\": [\"c-cell\"],\n",
    "    \"hyperplasia\": [\"hyperplasia\"],\n",
    "    \"hepatosteatosis\": [\"hepatosteatosis\"],\n",
    "    \"non-alcoholic fatty liver disease\": [\"non-alcoholic fatty liver disease\"],\n",
    "    \"non-alcoholic steatohepatitis\": [\"non-alcoholic steatohepatitis\"],\n",
    "    \"fatty liver disease\":[\"fatty liver disease\"],\n",
    "    \"non-alcoholic fatty liver disease\": [\n",
    "        \"non-alcoholic fatty liver disease\"\n",
    "    ],\n",
    "    \"sema-nash\": [\"sema-nash\"],\n",
    "    \"aga\": [\"aga\"],\n",
    "    \"nafd/nash\": [\"nafd/nash\"],\n",
    "    \"meal\": [\"meal\"],\n",
    "    \"antiemetic\": [\"antiemetic\"],\n",
    "    \"nauseous\": [\"nauseous\"],\n",
    "    \"queasy\": [\"queasy\"],\n",
    "    \"versus truliticy\": [\"versus truliticy\"],\n",
    "    \"versus dulaglutide\": [\"versus dulaglutide\"],\n",
    "    \"compared to trulicity\": [\"compared to trulicity\"],\n",
    "    \"compared to dulaglutide\": [\"compared to dulaglutide\"],\n",
    "    \"versus exenatide\": [\"versus exenatide\"],\n",
    "    \"versus bydureon\": [\"versus bydureon\"],\n",
    "    \"compared to bydureon\": [\"compared to bydureon\"],\n",
    "    \"compared to exenatide\": [\"compared to exenatide\"],\n",
    "    \"nedosiran\": [\"nedosiran\"],\n",
    "    \"rnai\": [\"rnai\"],\n",
    "    \"dicerna\": [\"dicerna\"],\n",
    "    \"ph\": [\"ph\"],\n",
    "    \"primary hyperoxaluria\": [\"primary hyperoxaluria\"],\n",
    "    \"rare renal\": [\"rare renal\"],\n",
    "    \"hyperoxaluria\": [\"hyperoxaluria\"],\n",
    "    \"rna\": [\"rna\"],\n",
    "    \"neonates\": [\"neonates\"],\n",
    "    \"infant\": [\"infant\"],\n",
    "    \"carcinogenic\": [\"carcinogenic\"],\n",
    "    \"malignancy\": [\"malignancy\",\"malignancies\",\"malignant\"],\n",
    "    \"benign\": [\"benign\"],\n",
    "    \"pancreatic\": [\"pancreatic\"],\n",
    "    \"neuropsychiatric\": [\"neuropsychiatric\"],\n",
    "    \"suicide\": [\"suicide\",\"suicidal\"],\n",
    "    \"ideation\": [\"ideation\"],\n",
    "    \"insomnia\": [\"insomnia\"],\n",
    "    \"niosh\": [\"niosh\"],\n",
    "    \"hazardous\": [\"hazardous\"],\n",
    "    \"ndc\": [\"ndc\"],\n",
    "    \"insulin aspart protamine\": [\"insulin aspart protamine\"],\n",
    "    \"no data\": [\"no data\"],\n",
    "    \"no\": [\"no\"],\n",
    "    \"concizumab\": [\"concizumab\"],\n",
    "    \"pipeline\": [\"pipeline\"],\n",
    "    \"(not applicable)\": [\"(not applicable)\"],\n",
    "    \"lagh\": [\"lagh\"],\n",
    "    \"gh\": [\"gh\"],\n",
    "    \"growth hormone\": [\"growth hormone\"],\n",
    "    \"somapacitan\": [\"somapacitan\"],\n",
    "    \"clinical overview\": [\"clinical overview\"],\n",
    "    \"overfill\": [\"overfill\"],\n",
    "    \"flexpro\": [\"flexpro\"],\n",
    "    \"norditropin\": [\"norditropin\"],\n",
    "    \"4 pg\": [\"4 pg\"],\n",
    "    \"growth\": [\"growth\"],\n",
    "    \"skytrofa\": [\"skytrofa\"],\n",
    "    \"lonapegsomatropin-tcgd\": [\"lonapegsomatropin-tcgd\"],\n",
    "    \"affordability\": [\"affordability\"],\n",
    "    \"assistance\": [\"assistance\"],\n",
    "    \"coupon\": [\"coupon\"],\n",
    "    \"offerings\": [\"offerings\"],\n",
    "    \"options\": [\"options\"],\n",
    "    \"needles\": [\"needles\"],\n",
    "    \"fit\": [\"fit\"],\n",
    "    \"bd\": [\"bd\"],\n",
    "    \"fits\": [\"fits\"],\n",
    "    \"profile\": [\"profile\"],\n",
    "    \"number\": [\"number\"],\n",
    "    \"needed\": [\"needed\"],\n",
    "    \"treat\": [\"treat\"],\n",
    "    \"bid\": [\"bid\"],\n",
    "    \"tablet\": [\"tablet\"],\n",
    "    \"oasis\": [\"oasis\"],\n",
    "    \"overdose\": [\"overdose\",\"overdosage\"],\n",
    "    \"medication error\": [\"medication error\"],\n",
    "    \"accidental\": [\"accidental\"],\n",
    "    \"intentional\": [\"intentional\"],\n",
    "    \"amount\": [\"amount\"],\n",
    "    \"empty\": [\"empty\"],\n",
    "    \"excel\": [\"excel\"],\n",
    "    \"elixa\": [\"elixa\"],\n",
    "    \"harmony\": [\"harmony\"],\n",
    "    \"p&t\": [\"p&t\"],\n",
    "    \"pancreatic cancer\": [\"pancreatic cancer\"],\n",
    "    \"adenoma\": [\"adenoma\"],\n",
    "    \"pancreatic enzymes\": [\"pancreatic enzymes\"],\n",
    "    \"paradigm\": [\"paradigm\"],\n",
    "    \"7\": [\"7\"],\n",
    "    \"alprolix\": [\"alprolix\"],\n",
    "    \"rfixfc\": [\"rfixfc\"],\n",
    "    \"model\": [\"model\"],\n",
    "    \"novo nordisk\": [\"novo nordisk\"],\n",
    "    \"partner\": [\"partner\",\"partnering\"],\n",
    "    \"speaker\": [\"speaker\"],\n",
    "    \"presenter\": [\"presenter\"],\n",
    "    \"passover\": [\"passover\"],\n",
    "    \"kosher\": [\"kosher\"],\n",
    "    \"passover; kosher\": [\"passover; kosher\"],\n",
    "    \"corn\": [\"corn\"],\n",
    "    \"grain\": [\"grain\"],\n",
    "    \"pap\": [\"pap\"],\n",
    "    \"patient assistance\": [\"patient assistance\"],\n",
    "    \"pause\": [\"pause\"],\n",
    "    \"te\": [\"te\"],\n",
    "    \"thromb\": [\"thromb\"],\n",
    "    \"pcos\": [\"pcos\"],\n",
    "    \"polycystic\": [\"polycystic\"],\n",
    "    \"ovary\": [\"ovary\"],\n",
    "    \"syndrome\": [\"syndrome\"],\n",
    "    \"pcod\": [\"pcod\"],\n",
    "    \"ovarian\": [\"ovarian\"],\n",
    "    \"poly\": [\"poly\"],\n",
    "    \"polycystic ovary syndrome\": [\"polycystic ovary syndrome\"],\n",
    "    \"scale prediabetes and obesity\": [\"scale prediabetes and obesity\"],\n",
    "    \"pediatrics\": [\"pediatrics\"],\n",
    "    \"child\": [\"child\"],\n",
    "    \"kid\": [\"kid\",\"kids\"],\n",
    "    \"youth\": [\"youth\"],\n",
    "    \"peds\": [\"peds\"],\n",
    "    \"baby\": [\"baby\",\"babies\"],\n",
    "    \"neonate\": [\"neonate\",\"neonatal\"],\n",
    "    \"young\": [\"young\"],\n",
    "    \"click\": [\"click\",\"clicks\"],\n",
    "    \"flow\": [\"flow\"],\n",
    "    \"check\": [\"check\"],\n",
    "    \"pen overview\": [\"pen overview\"],\n",
    "    \"device overview\": [\"device overview\"],\n",
    "    \"unmarked dosing\": [\"unmarked dosing\"],\n",
    "    \"marked\": [\"marked\"],\n",
    "    \"unmarked\": [\"unmarked\"],\n",
    "    \"increment\": [\"increment\"],\n",
    "    \"dial\": [\"dial\"],\n",
    "    \"periop\": [\"periop\"],\n",
    "    \"major surgery\": [\"major surgery\"],\n",
    "    \"minor surgery\": [\"minor surgery\"],\n",
    "    \"pets\": [\"pets\"],\n",
    "    \"animals\": [\"animals\"],\n",
    "    \"cats\": [\"cats\"],\n",
    "    \"dogs\": [\"dogs\"],\n",
    "    \"glucose-dependant\": [\"glucose-dependant\"],\n",
    "    \"state\": [\"state\"],\n",
    "    \"4492\": [\"4492\"],\n",
    "    \"product information\": [\"product information\"],\n",
    "    \"package insert\": [\"package insert\"],\n",
    "    \"pilot\": [\"pilot\"],\n",
    "    \"airplane\": [\"airplane\"],\n",
    "    \"fly\": [\"fly\"],\n",
    "    \"aviation\": [\"aviation\"],\n",
    "    \"truck\": [\"truck\"],\n",
    "    \"drive\": [\"drive\",\"driving\"],\n",
    "    \"cdl\": [\"cdl\"],\n",
    "    \"commerce\": [\"commerce\"],\n",
    "    \"machinery\": [\"machinery\"],\n",
    "    \"empa-reg\": [\"empa-reg\"],\n",
    "    \"phase 3a\": [\"phase 3a\"],\n",
    "    \"onset\": [\"onset\"],\n",
    "    \"peak\": [\"peak\"],\n",
    "    \"bioequivalence\": [\"bioequivalence\",\"bioequivalent\"],\n",
    "    \"obese\": [\"obese\"],\n",
    "    \"spike\": [\"spike\"],\n",
    "    \"pk pd\": [\"pk pd\"],\n",
    "    \"therapy\": [\"therapy\"],\n",
    "    \"place\": [\"place\"],\n",
    "    \"place aace ada\": [\"place aace ada\"],\n",
    "    \"pneumatic\": [\"pneumatic\"],\n",
    "    \"transport\": [\"transport\"],\n",
    "    \"move\": [\"move\",\"moving\"],\n",
    "    \"send\": [\"send\",\"sending\"],\n",
    "    \"tube\": [\"tube\",\"tubes\"],\n",
    "    \"post-oad\": [\"post-oad\"],\n",
    "    \"post-oral\": [\"post-oral\"],\n",
    "    \"postprandial\": [\"postprandial\"],\n",
    "    \"after\": [\"after\"],\n",
    "    \"post-prandial\": [\"post-prandial\"],\n",
    "    \"post\": [\"post\"],\n",
    "    \"atherosclerotic\": [\"atherosclerotic\"],\n",
    "    \"atherosclerosis\": [\"atherosclerosis\"],\n",
    "    \"site\": [\"site\"],\n",
    "    \"investigator\": [\"investigator\"],\n",
    "    \"clinical trial site\": [\"clinical trial site\"],\n",
    "    \"pre-diabetes\": [\"pre-diabetes\",\"pre-diabetic\",\"prediabetic\"],\n",
    "    \"step 10\": [\"step 10\"],\n",
    "    \"predrawn\": [\"predrawn\"],\n",
    "    \"gdm\": [\"gdm\"],\n",
    "    \"gestational\": [\"gestational\"],\n",
    "    \"conception\": [\"conception\"],\n",
    "    \"congenital\": [\"congenital\"],\n",
    "    \"nursing\": [\"nursing\"],\n",
    "    \"birth\": [\"birth\"],\n",
    "    \"lactation\": [\"lactation\"],\n",
    "    \"breastfeeding\": [\"breastfeeding\",\"breastfeed\",\"breastfed\"],\n",
    "    \"maternal\": [\"maternal\"],\n",
    "    \"fetal\": [\"fetal\"],\n",
    "    \"fertile\": [\"fertile\",\"fertility\"],\n",
    "    \"teratogenicity\": [\"teratogenicity\"],\n",
    "    \"fetus\": [\"fetus\"],\n",
    "    \"press\": [\"press\"],\n",
    "    \"release\": [\"release\"],\n",
    "    \"product\": [\"product\"],\n",
    "    \"sample\": [\"sample\"],\n",
    "    \"request\": [\"request\"],\n",
    "    \"prophylaxis\": [\"prophylaxis\"],\n",
    "    \"prophy\": [\"prophy\"],\n",
    "    \"px\": [\"px\"],\n",
    "    \"inhibitors\": [\"inhibitors\"],\n",
    "    \"bypassing\": [\"bypassing\"],\n",
    "    \"ptc\": [\"ptc\"],\n",
    "    \"papillary\": [\"papillary\"],\n",
    "    \"follicular\": [\"follicular\"],\n",
    "    \"qt prolongation\": [\"qt prolongation\"],\n",
    "    \"ekg\": [\"ekg\"],\n",
    "    \"qtc\": [\"qtc\"],\n",
    "    \"thorough qt\": [\"thorough qt\"],\n",
    "    \"klaus\": [\"klaus\"],\n",
    "    \"lissy\": [\"lissy\"],\n",
    "    \"ramadan\": [\"ramadan\"],\n",
    "    \"fast\": [\"fast\"],\n",
    "    \"muslim\": [\"muslim\"],\n",
    "    \"islam\": [\"islam\"],\n",
    "    \"cv indication\": [\"cv indication\"],\n",
    "    \"cv risk reduction\": [\"cv risk reduction\"],\n",
    "    \"once daily\": [\"once daily\"],\n",
    "    \"week\": [\"week\"],\n",
    "    \"investigating\": [\"investigating\"],\n",
    "    \"produce\": [\"produce\"],\n",
    "    \"synthesize\": [\"synthesize\"],\n",
    "    \"production\": [\"production\"],\n",
    "    \"made\": [\"made\"],\n",
    "    \"make\": [\"make\"],\n",
    "    \"yeast\": [\"yeast\"],\n",
    "    \"saccharomyces\": [\"saccharomyces\"],\n",
    "    \"cerevisiae\": [\"cerevisiae\"],\n",
    "    \"manufacture\": [\"manufacture\"],\n",
    "    \"manufacturing\": [\"manufacturing\"],\n",
    "    \"dna\": [\"dna\"],\n",
    "    \"recombinant\": [\"recombinant\"],\n",
    "    \"gene\": [\"gene\"],\n",
    "    \"manufactures\": [\"manufactures\"],\n",
    "    \"treatment\": [\"treatment\"],\n",
    "    \"reconstitute\": [\"reconstitute\"],\n",
    "    \"reconstitution\": [\"reconstitution\"],\n",
    "    \"saline\": [\"saline\"],\n",
    "    \"histidine\": [\"histidine\"],\n",
    "    \"histidine diluent\": [\"histidine diluent\"],\n",
    "    \"swfi\": [\"swfi\"],\n",
    "    \"concentration\": [\"concentration\"],\n",
    "    \"redosing\": [\"redosing\"],\n",
    "    \"half\": [\"half\"],\n",
    "    \"regulatory\": [\"regulatory\"],\n",
    "    \"filing\": [\"filing\"],\n",
    "    \"submission\": [\"submission\"],\n",
    "    \"kidney\": [\"kidney\"],\n",
    "    \"egfr\": [\"egfr\"],\n",
    "    \"creatinine\": [\"creatinine\"],\n",
    "    \"clearance\": [\"clearance\"],\n",
    "    \"crcl\": [\"crcl\"],\n",
    "    \"nephrotic\": [\"nephrotic\"],\n",
    "    \"impair\": [\"impair\"],\n",
    "    \"end-stage\": [\"end-stage\"],\n",
    "    \"glomerular\": [\"glomerular\"],\n",
    "    \"transplant\": [\"transplant\"],\n",
    "    \"uar\": [\"uar\"],\n",
    "    \"scr\": [\"scr\"],\n",
    "    \"nephropathy\": [\"nephropathy\"],\n",
    "    \"renal progression\": [\"renal progression\"],\n",
    "    \"improvement of renal function\": [\"improvement of renal function\"],\n",
    "    \"microalbuminuria\": [\"microalbuminuria\"],\n",
    "    \"albuminuria\": [\"albuminuria\"],\n",
    "    \"macroalbuminuria\": [\"macroalbuminuria\"],\n",
    "    \"remodel\": [\"remodel\"],\n",
    "    \"educational\": [\"educational\"],\n",
    "    \"material\": [\"material\"],\n",
    "    \"inflammation\": [\"inflammation\"],\n",
    "    \"carter\": [\"carter\"],\n",
    "    \"supply\": [\"supply\"],\n",
    "    \"cold\": [\"cold\"],\n",
    "    \"va\": [\"va\"],\n",
    "    \"veterans\": [\"veterans\"],\n",
    "    \"affairs\": [\"affairs\"],\n",
    "    \"shipping\": [\"shipping\"],\n",
    "    \"transit\": [\"transit\"],\n",
    "    \"temperature\": [\"temperature\"],\n",
    "    \"dr\": [\"dr\"],\n",
    "    \"retinal\": [\"retinal\"],\n",
    "    \"reversal\": [\"reversal\"],\n",
    "    \"fxa\": [\"fxa\",\"factor xa\"],\n",
    "    \"doac\": [\"doac\"],\n",
    "    \"anticoagulant\": [\"anticoagulant\"],\n",
    "    \"apixaban\": [\"apixaban\"],\n",
    "    \"edoxaban\": [\"edoxaban\"],\n",
    "    \"rivaroxaban\": [\"rivaroxaban\"],\n",
    "    \"pcc\": [\"pcc\"],\n",
    "    \"rfviia\": [\"rfviia\"],\n",
    "    \"blister\": [\"blister\"],\n",
    "    \"bottle\": [\"bottle\"],\n",
    "    \"new packaging\": [\"new packaging\"],\n",
    "    \"blue cap\": [\"blue cap\"],\n",
    "    \"desiccant\": [\"desiccant\"],\n",
    "    \"soul\": [\"soul\"],\n",
    "    \"cardiovascular outcomes\": [\"cardiovascular outcomes\"],\n",
    "    \"ongoing\": [\"ongoing\"],\n",
    "    \"rybelsus\": [\"rybelsus\"],\n",
    "    \"semglutide\": [\"semglutide\"],\n",
    "    \"additives\": [\"additives\"],\n",
    "    \"glucagon-like peptide\": [\"glucagon-like peptide\"],\n",
    "    \"glutide\": [\"glutide\"],\n",
    "    \"sharing\": [\"sharing\"],\n",
    "    \"share\": [\"share\",\"shares\"],\n",
    "    \"microbial\": [\"microbial\"],\n",
    "    \"pathogen\": [\"pathogen\"],\n",
    "    \"transmit\": [\"transmit\"],\n",
    "    \"transmists\": [\"transmists\"],\n",
    "    \"sick\": [\"sick\"],\n",
    "    \"sliding scale\": [\"sliding scale\"],\n",
    "    \"ssi\": [\"ssi\"],\n",
    "    \"sodium n-(8-(2-hydroxybenzoyl) amino) caprylate\": [\n",
    "        \"sodium n-(8-(2-hydroxybenzoyl) amino) caprylate\"\n",
    "    ],\n",
    "    \"stack\": [\"stack\",\"stacking\"],\n",
    "    \"accumulate\": [\"accumulate\",\"accumulation\",\"accumulates\"],\n",
    "    \"status\": [\"status\"],\n",
    "    \"overweight\": [\"overweight\"],\n",
    "    \"expiration\": [\"expiration\"],\n",
    "    \"fridge\": [\"fridge\"],\n",
    "    \"frozen\": [\"frozen\"],\n",
    "    \"freeze\": [\"freeze\"],\n",
    "    \"heat\": [\"heat\"],\n",
    "    \"hot\": [\"hot\"],\n",
    "    \"store\": [\"store\"],\n",
    "    \"temp\": [\"temp\"],\n",
    "    \"unopen\": [\"unopen\",\"unponed\"],\n",
    "    \"warm\": [\"warm\"],\n",
    "    \"room\": [\"room\"],\n",
    "    \"cool\": [\"cool\"],\n",
    "    \"stored\": [\"stored\"],\n",
    "    \"56\": [\"56\"],\n",
    "    \"use\": [\"use\"],\n",
    "    \"refrigerated\": [\"refrigerated\"],\n",
    "    \"expired\": [\"expired\"],\n",
    "    \"opened\": [\"opened\"],\n",
    "    \"n8gp\": [\"n8gp\"],\n",
    "    \"in vitro\": [\"in vitro\"],\n",
    "    \"handling\": [\"handling\"],\n",
    "    \"ship\": [\"ship\"],\n",
    "    \"ambient\": [\"ambient\"],\n",
    "    \"structure\": [\"structure\"],\n",
    "    \"potency\": [\"potency\"],\n",
    "    \"modifications\": [\"modify\",\"modification\",\"modifications\"],\n",
    "    \"higher doses\": [\"higher doses\"],\n",
    "    \"25 mg\": [\"25 mg\"],\n",
    "    \"50 mg\": [\"50 mg\"],\n",
    "    \"pioneer plus\": [\"pioneer plus\"],\n",
    "    \"novoseven\": [\"novoseven\"],\n",
    "    \"novoseven rt\": [\"novoseven rt\"],\n",
    "    \"subcutaneous\": [\"subcutaneous\"],\n",
    "    \"subcutaneous administration\": [\"subcutaneous administration\"],\n",
    "    \"shortage\": [\"shortage\"],\n",
    "    \"operation\": [\"operation\"],\n",
    "    \"pre-op\": [\"pre-op\"],\n",
    "    \"anesthesia\": [\"anesthesia\"],\n",
    "    \"failure\": [\"failure\"],\n",
    "    \"hospitalization\": [\"hospitalization\"],\n",
    "    \"nyha\": [\"nyha\"],\n",
    "    \"dose-dependent\": [\"dose-dependent\"],\n",
    "    \"risk\": [\"risk\"],\n",
    "    \"switch 1\": [\"switch 1\"],\n",
    "    \"switch 2\": [\"switch 2\"],\n",
    "    \"characteristics\": [\"characteristics\"],\n",
    "    \"arr\": [\"arr\"],\n",
    "    \"morning\": [\"morning\"],\n",
    "    \"evening\": [\"evening\"],\n",
    "    \"postprandial glucose\": [\"postprandial glucose\"],\n",
    "    \"conversion\": [\"conversion\"],\n",
    "    \"transition\": [\"transitioning\",\"transition\",\"transitions\"],\n",
    "    \"switches\": [\"switches\"],\n",
    "    \"converts\": [\"converts\"],\n",
    "    \"basal-bolus\": [\"basal-bolus\"],\n",
    "    \"basal-bolus glp1\": [\"basal-bolus glp1\"],\n",
    "    \"glp1-ra\": [\"glp1-ra\",\"glp1ra\",\"glp-1ra\"],\n",
    "    \"gpl1\": [\"gpl1\"],\n",
    "    \"daily gh\": [\"daily gh\"],\n",
    "    \"mean doses\": [\"mean doses\"],\n",
    "    \"pk/pd\": [\"pk/pd\"],\n",
    "    \"igf-i\": [\"igf-i\"],\n",
    "    \"somatropin\": [\"somatropin\"],\n",
    "    \"lorcaserin\": [\"lorcaserin\"],\n",
    "    \"belviq\": [\"belviq\"],\n",
    "    \"premix\": [\"premix\"],\n",
    "    \"glucagon-like\": [\"glucagon-like\"],\n",
    "    \"conversion. liraglutide\": [\"conversion. liraglutide\"],\n",
    "    \"anti-obesity medication\": [\"anti-obesity medication\"],\n",
    "    \"glp\": [\"glp\"],\n",
    "    \"dose conversion\": [\"dose conversion\"],\n",
    "    \"soliqua\": [\"soliqua\"],\n",
    "    \"100/33\": [\"100/33\"],\n",
    "    \"lixilan\": [\"lixilan\"],\n",
    "    \"suggestion\": [\"suggestion\"],\n",
    "    \"hypothyroidism\": [\"hypothyroidism\"],\n",
    "    \"hyperthyroidism\": [\"hyperthyroidism\"],\n",
    "    \"goiter\": [\"goiter\"],\n",
    "    \"nodules\": [\"nodules\"],\n",
    "    \"thyroidectomy\": [\"thyroidectomy\"],\n",
    "    \"papillary thyroid carcinoma\": [\"papillary thyroid carcinoma\"],\n",
    "    \"men2\": [\"men2\"],\n",
    "    \"multiple endocrine neoplasia syndrome type 2\": [\n",
    "        \"multiple endocrine neoplasia syndrome type 2\"\n",
    "    ],\n",
    "    \"nodule\": [\"nodule\"],\n",
    "    \"hypothyroid\": [\"hypothyroid\"],\n",
    "    \"thyroid conditions\": [\"thyroid conditions\"],\n",
    "    \"pre-existing thyroid conditions\": [\"pre-existing thyroid conditions\"],\n",
    "    \"thyroid follicular tissue\": [\"thyroid follicular tissue\"],\n",
    "    \"thyroid gland\": [\"thyroid gland\"],\n",
    "    \"thyroid hormones\": [\"thyroid hormones\"],\n",
    "    \"men\": [\"men\"],\n",
    "    \"neoplasia\": [\"neoplasia\"],\n",
    "    \"thyroid neoplasms\": [\"thyroid neoplasms\"],\n",
    "    \"calcitonin\": [\"calcitonin\"],\n",
    "    \"follicular thyroid cancer\": [\"follicular thyroid cancer\"],\n",
    "    \"ftc\": [\"ftc\"],\n",
    "    \"tid\": [\"tid\"],\n",
    "    \"timing\": [\"timing\"],\n",
    "    \"pks\": [\"pks\"],\n",
    "    \"pds\": [\"pds\"],\n",
    "    \"time of dosing comparison\": [\"time of dosing comparison\"],\n",
    "    \"sunshine\": [\"sunshine\"],\n",
    "    \"act\": [\"act\"],\n",
    "    \"transparency\": [\"transparency\"],\n",
    "    \"payments\": [\"payments\"],\n",
    "    \"solid organ transplant\": [\"solid organ transplant\"],\n",
    "    \"kidney transplant\": [\"kidney transplant\"],\n",
    "    \"liver transplant\": [\"liver transplant\"],\n",
    "    \"transplant eligibility\": [\"transplant eligibility\"],\n",
    "    \"qualify for transplant\": [\"qualify for transplant\"],\n",
    "    \"treat-to-target\": [\"treat-to-target\"],\n",
    "    \"type 1\": [\"type 1\",\"type-1\",\"type1\",\"typei\",\"type i\",\"type-i\"],\n",
    "    \"t1d\": [\"t1d\",\"t1dm\",\"tidm\",\"type 1 diabetes\"],\n",
    "    \"t1dm\":[\"t1dm\",\"tidm\",\"type 1 diabetes mellitus\"],\n",
    "    \"off-label\": [\"off-label\"],\n",
    "    \"u500\": [\"u500\",\"u-500\",\"u 500\"],\n",
    "    \"500\": [\"500\"],\n",
    "    \"concentrated\": [\"concentrated\"],\n",
    "    \"500u/ml\": [\"500u/ml\"],\n",
    "    \"contact\": [\"contact\"],\n",
    "    \"reach\": [\"reach\"],\n",
    "    \"mentor\": [\"mentor\"],\n",
    "    \"coronavirus\": [\"coronavirus\"],\n",
    "    \"covid-19\": [\"covid-19\"],\n",
    "    \"covid\": [\"covid\"],\n",
    "    \"coagulopathy\": [\"coagulopathy\"],\n",
    "    \"injections\": [\"injections\"],\n",
    "    \"0.5\": [\"0.5\"],\n",
    "    \"past\": [\"past\"],\n",
    "    \"variation\": [\"variation\"],\n",
    "    \"meal-time\": [\"meal-time\"],\n",
    "    \"duration-6\": [\"duration-6\"],\n",
    "    \"75/25\": [\"75/25\"],\n",
    "    \"70/30\": [\"70/30\"],\n",
    "    \"human\": [\"human\"],\n",
    "    \"novolin\": [\"novolin\"],\n",
    "    \"rhi\": [\"rhi\"],\n",
    "    \"humulin\": [\"humulin\"],\n",
    "    \"regular\": [\"regular\"],\n",
    "    \"xultophy 100/3.6\": [\"xultophy 100/3.6\"],\n",
    "    \"mounjaro\": [\"mounjaro\"],\n",
    "    \"surpass\": [\"surpass\"],\n",
    "    \"gip\": [\"gip\"],\n",
    "    \"lomaira\": [\"lomaira\"],\n",
    "    \"eli\": [\"eli\"],\n",
    "    \"gate\": [\"gate\"],\n",
    "    \"genentech\": [\"genentech\"],\n",
    "    \"genotropin\": [\"genotropin\"],\n",
    "    \"humatrope\": [\"humatrope\"],\n",
    "    \"lilly\": [\"lilly\"],\n",
    "    \"nutropin\": [\"nutropin\"],\n",
    "    \"omnitrope\": [\"omnitrope\"],\n",
    "    \"pfizer\": [\"pfizer\"],\n",
    "    \"protropin\": [\"protropin\"],\n",
    "    \"saizen\": [\"saizen\"],\n",
    "    \"sandoz\": [\"sandoz\"],\n",
    "    \"serono\": [\"serono\"],\n",
    "    \"serostim\": [\"serostim\"],\n",
    "    \"tev-tropin\": [\"tev-tropin\"],\n",
    "    \"zorbtive\": [\"zorbtive\"],\n",
    "    \"valtropin\": [\"valtropin\"],\n",
    "    \"semaglutide sq\": [\"semaglutide sq\"],\n",
    "    \"semaglutide sc\": [\"semaglutide sc\"],\n",
    "    \"semaglutide subcutaneous\": [\"semaglutide subcutaneous\"],\n",
    "    \"semaglutide comparison\": [\"semaglutide comparison\"],\n",
    "    \"2.0 mg\": [\"2.0 mg\"],\n",
    "    \"actrapid\": [\"actrapid\"],\n",
    "    \"sevenfact\": [\"sevenfact\"],\n",
    "    \"factor viia\": [\"factor viia\"],\n",
    "    \"surmount\": [\"surmount\"],\n",
    "    \"tirzepatide\": [\"tirzepatide\"],\n",
    "    \"award-6\": [\"award-6\"],\n",
    "    \"award\": [\"award\"],\n",
    "    \"admelog\": [\"admelog\"],\n",
    "    \"afrezza\": [\"afrezza\"],\n",
    "    \"inhaled\": [\"inhaled\"],\n",
    "    \"inhale\": [\"inhale\"],\n",
    "    \"aabc\": [\"aabc\"],\n",
    "    \"fiasp vs novolog\": [\"fiasp vs novolog\"],\n",
    "    \"aspart comparison\": [\"aspart comparison\"],\n",
    "    \"junior\": [\"junior\"],\n",
    "    \"jr\": [\"jr\"],\n",
    "    \"stimulation\": [\"stimulation\"],\n",
    "    \"diagnosis\": [\"diagnosis\"],\n",
    "    \"tolerance\": [\"tolerance\"],\n",
    "    \"waist\": [\"waist\"],\n",
    "    \"inches\": [\"inches\"],\n",
    "    \"circumference\": [\"circumference\"],\n",
    "    \"bmi\": [\"bmi\"],\n",
    "    \"kg\": [\"kg\"],\n",
    "    \"lb\": [\"lb\"],\n",
    "    \"lbs\": [\"lbs\"],\n",
    "    \"1.7\": [\"1.7\"],\n",
    "    \"1.0\": [\"1.0\"],\n",
    "    \"regain\": [\"regain\"],\n",
    "    \"body weight\": [\"body weight\"],\n",
    "    \"body mass index\": [\"body mass index\"],\n",
    "    \"lower doses\": [\"lower doses\"],\n",
    "    \"weight reduction\": [\"weight reduction\"],\n",
    "    \"phase 2 dose-finding\": [\"phase 2 dose-finding\"],\n",
    "    \"scale diabetes\": [\"scale diabetes\"],\n",
    "    \"levemir vs tresiba\": [\"levemir vs tresiba\"],\n",
    "    \"glargine u-300\": [\"glargine u-300\"],\n",
    "    \"mechansim\": [\"mechansim\"],\n",
    "    \"theory\": [\"theory\"],\n",
    "    \"a1c comparison\": [\"a1c comparison\"],\n",
    "    \"reductions\": [\"reductions\"],\n",
    "    \"theories\": [\"theories\"],\n",
    "    \"withdrawal\": [\"withdrawal\"],\n",
    "    \"zn\": [\"zn\"],\n",
    "}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ccb1c37e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "provid ha a patient with type 2 diabet who wa diagnos with a benign tumor on the pancreas. she want to find out if we have ani studi that includ patient with the same condition, and is it safe to start them on ozempic?\n"
     ]
    }
   ],
   "source": [
    "import spacy\n",
    "import en_core_web_sm\n",
    "nlp = spacy.load(\"en_core_web_sm\")\n",
    "\n",
    "# def lemmatize_text(text):\n",
    "#     doc = nlp(text)\n",
    "#     lemmatized_text = \" \".join([token.lemma_ for token in doc])\n",
    "#     return lemmatized_text\n",
    "\n",
    "# text = \"Provider has a patient with type 2 diabetes who was diagnosed with a benign tumor on the pancreas. She wanted to find out if we have any studies that included patients with the same condition, and is it safe to start them on Ozempic?\"\n",
    "# lemmatized_text = lemmatize_text(text)\n",
    "# print(lemmatized_text)\n",
    "from textblob import Word\n",
    "\n",
    "def stem_text(text):\n",
    "    words = text.split()\n",
    "    stemmed_words = [Word(word).stem() for word in words]\n",
    "    stemmed_text = \" \".join(stemmed_words)\n",
    "    return stemmed_text\n",
    "\n",
    "text = \"Provider has a patient with type 2 diabetes who was diagnosed with a benign tumor on the pancreas. She wanted to find out if we have any studies that included patients with the same condition, and is it safe to start them on Ozempic?\"\n",
    "stemmed_text = stem_text(text)\n",
    "print(stemmed_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "b374fc8a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting textblob\n",
      "  Downloading textblob-0.17.1-py2.py3-none-any.whl (636 kB)\n",
      "     -------------------------------------- 636.8/636.8 kB 5.0 MB/s eta 0:00:00\n",
      "Requirement already satisfied: nltk>=3.1 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from textblob) (3.7)\n",
      "Requirement already satisfied: regex>=2021.8.3 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (2022.7.9)\n",
      "Requirement already satisfied: click in c:\\users\\owner\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (8.0.4)\n",
      "Requirement already satisfied: joblib in c:\\users\\owner\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (1.1.0)\n",
      "Requirement already satisfied: tqdm in c:\\users\\owner\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (4.64.1)\n",
      "Requirement already satisfied: colorama in c:\\users\\owner\\anaconda3\\lib\\site-packages (from click->nltk>=3.1->textblob) (0.4.6)\n",
      "Installing collected packages: textblob\n",
      "Successfully installed textblob-0.17.1\n"
     ]
    }
   ],
   "source": [
    "!pip install textblob"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "3f06c7e7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e63b75e58085462595ffff85ec2f0b95",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading https://raw.githubusercontent.com/stanfordnlp/stanza-resources/main/resources_1.5.0.json:   0%|   …"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-05 10:21:07 INFO: Downloading default packages for language: en (English) ...\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "396edeec765d4205b708eb3da780391f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading https://huggingface.co/stanfordnlp/stanza-en/resolve/v1.5.0/models/default.zip:   0%|          | 0…"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-05 10:23:23 INFO: Finished downloading models and saved to C:\\Users\\Owner\\stanza_resources.\n",
      "2023-06-05 10:23:23 INFO: Checking for updates to resources.json in case models have been updated.  Note: this behavior can be turned off with download_method=None or download_method=DownloadMethod.REUSE_RESOURCES\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0cb05b2eb331416391b10816d747c75c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading https://raw.githubusercontent.com/stanfordnlp/stanza-resources/main/resources_1.5.0.json:   0%|   …"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-05 10:23:24 WARNING: Can not find mwt: default from official model list. Ignoring it.\n",
      "2023-06-05 10:23:25 INFO: Loading these models for language: en (English):\n",
      "========================\n",
      "| Processor | Package  |\n",
      "------------------------\n",
      "| tokenize  | combined |\n",
      "| pos       | combined |\n",
      "| lemma     | combined |\n",
      "| depparse  | combined |\n",
      "========================\n",
      "\n",
      "2023-06-05 10:23:25 INFO: Using device: cpu\n",
      "2023-06-05 10:23:25 INFO: Loading: tokenize\n",
      "2023-06-05 10:23:25 INFO: Loading: pos\n",
      "2023-06-05 10:23:26 INFO: Loading: lemma\n",
      "2023-06-05 10:23:26 INFO: Loading: depparse\n",
      "2023-06-05 10:23:27 INFO: Done loading processors!\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "provider have a patient with type 2 diabete who be diagnose with a benign tumor on the pancrea . she want to find out if we have any study that include patient with the same condition , and be it safe to start they on Ozempic ?\n"
     ]
    }
   ],
   "source": [
    "import stanza\n",
    "\n",
    "def stem_text(text):\n",
    "    stanza.download('en')  # Download the English models\n",
    "\n",
    "    nlp = stanza.Pipeline(lang='en', processors='tokenize,mwt,pos,lemma,depparse')  # Initialize the pipeline\n",
    "\n",
    "    doc = nlp(text)\n",
    "    stemmed_text = ' '.join([word.lemma for sent in doc.sentences for word in sent.words])\n",
    "    return stemmed_text\n",
    "\n",
    "text = \"Provider has a patient with type 2 diabetes who was diagnosed with a benign tumor on the pancreas. She wanted to find out if we have any studies that included patients with the same condition, and is it safe to start them on Ozempic?\"\n",
    "stemmed_text = stem_text(text)\n",
    "print(stemmed_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "53b40943",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting stanza\n",
      "  Downloading stanza-1.5.0-py3-none-any.whl (802 kB)\n",
      "     -------------------------------------- 802.5/802.5 kB 4.6 MB/s eta 0:00:00\n",
      "Requirement already satisfied: tqdm in c:\\users\\owner\\anaconda3\\lib\\site-packages (from stanza) (4.64.1)\n",
      "Requirement already satisfied: requests in c:\\users\\owner\\anaconda3\\lib\\site-packages (from stanza) (2.28.1)\n",
      "Collecting emoji\n",
      "  Downloading emoji-2.4.0.tar.gz (353 kB)\n",
      "     -------------------------------------- 353.7/353.7 kB 5.5 MB/s eta 0:00:00\n",
      "  Preparing metadata (setup.py): started\n",
      "  Preparing metadata (setup.py): finished with status 'done'\n",
      "Requirement already satisfied: protobuf in c:\\users\\owner\\anaconda3\\lib\\site-packages (from stanza) (3.19.6)\n",
      "Requirement already satisfied: six in c:\\users\\owner\\anaconda3\\lib\\site-packages (from stanza) (1.16.0)\n",
      "Collecting torch>=1.3.0\n",
      "  Downloading torch-2.0.1-cp39-cp39-win_amd64.whl (172.4 MB)\n",
      "     -------------------------------------- 172.4/172.4 MB 2.9 MB/s eta 0:00:00\n",
      "Requirement already satisfied: numpy in c:\\users\\owner\\anaconda3\\lib\\site-packages (from stanza) (1.21.5)\n",
      "Requirement already satisfied: filelock in c:\\users\\owner\\anaconda3\\lib\\site-packages (from torch>=1.3.0->stanza) (3.6.0)\n",
      "Requirement already satisfied: sympy in c:\\users\\owner\\anaconda3\\lib\\site-packages (from torch>=1.3.0->stanza) (1.10.1)\n",
      "Requirement already satisfied: networkx in c:\\users\\owner\\anaconda3\\lib\\site-packages (from torch>=1.3.0->stanza) (2.8.4)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from torch>=1.3.0->stanza) (2.11.3)\n",
      "Requirement already satisfied: typing-extensions in c:\\users\\owner\\anaconda3\\lib\\site-packages (from torch>=1.3.0->stanza) (4.3.0)\n",
      "Requirement already satisfied: charset-normalizer<3,>=2 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from requests->stanza) (2.0.4)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from requests->stanza) (2022.9.14)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from requests->stanza) (3.3)\n",
      "Requirement already satisfied: urllib3<1.27,>=1.21.1 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from requests->stanza) (1.26.11)\n",
      "Requirement already satisfied: colorama in c:\\users\\owner\\anaconda3\\lib\\site-packages (from tqdm->stanza) (0.4.6)\n",
      "Requirement already satisfied: MarkupSafe>=0.23 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from jinja2->torch>=1.3.0->stanza) (2.0.1)\n",
      "Requirement already satisfied: mpmath>=0.19 in c:\\users\\owner\\anaconda3\\lib\\site-packages (from sympy->torch>=1.3.0->stanza) (1.2.1)\n",
      "Building wheels for collected packages: emoji\n",
      "  Building wheel for emoji (setup.py): started\n",
      "  Building wheel for emoji (setup.py): finished with status 'done'\n",
      "  Created wheel for emoji: filename=emoji-2.4.0-py2.py3-none-any.whl size=350810 sha256=969d732939157e7f697a04e7abe1e2f89669408633485ac5f8dfc8094f9d5b40\n",
      "  Stored in directory: c:\\users\\owner\\appdata\\local\\pip\\cache\\wheels\\d5\\c5\\45\\6c3b2e538c10e9667495d6bff243ee0a296c3c246478007df3\n",
      "Successfully built emoji\n",
      "Installing collected packages: emoji, torch, stanza\n",
      "Successfully installed emoji-2.4.0 stanza-1.5.0 torch-2.0.1\n"
     ]
    }
   ],
   "source": [
    "!pip install stanza"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3f5871c4",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
